PATENT ABSTRACT
Methods of preparing highly purified steviol glycosides, particularly rebaudiosides A, D and M are described. The methods include utilizing recombinant microorganisms for converting various staring compositions to target steviol glycosides. In addition, novel steviol glycosides reb D2 and reb M2 are disclosed, as are methods of preparing the same. The highly purified rebaudiosides are useful as non-caloric sweetener in edible and chewable compositions such as any beverages, confectioneries, bakery products, cookies, and chewing gums.

PATENT DESCRIPTION
RELATED APPLICATIONS 
     This application claims the benefit of priority from U.S. Provisional Application No. 61/827,922, filed on May 28, 2013, U.S. Provisional Application No. 61/843,544, filed on Jul. 8, 2013, U.S. Provisional Application No. 61/861,528, filed on Aug. 2, 2013, U.S. Provisional Application No. 61/881,166, filed on Sep. 23, 2013, U.S. Provisional Application No. 61/885,084, filed on Oct. 1, 2013, U.S. Provisional Application No. 61/904,751, filed on Nov. 15, 2013, U.S. Provisional Application No. 61/913,482, filed on Dec. 9, 2013, U.S. Provisional Application No. 61/921,635, filed on Dec. 30, 2013, U.S. Provisional Application No. 61/925,329, filed on Jan. 9, 2014, and U.S. Provisional Application No. 61/939,855, filed on Feb. 14, 2014. 
    
    
     TECHNICAL FIELD 
     The present invention relates to a biocatalytic process for preparing compositions comprising steviol glycosides, including highly purified steviol glycoside compositions. The present invention also relates to novel steviol glycosides, methods for isolation of the same and uses for the novel steviol glycosides. 
     BACKGROUND OF THE INVENTION 
     High intensity sweeteners possess a sweetness level that is many times greater than the sweetness level of sucrose. They are essentially non-caloric and are commonly used in diet and reduced-calorie products, including foods and beverages. High intensity sweeteners do not elicit a glycemic response, making them suitable for use in products targeted to diabetics and others interested in controlling for their intake of carbohydrates. 
     Steviol glycosides are a class of compounds found in the leaves of  Stevia rebaudiana  Bertoni, a perennial shrub of the Asteraceae (Compositae) family native to certain regions of South America. They are characterized structurally by a single base, steviol, differing by the presence of carbohydrate residues at positions C13 and C19. They accumulate in  Stevia  leaves, composing approximately 10%-20% of the total dry weight. On a dry weight basis, the four major glycosides found in the leaves of  Stevia  typically include stevioside (9.1%), rebaudioside A (3.8%), rebaudioside C (0.6-1.0%) and dulcoside A (0.3%). Other known steviol glycosides include rebaudioside B, C, D, E, F and M, steviolbioside and rubusoside. 
     Although methods are known for preparing steviol glycosides from  Stevia rebaudiana , many of these methods are unsuitable for use commercially. 
     Accordingly, there remains a need for simple, efficient, and economical methods for preparing compositions comprising steviol glycosides, including highly purified steviol glycoside compositions. 
     Additionally, there remains a need for novel steviol glycosides and methods of preparing and isolating the same. 
     SUMMARY OF THE INVENTION 
     The present invention provides a biocatalytic process for preparing a composition comprising a target steviol glycoside by contacting a starting composition comprising an organic substrate with a microorganism and/or biocatalyst, thereby producing a composition comprising a target steviol glycoside. 
     The starting composition can be any organic compound comprising at least one carbon atom. In one embodiment, the starting composition is selected from the group consisting of polyols or sugar alcohols, various carbohydrates. 
     The target steviol glycoside can be any steviol glycoside. In one embodiment, the target steviol glycoside is steviolmonoside, steviolbioside, rubusoside, dulcoside B, dulcoside A, rebaudioside B, rebaudioside G, stevioside, rebaudioside C, rebaudioside F, rebaudioside A, rebaudioside I, rebaudioside E, rebaudioside H, rebaudioside L, rebaudioside K, rebaudioside J, rebaudioside M, rebaudioside M2, rebaudioside D, rebaudioside D2, rebaudioside N, rebaudioside O or a synthetic steviol glycoside. 
     In one embodiment, the target steviol glycoside is stevioside. 
     In another embodiment, the target steviol glycoside is rebaudioside A. 
     In still another embodiment, the target steviol glycoside is rebaudioside D. 
     In yet another embodiment, the target steviol glycoside is rebaudioside M (also known as rebaudioside X). 
     The microorganism can be any microorganism possessing the necessary enzymes for converting the starting composition to target steviol glycosides. 
     The biocatalysts will comprise at least one enzyme for converting the starting composition to target steviol glycosides. 
     The biocatalysts can be located on the surface and/or inside the cell of the microorganism or can be secreted out of the microorganism. 
     The biocatalyst can be whole cell suspension, crude lysate or purified enzymes. 
     The biocatalyst can be in free form or immobilized to a solid support made from inorganic or organic materials. 
     The enzymes necessary for converting the starting composition to target steviol glycosides include the steviol biosynthesis enzymes, UDP-glycosyltransferases (UGTs) and/or UDP-recycling enzyme. 
     In one embodiment the steviol biosynthesis enzymes include mevalonate (MVA) pathway enzymes. 
     In another embodiment the steviol biosynthesis enzymes include non-mevalonate 2-C-methyl-D-erythritol-4-phosphate pathway (MEP/DOXP) enzymes. 
     In one embodiment the steviol biosynthesis enzymes are selected from the group including geranylgeranyl diphosphate synthase, copalyl diphosphate synthase, kaurene synthase, kaurene oxidase, kaurenoic acid 13-hydroxylase (KAH), steviol synthetase, deoxyxylulose 5-phosphate synthase (DXS), D-1-deoxyxylulose 5-phosphate reductoisomerase (DXR), 4-diphosphocytidyl-2-C-methyl-D-erythritol synthase (CMS), 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase (CMK), 4-diphosphocytidyl-2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase (MCS), 1-hydroxy-2-methyl-2(E)-butenyl 4-diphosphate synthase (HDS), 1-hydroxy-2-methyl-2(E)-butenyl 4-diphosphate reductase (HDR), acetoacetyl-CoA thiolase, truncated HMG-CoA reductase, mevalonate kinase, phosphomevalonate kinase, mevalonate pyrophosphate decarboxylase, cytochrome P450 reductase etc. 
     The UDP-glucosyltransferase can be any UDP-glucosyltransferase capable of adding at least one glucose unit to the steviol and or steviol glycoside substrate to provide the target steviol glycoside. 
     In one embodiment, steviol biosynthesis enzymes and UDP-glucosyltransferases are produced in a microorganism. The microorganism may be, for example,  E. coli, Saccharomyces  sp.,  Aspergillus  sp.,  Pichia  sp,  Bacillus  sp.,  Yarrowia  sp. etc. In another embodiment, the UDP-glucosyltransferases are synthesized. 
     In one embodiment, the UDP-glucosyltransferase is selected from group including UGT74G1, UGT85C2, UGT76G1, UGT91D2 and UGTs having substantial (&gt;85%) identity to these polypeptides as well as isolated nucleic acid molecules that code for these UGTs. 
     In one embodiment, steviol biosynthesis enzymes, UGTs and UDP-glucose recycling system are present in one microorganism. The microorganism may be for example,  E. coli, Saccharomyces  sp.,  Aspergillus  sp.,  Pichia  sp,  Bacillus  sp.,  Yarrowia  sp. 
     In one embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rubusoside to form stevioside. In a particular embodiment, the UDP-glucosyltransferase is UGT91D2. 
     In one embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to stevioside to form rebaudioside A. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1. 
     In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside A to form rebaudioside D. In a particular embodiment, the UDP-glucosyltransferase is UGT91D2. In another embodiment, the UGT is an improved variant of UGT91D2 with higher activity and/or selectivity produced by directed evolution. 
     In yet another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside D to form rebaudioside M. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1. In another embodiment, the UGT is an improved variant of UGT76G1 with higher activity and/or selectivity produced by directed evolution. 
     Optionally, the method of the present invention further comprises recycling UDP to provide UDP-glucose. In one embodiment, the method comprises recycling UDP by providing a recycling catalyst and a recycling substrate, such that the biotransformation of the steviol glycoside substrate to the target steviol glycoside is carried out using catalytic amounts of UDP-glucosyltransferase and UDP-glucose ( FIG. 3 ). 
     In one embodiment, the recycling catalyst is sucrose synthase. 
     In one embodiment, the recycling substrate is sucrose. 
     Optionally, the method of the present invention further comprises separating the target steviol glycoside from the starting composition. The target steviol glycoside can be separated by at least one suitable method, such as, for example, crystallization, separation by membranes, centrifugation, extraction, chromatographic separation or a combination of such methods. 
     In one embodiment, the target steviol glycoside can be produced within the microorganism. In another embodiment, the target steviol glycoside can be secreted out in the medium. In one another embodiment, the released steviol glycoside can be continuously removed from the medium. In yet another embodiment, the target steviol glycoside is separated after the completion of the reaction. 
     In one embodiment, separation produces a composition comprising greater than about 80% by weight of the target steviol glycoside on an anhydrous basis, i.e., a highly purified steviol glycoside composition. In another embodiment, separation produces a composition comprising greater than about 90% by weight of the target steviol glycoside. In particular embodiments, the composition comprises greater than about 95% by weight of the target steviol glycoside. In other embodiments, the composition comprises greater than about 99% by weight of the target steviol glycoside. 
     The target steviol glycoside can be in any polymorphic or amorphous form, including hydrates, solvates, anhydrous or combinations thereof. 
     Purified target steviol glycosides can be used in consumable products as a sweetener. Suitable consumer products include, but are not limited to, food, beverages, pharmaceutical compositions, tobacco products, nutraceutical compositions, oral hygiene compositions, and cosmetic compositions. 
     The present invention also provides novel steviol glycosides rebaudioside D2 (reb D2, isomer of rebaudioside D) and rebaudioside M2 (reb M2, isomer of rebaudioside M), which are isomers of reb D and reb M, respectively. In one embodiment, isolated and purified reb D2 is provided. In another embodiment, isolated and purified reb M2 is provided. Reb D2 and reb M2 may also be present in any consumable products disclosed herein. In a particular embodiment, beverages comprising reb D2 and/or reb M2 are provided. 
     Methods of preparing reb D2 and reb M2 are also provided herein. Both are formed during the biotransformation of reb A to reb D. Reb M2 is believed to form from biotransformation of reb D2 in situ. 
     In one embodiment, the present invention is a method for the preparation of a composition comprising reb D2 comprising: (a) contacting a starting composition comprising reb A with an enzyme capable of transforming reb A to reb D2, UDP-glucose, and optionally UDP-glucose recycling enzymes, to produce a composition comprising reb D2, and (b) isolating the composition comprising reb D2. 
     In another embodiment, the present invention is a method for the preparation of a composition comprising reb M2 comprising (a) contacting a starting composition comprising reb D2 with an enzyme capable of transforming reb D2 to reb M2, UDP-glucose, and optionally UDP-glucose recycling enzymes, to produce a composition comprising reb M2, and (b) and isolating the composition comprising reb M2. 
     A further method for the preparation of a composition comprising reb M2 comprises (a) contacting a starting composition comprising reb A with an enzyme capable of transforming reb A to reb D2, UDP-glucose, and optionally UDP-glucose recycling enzymes, to produce a composition comprising reb D2, (b) optionally, isolating the composition comprising reb D2, (c) contacting the composition comprising reb D2 with an enzyme capable of transforming reb D2 to reb M2, UDP-glucose, and optionally UDP-glucose recycling enzymes to produce a composition comprising reb M2, and (d) isolating the composition comprising reb M2. 
     The composition can be further purified to provide reb D2 or reb M2 with purities greater than about 95% by weight on a dry basis. 
    
    
     
       BRIEF DESCRIPTION OF THE DRAWINGS 
       The accompanying drawings are included to provide a further understanding of the invention. The drawings illustrate embodiments of the invention and together with the description serve to explain the principles of the embodiments of the invention. 
         FIG. 1  shows the structure of reb M. 
         FIG. 2  shows the biocatalytic production of reb M from stevioside. 
         FIG. 3  shows the biocatalytic production of reb A from stevioside using the enzyme UGT76G1 and concomitant recycling of UDP to UDP glucose via sucrose synthase. 
         FIG. 4  shows the IR spectrum of reb M. 
         FIG. 5 . shows the HPLC chromatogram of the product of the biocatalytic production of reb M from reb D, as detailed in Example 14. The peak with retention time of 24.165 minutes corresponds to unreacted reb D. The peak with retention time of 31.325 minutes corresponds to reb M. 
         FIG. 6 . shows the HPLC chromatogram of purified reb M produced by biocatalysts from reb D. 
         FIG. 7  shows the HPLC chromatogram of a reb M standard. 
         FIG. 8  shows the HPLC chromatogram of co-injection of a reb M standard and reb M purified from biotransformation from reb D. 
         FIG. 9  shows an overlay of the  1 H NMR spectra of a reb M standard and reb M purified following biosynthesis from reb D. 
         FIG. 10  shows the HRMS spectrum of reb M purified following biocatalytic production from reb D. 
         FIG. 11  shows LC-MS analysis of semi-synthetic steviol glycoside mixture, Lot number CB-2977-106, showing TIC (A), MS of peak at 1.8 min (B), MS of reb M2 peak at 4.1 min (C), MS of reb D peak at 6.0 min (D), MS of reb D2 peak at 7.7 min (E), MS of peak at 9.4 min (F), MS of rebaudioside A peak at 15.2 min (G), MS of peak at 16.5 min (H), and MS of peak at 18.3 min (I). 
         FIG. 12  shows the trace of semi-synthetic steviol glycoside mixture, Lot number CB-2977-106. Chromatogram gridlines are not homogeneous as the detector was re-calibrated 14 min following injection. 
         FIG. 13  shows HPLC analysis of semi-synthetic steviol glycoside mixture, Lot number CB-2977-106 (A), Isolated reb M2 (B), isolated reb D (C) and isolated reb D2 (D). 
         FIG. 14  shows the  1 H NMR spectrum of reb D2 (500 MHz, pyridine-d 5 ). 
         FIG. 15  shows the  13 C NMR spectrum of reb D2 (125 MHz, pyridine-d 5 ). 
         FIG. 16  shows an expansion of the  13 C NMR spectrum of reb D2 (125 MHz, pyridine-d 5 ). 
         FIG. 17  shows the  1 H- 1 H COSY Spectrum of reb D2 (500 MHz, pyridine-d 5 ). 
         FIG. 18  shows the HSQC-DEPT spectrum of reb D2 (500 MHz, pyridine-d 5 ). 
         FIG. 19  shows the HMBC spectrum of reb D2. 
         FIG. 20  shows an expansion of HMBC spectrum of reb D2 (500 MHz, pyridine-d 5 ). 
         FIG. 21  shows the  1 H NMR spectrum of reb M2 (500 MHz, D 2 O). 
         FIG. 22  shows the  13 C NMR spectrum of reb M2 (125 MHz, D 2 O/TSP). 
         FIG. 23  shows an expansion of the  13 C NMR spectrum of reb M2 (125 MHz, D 2 O/TSP). 
         FIG. 24  shows the  1 H- 1 H COSY spectrum of reb M2 (500 MHz, D 2 O). 
         FIG. 25  shows the HSQC-DEPT spectrum of reb M2 (500 MHz, D 2 O). 
         FIG. 26  shows the HMBC spectrum of reb M2 (500 MHz, D 2 O). 
         FIG. 27  shows an expansion of HMBC spectrum of reb M2 (500 MHz, D 2 O). 
         FIG. 28  shows another HMBC spectrum of reb M2. 
         FIG. 29  shows a  1 H NMR spectrum of reb M2. 
         FIG. 30  shows a  13 C NMR spectrum of reb M2. 
         FIG. 31  shows another  13 C NMR spectrum of reb M2. 
         FIG. 32  shows a  1 H- 1 H COSY spectrum of reb M2. 
         FIG. 33  shows a HSQC-DEPT spectrum of reb M2. 
         FIG. 34  shows an HMBC spectrum of reb M2. 
         FIG. 35  shows another HMBC spectrum of reb M2. 
         FIG. 36  shows a 1D-TOCSY spectrum of reb M2. 
         FIG. 37  shows a 1D-TOCSY spectrum of reb M2. 
         FIG. 38  shows a 1D-TOCSY spectrum of reb M2. 
         FIG. 39  shows a 1D-TOCSY spectrum of reb M2. 
         FIG. 40  shows an HPLC (CAD) analysis. 
         FIG. 41  shows an HPLC (CAD) analysis. 
         FIG. 42  shows an HPLC (CAD) analysis. 
         FIG. 43  shows an HPLC (CAD) analysis. 
         FIG. 44  shows an HPLC (CAD) analysis. 
         FIG. 45  shows an HPLC (CAD) analysis. 
         FIG. 46  shows an HPLC (CAD) analysis. 
         FIG. 47  shows an HPLC (CAD) analysis. 
         FIG. 48  shows an HPLC (CAD) analysis. 
         FIG. 49  shows an HPLC (CAD) analysis. 
         FIG. 50  shows an HPLC (CAD) analysis. 
         FIG. 51  shows an HPLC (CAD) analysis. 
         FIG. 52  shows an HPLC (CAD) analysis. 
         FIG. 53  shows an LCMS chromatogram. 
         FIG. 54  shows an LCMS chromatogram. 
         FIG. 55  shows an LCMS chromatogram. 
         FIG. 56  shows an LCMS chromatogram. 
         FIG. 57  shows a reaction profile. 
         FIG. 58  shows an HPLC (CAD) analysis. 
         FIG. 59  shows an HPLC (CAD) analysis. 
         FIG. 60  shows an HPLC (CAD) analysis. 
         FIG. 61  shows an HPLC (CAD) analysis. 
         FIG. 62  shows an HPLC (CAD) analysis. 
         FIG. 63  shows an LCMS chromatogram. 
         FIG. 64  shows an HPLC (CAD) analysis. 
         FIG. 65  shows an HPLC (CAD) analysis. 
         FIG. 66  shows an HPLC (CAD) analysis. 
         FIG. 67  shows an HPLC (CAD) analysis. 
         FIG. 68  shows an HPLC (CAD) analysis. 
         FIG. 69  shows the results of an HPLC analysis. 
     
    
    
     DETAILED DESCRIPTION 
     The present invention provides a biocatalytic process for preparing a composition comprising a target steviol glycoside by contacting a starting composition, comprising an organic substrate, with a microorganism and/or biocatalyst, thereby producing a composition comprising a target steviol glycoside. 
     One object of the invention is to provide an efficient biocatalytic method for preparing steviol glycosides, particularly stevioside, reb E, reb A, reb D, reb D2, reb M, and reb M2 from various starting compositions. 
     As used herein, “biocatalysis” or “biocatalytic” refers to the use of natural or genetically engineered biocatalysts, such as cells, protein enzymes, to perform single or multiple step chemical transformations on organic compounds. Biocatalysis include fermentation, biosynthesis and biotransformation processes. Both, isolated enzyme and whole-cell biocatalysis methods, using biocatalysts in free as well as immobilized forms, are known in the art. Biocatalyst protein enzymes can be naturally occurring or recombinant proteins. 
     As used herein, the term “steviol glycoside(s)” refers to a glycoside of steviol, including, but not limited to, naturally occurring steviol glycosides, e.g. steviolmonoside, steviolbioside, rubusoside, dulcoside B, dulcoside A, rebaudioside B, rebaudioside G, stevioside, rebaudioside C, rebaudioside F, rebaudioside A, rebaudioside I, rebaudioside E, rebaudioside H, rebaudioside L, rebaudioside K, rebaudioside J, rebaudioside M, rebaudioside M2, rebaudioside D, rebaudioside D2, rebaudioside N, rebaudioside O, synthetic steviol glycosides, e.g. enzymatically glucosylated steviol glycosides and combinations thereof. 
                                           Chemical structures of steviol and its glycosides                                                      Compound   R 1     R 2                 Steviol   H   H       Steviolmonoside   H   β-Glc       Steviol monoglucosyl ester   β-Glc   H       Rubusoside   β-Glc   β-Glc       Steviolbioside   H   β-Glc-β-Glc (2→1)       Stevioside   β-Glc   β-Glc-β-Glc (2→1)               Rebaudioside A   β-Glc                                             Rebaudioside D   β-Glc-β-Glc (2→1)                                             Rebaudioside E   β-Glc-β-Glc (2→1)   β-Glc-β-Glc (2→1)               Rebaudioside M                                                                           (Glc = glucose)            
Starting Composition
 
     As used herein, “starting composition” refers to any composition (generally an aqueous solution) containing one or more organic compound comprising at least one carbon atom. 
     In one embodiment, the starting composition is selected from the group consisting of polyols and various carbohydrates. 
     The term “polyol” refers to a molecule that contains more than one hydroxyl group. A polyol may be a diol, triol, or a tetraol which contain 2, 3, and 4 hydroxyl groups, respectively. A polyol also may contain more than four hydroxyl groups, such as a pentaol, hexaol, heptaol, or the like, which contain 5, 6, or 7 hydroxyl groups, respectively. Additionally, a polyol also may be a sugar alcohol, polyhydric alcohol, or polyalcohol which is a reduced form of carbohydrate, wherein the carbonyl group (aldehyde or ketone, reducing sugar) has been reduced to a primary or secondary hydroxyl group. Examples of polyols include, but are not limited to, erythritol, maltitol, mannitol, sorbitol, lactitol, xylitol, inositol, isomalt, propylene glycol, glycerol, threitol, galactitol, hydrogenated isomaltulose, reduced isomalto-oligosaccharides, reduced xylo-oligosaccharides, reduced gentio-oligosaccharides, reduced maltose syrup, reduced glucose syrup, hydrogenated starch hydrolyzates, polyglycitols and sugar alcohols or any other carbohydrates capable of being reduced. 
     The term “carbohydrate” refers to aldehyde or ketone compounds substituted with multiple hydroxyl groups, of the general formula (CH 2 O) n , wherein n is 3-30, as well as their oligomers and polymers. The carbohydrates of the present invention can, in addition, be substituted or deoxygenated at one or more positions. Carbohydrates, as used herein, encompass unmodified carbohydrates, carbohydrate derivatives, substituted carbohydrates, and modified carbohydrates. As used herein, the phrases “carbohydrate derivatives”, “substituted carbohydrate”, and “modified carbohydrates” are synonymous. Modified carbohydrate means any carbohydrate wherein at least one atom has been added, removed, or substituted, or combinations thereof. Thus, carbohydrate derivatives or substituted carbohydrates include substituted and unsubstituted monosaccharides, disaccharides, oligosaccharides, and polysaccharides. The carbohydrate derivatives or substituted carbohydrates optionally can be deoxygenated at any corresponding C-position, and/or substituted with one or more moieties such as hydrogen, halogen, haloalkyl, carboxyl, acyl, acyloxy, amino, amido, carboxyl derivatives, alkylamino, dialkylamino, arylamino, alkoxy, aryloxy, nitro, cyano, sulfo, mercapto, imino, sulfonyl, sulfenyl, sulfinyl, sulfamoyl, carboalkoxy, carboxamido, phosphonyl, phosphinyl, phosphoryl, phosphino, thioester, thioether, oximino, hydrazino, carbamyl, phospho, phosphonato, or any other viable functional group provided the carbohydrate derivative or substituted carbohydrate functions to improve the sweet taste of the sweetener composition. 
     Examples of carbohydrates which may be used in accordance with this invention include, but are not limited to, tagatose, trehalose, galactose, rhamnose, various cyclodextrins, cyclic oligosaccharides, various types of maltodextrins, dextran, sucrose, glucose, ribulose, fructose, threose, arabinose, xylose, lyxose, allose, altrose, mannose, idose, lactose, maltose, invert sugar, isotrehalose, neotrehalose, isomaltulose, erythrose, deoxyribose, gulose, idose, talose, erythrulose, xylulose, psicose, turanose, cellobiose, amylopectin, glucosamine, mannosamine, fucose, glucuronic acid, gluconic acid, glucono-lactone, abequose, galactosamine, beet oligosaccharides, isomalto-oligosaccharides (isomaltose, isomaltotriose, panose and the like), xylo-oligosaccharides (xylotriose, xylobiose and the like), xylo-terminated oligosaccharides, gentio-oligosaccharides (gentiobiose, gentiotriose, gentiotetraose and the like), sorbose, nigero-oligosaccharides, palatinose oligosaccharides, fructooligosaccharides (kestose, nystose and the like), maltotetraol, maltotriol, malto-oligosaccharides (maltotriose, maltotetraose, maltopentaose, maltohexaose, maltoheptaose and the like), starch, inulin, inulo-oligosaccharides, lactulose, melibiose, raffinose, ribose, isomerized liquid sugars such as high fructose corn syrups, coupling sugars, and soybean oligosaccharides. Additionally, the carbohydrates as used herein may be in either the D- or L-configuration. 
     The starting composition may be synthetic or purified (partially or entirely), commercially available or prepared. 
     In one embodiment, the starting composition is glycerol. 
     In another embodiment, the starting composition is glucose. 
     In still another embodiment, the starting composition is sucrose. 
     In yet another embodiment, the starting composition is starch. 
     In another embodiment, the starting composition is maltodextrin. 
     The organic compound(s) of starting composition serve as a substrate(s) for the production of the target steviol glycoside(s), as described herein. 
     Target Steviol Glycoside 
     The target steviol glycoside of the present method can be any steviol glycoside that can be prepared by the process disclosed herein. In one embodiment, the target steviol glycoside is selected from the group consisting of steviolmonoside, steviolbioside, rubusoside, dulcoside B, dulcoside A, rebaudioside B, rebaudioside G, stevioside, rebaudioside C, rebaudioside F, rebaudioside A, rebaudioside I, rebaudioside E, rebaudioside H, rebaudioside L, rebaudioside K, rebaudioside J, rebaudioside M, rebaudioside M2, rebaudioside D, rebaudioside D2, rebaudioside N or rebaudioside O, or other glycoside of steviol. 
     In one embodiment, the target steviol glycoside is stevioside. In another embodiment, the target steviol glycoside is reb A. In still another embodiment, the target steviol glycoside is reb E. In yet another embodiment, the target steviol glycoside is reb D. In yet another embodiment, the target steviol glycoside is reb D2. In a further embodiment, the target steviol glycoside is reb M. In a still further another embodiment, the target steviol glycoside is reb M2. 
     The target steviol glycoside can be in any polymorphic or amorphous form, including hydrates, solvates, anhydrous or combinations thereof. 
     In one embodiment, the present invention is a biocatalytic process for the production of reb D. 
     In yet another embodiment, the present invention is a biocatalytic process for the production of reb D2. 
     In still another embodiment, the present invention is a biocatalytic process for the production of reb M. 
     In a further embodiment, the present invention is a biocatalytic process for the production of reb M2. 
     Optionally, the method of the present invention further comprises separating the target steviol glycoside from the starting composition. The target steviol glycoside can be separated by any suitable method, such as, for example, crystallization, separation by membranes, centrifugation, extraction, chromatographic separation or a combination of such methods. 
     In particular embodiments, the process described herein results in a highly purified target steviol glycoside composition. The term “highly purified”, as used herein, refers to a composition having greater than about 80% by weight of the target steviol glycoside on an anhydrous basis. In one embodiment, the highly purified target steviol glycoside composition contains greater than about 90% by weight of the target steviol glycoside on an anhydrous basis, such as, for example, greater than about 91%, greater than about 92%, greater than about 93%, greater than about 94%, greater than about 95%, greater than about 96%, greater than about 97%, greater than about 98% or greater than about 99% target steviol glycoside content on a dry basis. 
     In one embodiment, when the target steviol glycoside is reb M, the process described herein provides a composition having greater than about 90% reb M content by weight on a dry basis. In another particular embodiment, when the target steviol glycoside is reb M, the process described herein provides a composition comprising greater than about 95% reb M content by weight on a dry basis. 
     In another embodiment, when the target steviol glycoside is reb M2, the process described herein provides a composition having greater than about 90% reb M2 content by weight on a dry basis. In another particular embodiment, when the target steviol glycoside is reb M2, the process described herein provides a composition comprising greater than about 95% reb M2 content by weight on a dry basis. 
     In yet another embodiment, when the target steviol glycoside is reb D, the process described herein provides a composition greater than about 90% reb D content by weight on a dry basis. In another particular embodiment, when the target steviol glycoside is reb D, the process described herein provides a composition comprising greater than about 99% reb D content by weight on a dry basis. 
     In still another embodiment, when the target steviol glycoside is reb D2, the process described herein provides a composition greater than about 90% reb D2 content by weight on a dry basis. In another particular embodiment, when the target steviol glycoside is reb D2, the process described herein provides a composition comprising greater than about 95% reb D2 content by weight on a dry basis. 
     In a further embodiment, when the target steviol glycoside is reb A, the process described herein provides a composition comprising greater than about 90% reb A content by weight on a dry basis. In another particular embodiment, when the target steviol glycoside is reb A, the process described herein provides a composition comprising greater than about 95% reb A content by weight on a dry basis. 
     In a still further embodiment, when the target steviol glycoside is reb E, the process described herein provides a composition comprising greater than about 90% reb E content by weight on a dry basis. In another particular embodiment, when the target steviol glycoside is reb E, the process described herein provides a composition comprising greater than about 95% reb E content by weight on a dry basis. 
     In a still further embodiment, when the target steviol glycoside is reb I, the process described herein provides a composition comprising greater than about 90% reb I content by weight on a dry basis. In another particular embodiment, when the target steviol glycoside is reb I, the process described herein provides a composition comprising greater than about 95% reb I content by weight on a dry basis. 
     In yet a further embodiment, when the target steviol glycoside is stevioside, the process described herein provides a composition comprising greater than about 90% stevioside content by weight on a dry basis. In another particular embodiment, when the target steviol glycoside is stevioside, the process described herein provides a composition comprising greater than about 95% stevioside content by weight on a dry basis. 
     Microorganism and Biocatalysts 
     In one embodiment of present invention, a microorganism or biocatalyst is contacted with the starting composition to produce target steviol glycosides. The microorganism can be any microorganism possessing the necessary enzymes for converting the starting composition to target steviol glycosides. These enzymes are encoded within the microorganism&#39;s genome. 
     In one embodiment the microoganism may be, for example,  E. coli, Saccharomyces  sp.,  Aspergillus  sp.,  Pichia  sp.,  Bacillus  sp.,  Yarrowia  sp. etc. 
     The enzymes can be located on the surface and/or inside the cell of the microorganism and/or can be secreted out in the medium by the microorganism. 
     The biocatalyst comprises at least one enzyme and can be whole cell suspension, crude lysate or purified enzyme. 
     The enzymes necessary for converting the starting composition to target steviol glycosides include the steviol biosynthesis enzymes and UDP-glycosyltransferases (UGTs). Optionally it may include UDP recycling enzyme(s). The UDP recycling enzyme can be sucrose synthase and the recycling substrate can be sucrose. 
     In one embodiment the steviol biosynthesis enzymes include mevalonate (MVA) pathway enzymes. 
     In another embodiment the steviol biosynthesis enzymes include non-mevalonate 2-C-methyl-D-erythritol-4-phosphate pathway (MEP/DOXP) enzymes. 
     In one embodiment the steviol biosynthesis enzymes are selected from the group including geranylgeranyl diphosphate synthase, copalyl diphosphate synthase, kaurene synthase, kaurene oxidase, kaurenoic acid 13-hydroxylase (KAH), steviol synthetase, deoxyxylulose 5-phosphate synthase (DXS), D-1-deoxyxylulose 5-phosphate reductoisomerase (DXR), 4-diphosphocytidyl-2-C-methyl-D-erythritol synthase (CMS), 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase (CMK), 4-diphosphocytidyl-2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase (MCS), 1-hydroxy-2-methyl-2(E)-butenyl 4-diphosphate synthase (HDS), 1-hydroxy-2-methyl-2(E)-butenyl 4-diphosphate reductase (HDR), acetoacetyl-CoA thiolase, truncated HMG-CoA reductase, mevalonate kinase, phosphomevalonate kinase, mevalonate pyrophosphate decarboxylase, cytochrome P450 reductase etc. 
     The UDP-glucosyltransferase can be any UDP-glucosyltransferase capable of adding at least one glucose unit to the steviol and or steviol glycoside substrate to provide the target steviol glycoside. 
     In one embodiment, the microorganism is free. In another embodiment, the microorganism is immobilized. For example, the microorganism may be immobilized to a solid support made from inorganic or organic materials. Non-limiting examples of solid supports suitable to immobilize the microorganism include derivatized cellulose or glass, ceramics, metal oxides or membranes. The microorganism may be immobilized to the solid support, for example, by covalent attachment, adsorption, cross-linking, entrapment or encapsulation. 
     In one embodiment the microorganism is in aqueous medium, comprising water, and various components selected form group including carbon sources, energy sources, nitrogen sources, microelements, vitamins, nucleosides, nucleoside phosphates, nucleoside diphosphates, nucleoside triphosphates, organic and inorganic salts, organic and mineral acids, bases etc. Carbon sources include glycerol, glucose, carbon dioxide, carbonates, bicarbonates. Nitrogen sources can include nitrates, nitrites, amino acids, peptides, peptones, or proteins. 
     In a particular embodiment, the medium comprises buffer. Suitable buffers include, but are not limited to, PIPES buffer, acetate buffer and phosphate buffer. In a particular embodiment, the medium comprises phosphate buffer. 
     In one embodiment, the medium can also include an organic solvent. 
     In one embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rubusoside, thereby producing stevioside. The UDP-glucosyltransferase may be, for example, UGT91D2. 
     In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rubusoside, thereby producing rebaudioside E. The UDP-glucosyltransferase may be, for example, UGTSL2. 
     In still another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside E, thereby producing rebaudioside D. The UDP-glucosyltransferase may be, for example, UGT76G1. 
     In yet embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to stevioside, thereby producing rebaudioside A. The UDP-glucosyltransferase may be, for example, UGT76G1. 
     In a further embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside A, thereby producing rebaudioside D and/or rebaudioside D2 and/or rebaudioside M2. The UDP-glucosyltransferase may be, for example, UGT91D2 or UGTSL2. 
     In another embodiment, the UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside A is selected from the following listing of GenInfo identifier numbers, preferably from the group presented in Table 1, and more preferably the group presented in Table 2. 
     
       
         
               
               
               
               
               
               
             
           
               
                   
               
             
             
               
                 397567 
                 30680413 
                 115480946 
                 147798902 
                 218193594 
                 225443294 
               
               
                 454245 
                 32816174 
                 116310259 
                 147811764 
                 218193942  
                 225444853 
               
               
                 1359905 
                 32816178  
                 116310985 
                 147827151 
                 219885307  
                 225449296 
               
               
                 1685003 
                 34393978 
                 116788066 
                 147836230 
                 222615927 
                 225449700 
               
               
                 1685005 
                 37993665  
                 116788606 
                 147839909 
                 222619587 
                 225454338 
               
               
                 2191136 
                 37993671  
                 116789315 
                 147846163 
                 222623142 
                 225454340 
               
               
                 2501497 
                 37993675 
                 119394507 
                 147855977 
                 222625633 
                 225454342 
               
               
                 2911049 
                 39104603 
                 119640480 
                 148905778 
                 222625635 
                 225454473 
               
               
                 4218003 
                 41469414 
                 122209731 
                 148905999 
                 222636620 
                 225454475 
               
               
                 4314356 
                 41469452 
                 125526997 
                 148906835 
                 222636621 
                 225458362 
               
               
                 13492674 
                 42566366  
                 125534279 
                 148907340 
                 222636628 
                 225461551 
               
               
                 13492676 
                 42570280  
                 125534461 
                 148908935 
                 222636629 
                 225461556 
               
               
                 15217773  
                 42572855 
                 125540090 
                 148909182 
                 224053242 
                 225461558 
               
               
                 15217796  
                 44890129 
                 125541516 
                 148909920 
                 224053386 
                 225469538 
               
               
                 15223396  
                 46806235 
                 125545408 
                 148910082 
                 224055535 
                 225469540 
               
               
                 15223589  
                 50284482 
                 125547340 
                 148910154 
                 224056138 
                 226316457 
               
               
                 15227766  
                 51090402 
                 125547520 
                 148910612 
                 224056160 
                 226492603 
               
               
                 15230017  
                 51090594  
                 125554547 
                 148910769 
                 224067918 
                 226494221 
               
               
                 15231757  
                 52839682  
                 125557592 
                 156138791 
                 224072747 
                 226495389 
               
               
                 15234056 
                 56550539  
                 125557593 
                 156138797 
                 224080189 
                 226495945 
               
               
                 15234195 
                 62734263  
                 125557608 
                 156138799 
                 224091845 
                 226502400 
               
               
                 15234196 
                 62857204 
                 125559566 
                 156138803 
                 224094703 
                 226507980 
               
               
                 15238503 
                 62857206 
                 125563266 
                 165972256 
                 224100653 
                 226531147 
               
               
                 15239523 
                 62857210 
                 125571055 
                 168016721 
                 224100657 
                 226532094 
               
               
                 15239525 
                 62857212 
                 125579728 
                 171674071 
                 224101569 
                 238477377 
               
               
                 15239543 
                 75265643  
                 125588307 
                 171906258 
                 224103105 
                 240254512 
               
               
                 15239937 
                 75285934  
                 125589492 
                 183013901 
                 224103633 
                 242032615 
               
               
                 15240305 
                 75288884  
                 125599469 
                 183013903 
                 224103637 
                 242032621 
               
               
                 15240534 
                 77550661  
                 125601477 
                 186478321 
                 224109218 
                 242038423 
               
               
                 15982889  
                 77556148  
                 126635837 
                 187373030 
                 224114583 
                 242043290 
               
               
                 18086351 
                 82791223  
                 126635845 
                 187373042 
                 224116284 
                 242044836 
               
               
                 18418378 
                 83778990  
                 126635847 
                 190692175 
                 224120552 
                 242051252 
               
               
                 18418380  
                 89953335  
                 126635863 
                 194701936 
                 224121288 
                 242056217 
               
               
                 18418382  
                 110741436 
                 126635867 
                 195620060 
                 224121296 
                 242056219 
               
               
                 19743740  
                 110743955 
                 126635883 
                 209954691 
                 224121300 
                 242056663 
               
               
                 19911201  
                 115438196 
                 126635887 
                 209954719 
                 224130358 
                 242059339 
               
               
                 20149064  
                 115438785 
                 133874210 
                 209954725 
                 224140703 
                 242059341 
               
               
                 20260654 
                 115441237 
                 133874212 
                 209954733 
                 224143404 
                 242060922 
               
               
                 21435782 
                 115454819 
                 145358033 
                 210063105 
                 224143406 
                 242067411 
               
               
                 21553613 
                 115456047 
                 147772508 
                 210063107 
                 224144306 
                 242067413 
               
               
                 21593514 
                 115457492 
                 147776893 
                 212275846 
                 224285244 
                 242076258 
               
               
                 22759895 
                 115459312 
                 147776894 
                 216296854 
                 225431707 
                 242076396 
               
               
                 23955910 
                 115464719 
                 147776895 
                 217074506 
                 225435532 
                 242084750 
               
               
                 26452040 
                 115471069 
                 147786916 
                 218185693 
                 225436321 
                 242091005 
               
               
                 28393204 
                 115471071 
                 147798900 
                 218187075 
                 225440041 
                 242095206 
               
               
                 30679796 
                 115474009 
                 147798901 
                 218189427 
                 225441116 
                 242345159 
               
               
                 242345161 
                 297724601 
                 326492035 
                 356523945 
                 357140904 
                 359486938 
               
               
                 255536859  
                 297725463 
                 326493430 
                 356523957 
                 357165849 
                 359487055 
               
               
                 255538228 
                 297728331  
                 326500410 
                 356523959 
                 357165852 
                 359488135 
               
               
                 255541676 
                 297738632  
                 326506816 
                 356523961 
                 357168415 
                 359488708 
               
               
                 255547075 
                 297745347 
                 326507826 
                 356523963 
                 357437837 
                 359493630 
               
               
                 255552620 
                 297745348 
                 326508394 
                 356524387 
                 357442755 
                 359493632 
               
               
                 255552622 
                 297795735 
                 326509445 
                 356524403 
                 357442757 
                 359493634 
               
               
                 255555343 
                 297796253 
                 326511261 
                 356527181 
                 357445729  
                 359493636 
               
               
                 255555361 
                 297796257 
                 326511866 
                 356533209 
                 357445731 
                 359493815 
               
               
                 255555363 
                 297796261 
                 326512412 
                 356533852 
                 357445733 
                 359495856 
               
               
                 255555365 
                 297797587 
                 326517673 
                 356534718 
                 357446799 
                 359495858 
               
               
                 255555369 
                 297798502 
                 326518800 
                 356535480 
                 357446805 
                 359495869 
               
               
                 255555373 
                 297799226 
                 326521124 
                 356542996 
                 357452779 
                 359495871 
               
               
                 255555377 
                 297805988 
                 326525567 
                 356543136 
                 357452781 
                 359497638 
               
               
                 255556812 
                 297807499 
                 326525957 
                 356543932 
                 357452783  
                 359807261 
               
               
                 255556818 
                 297809125 
                 326526607 
                 356549841 
                 357452787 
                 374256637 
               
               
                 255563008 
                 297809127 
                 326527141 
                 356549843 
                 357452789 
                 377655465 
               
               
                 255564074 
                 297811403 
                 326530093 
                 356554358 
                 357452791  
                 378405177 
               
               
                 255564531 
                 297820040 
                 326534036 
                 356554360 
                 357452797  
                 378829085 
               
               
                 255572878 
                 297821483 
                 326534312 
                 356558606 
                 357452799  
                 387135070 
               
               
                 255577901 
                 297825217 
                 332071132 
                 356560333 
                 357470367 
                 387135072 
               
               
                 255583249 
                 297832276 
                 339715876 
                 356560599 
                 357472193 
                 387135078 
               
               
                 255583253 
                 297832280 
                 342306012 
                 356560749 
                 357472195 
                 387135092 
               
               
                 255583255 
                 297832518 
                 342306016 
                 356566018 
                 357474295 
                 387135094 
               
               
                 255585664 
                 297832520 
                 343457675 
                 356566169 
                 357474493 
                 387135098 
               
               
                 255585666  
                 297840825 
                 343457677 
                 356566173 
                 357474497 
                 387135100 
               
               
                 255634688  
                 297840827 
                 350534960 
                 356567761 
                 357474499 
                 387135134 
               
               
                 255644801  
                 297847402 
                 356498085 
                 356574704 
                 357490035 
                 387135136 
               
               
                 255645821  
                 297849372 
                 356499771 
                 356576401 
                 357493567 
                 387135174 
               
               
                 255647456 
                 300078590 
                 356499777 
                 356577660 
                 357497139 
                 387135176 
               
               
                 255648275 
                 300669727 
                 356499779 
                 357114993 
                 357497581 
                 387135184 
               
               
                 260279126 
                 302142947 
                 356501328 
                 357115447 
                 357497671  
                 387135186 
               
               
                 260279128 
                 302142948 
                 356502523 
                 357115451 
                 357500579  
                 387135188 
               
               
                 261343326 
                 302142950 
                 356503180 
                 357115453 
                 357504663  
                 387135190 
               
               
                 283132367 
                 302142951 
                 356503184 
                 357116080 
                 357504691  
                 387135192 
               
               
                 283362112 
                 302765302 
                 356503295 
                 357116928 
                 357504699  
                 387135194 
               
               
                 289188052 
                 302796334 
                 356504436 
                 357117461 
                 357504707  
                 387135282 
               
               
                 295841350 
                 302811470 
                 356504523 
                 357117463 
                 357505859  
                 387135284 
               
               
                 296088529  
                 302821107 
                 356504765 
                 357117829 
                 357510851  
                 387135294 
               
               
                 296090415  
                 302821679 
                 356511113 
                 357117839 
                 357516975 
                 387135298 
               
               
                 296090524  
                 319759260 
                 356515120 
                 357125059 
                 359477003  
                 387135300 
               
               
                 296090526  
                 319759266 
                 356517088 
                 357126015 
                 359477998  
                 387135302 
               
               
                 297599503  
                 320148814 
                 356520732 
                 357134488 
                 359478043  
                 387135304 
               
               
                 297601531  
                 326489963 
                 356522586 
                 357135657 
                 359478286 
                 387135312 
               
               
                 297611791  
                 326490273 
                 356522588 
                 357138503 
                 359484299 
                 387135314 
               
               
                 297722841  
                 326491131 
                 356522590 
                 357139683 
                 359486936 
                 387135316 
               
               
                 387135318 
                 449440433 
                 460376293 
                 460413408 
                 462423864  
                 475546199 
               
               
                 387135320  
                 449445896 
                 460378310 
                 460416351 
                 470101924  
                 475556485 
               
               
                 387135322  
                 449446454 
                 460380744 
                 462394387 
                 470102280  
                 475559699 
               
               
                 387135324  
                 449447657 
                 460381726 
                 462394433 
                 470102858  
                 475578293 
               
               
                 387135326  
                 449449002 
                 460382093 
                 462394557 
                 470104211  
                 475591753 
               
               
                 387135328  
                 449449004 
                 460382095 
                 462395646 
                 470104264  
                 475593742 
               
               
                 388493506  
                 449449006 
                 460382754 
                 462395678 
                 470104266  
                 475612072 
               
               
                 388495496 
                 449451379 
                 460384935 
                 462396388 
                 470106317 
                 475622476 
               
               
                 388498446 
                 449451589 
                 460384937 
                 462396389 
                 470106357  
                 475622507 
               
               
                 388499220 
                 449451591 
                 460385076 
                 462396419 
                 470115448  
                 475623787 
               
               
                 388502176 
                 449451593 
                 460385872 
                 462396542 
                 470130404  
                 482550481 
               
               
                 388517521 
                 449453712 
                 460386018 
                 462397507 
                 470131550  
                 482550499 
               
               
                 388519407 
                 449453714 
                 460389217 
                 462399998 
                 470136482  
                 482550740 
               
               
                 388521413 
                 449453716 
                 460394872 
                 462400798 
                 470136484  
                 482550999 
               
               
                 388827901 
                 449453732 
                 460396139 
                 462401217 
                 470136488 
                 482552352 
               
               
                 388827903 
                 449457075 
                 460397862 
                 462402118 
                 470136492 
                 482554970 
               
               
                 388827907 
                 449467555 
                 460397864 
                 462402237 
                 470137933 
                 482555336 
               
               
                 388827909 
                 449468742 
                 460398541 
                 462402284 
                 470137937 
                 482555478 
               
               
                 388827913 
                 449495638 
                 460403139 
                 462402416 
                 470140422 
                 482556454 
               
               
                 393887637 
                 449495736 
                 460403141 
                 462404228 
                 470140426 
                 482557289 
               
               
                 393887646 
                 449499880 
                 460403143 
                 462406358 
                 470140908 
                 482558462 
               
               
                 393887649 
                 449502786 
                 460403145 
                 462408262 
                 470141232 
                 482558508 
               
               
                 393990627 
                 449503471 
                 460405998 
                 462409325 
                 470142008  
                 482558547 
               
               
                 397746860 
                 449503473 
                 460407578 
                 462409359 
                 470142010  
                 482561055 
               
               
                 397789318 
                 449515857 
                 460407590 
                 462409777 
                 470142012  
                 482561555 
               
               
                 413924864 
                 449518643 
                 460409128 
                 462411467 
                 470143607  
                 482562795 
               
               
                 414590349 
                 449519559 
                 460409134 
                 462414311 
                 470143939  
                 482562850 
               
               
                 414590661 
                 449522783 
                 460409136 
                 462414416 
                 470145404 
                 482565074 
               
               
                 414591157 
                 449524530 
                 460409459 
                 462414476 
                 473923244 
                 482566269 
               
               
                 414879558 
                 449524591 
                 460409461 
                 462415526 
                 474114354 
                 482566296 
               
               
                 414879559 
                 449528823 
                 460409463 
                 462415603 
                 474143634 
                 482566307 
               
               
                 414879560 
                 449528825 
                 460409465 
                 462415731 
                 474202268  
                 482568689 
               
               
                 414888074 
                 449534021 
                 460409467 
                 462416307 
                 474299266  
                 482570049 
               
               
                 431812559 
                 460365546 
                 460410124 
                 462416920 
                 474363119  
                 482570572 
               
               
                 449432064 
                 460366882 
                 460410126 
                 462416922 
                 474366157  
                 482575121 
               
               
                 449432066 
                 460369823 
                 460410128 
                 462416923 
                 474429346 
                   
               
               
                 449433069 
                 460369829 
                 460410130 
                 462416924 
                 475432777 
                   
               
               
                 449436944 
                 460369831 
                 460410132 
                 462417401 
                 475473002 
                   
               
               
                 449438665 
                 460369833 
                 460410134 
                 462419769 
                 475489790 
                   
               
               
                 449438667 
                 460370755 
                 460410213 
                 462420317 
                 475511330 
                   
               
               
                 449440431  
                 460374714 
                 460411200 
                 462423366 
                 475516200 
               
               
                   
               
             
          
         
       
     
     
       
         
               
               
               
             
               
               
               
             
           
               
                 TABLE 1 
               
               
                   
               
               
                 GI number 
                 Accession 
                 Origin 
               
               
                   
               
             
             
               
                   
               
             
          
           
               
                 190692175 
                 ACE87855.1 
                 
                   Stevia 
                   rebaudiana 
                 
               
               
                 41469452 
                 AAS07253.1 
                 
                   Oryza 
                   sativa 
                 
               
               
                 62857204 
                 BAD95881.1 
                 
                   Ipomoea 
                   nil 
                 
               
               
                 62857206 
                 BAD95882.1 
                 
                   Ipomoea 
                   purperea 
                 
               
               
                 56550539 
                 BAD77944.1 
                 
                   Bellis 
                   perennis 
                 
               
               
                 115454819 
                 NP_001051010.1 
                   Oryza   sativa  Japonica Group 
               
               
                 115459312 
                 NP_001053256.1 
                   Oryza   sativa  Japonica Group 
               
               
                 115471069 
                 NP_001059133.1 
                   Oryza   sativa  Japonica Group 
               
               
                 115471071 
                 NP_001059134.1 
                   Oryza   sativa  Japonica Group 
               
               
                 116310985 
                 CAH67920.1 
                   Oryza   sativa  Indica Group 
               
               
                 116788066 
                 ABK24743.1 
                 
                   Picea 
                   sitchensis 
                 
               
               
                 122209731 
                 Q2V6J9.1 
                   Fragaria  x  ananassa   
               
               
                 125534461 
                 EAY81009.1 
                   Oryza   saliva  Indica Group 
               
               
                 125559566 
                 EAZ05102.1 
                   Oryza   sativa  Indica Group 
               
               
                 125588307 
                 EAZ28971.1 
                   Oryza   sativa  Japonica Group 
               
               
                 148907340 
                 ABR16806.1 
                 
                   Picea 
                   sitchensis 
                 
               
               
                 148910082 
                 ABR18123.1 
                 
                   Picea 
                   sitchensis 
                 
               
               
                 148910612 
                 ABR18376.1 
                 
                   Picea 
                   sitchensis 
                 
               
               
                 15234195 
                 NP_194486.1 
                 
                   Arabidopsis 
                   thaliana 
                 
               
               
                 15239523 
                 NP_200210.1 
                 
                   Arabidopsis 
                   thaliana 
                 
               
               
                 15239937 
                 NP_196793.1 
                 
                   Arabidopsis 
                   thaliana 
                 
               
               
                 1685005 
                 AAB36653.1 
                 
                   Nicotiana 
                   tabacum 
                 
               
               
                 183013903 
                 ACC38471.1 
                 
                   Medicago 
                   truncatula 
                 
               
               
                 186478321 
                 NP_172511.3 
                 
                   Arabidopsis 
                   thaliana 
                 
               
               
                 187373030 
                 ACD03249.1 
                 
                   Avena 
                   strigosa 
                 
               
               
                 194701936 
                 ACF85052.1 
                 
                   Zea 
                   mays 
                 
               
               
                 19743740 
                 AAL92461.1 
                 
                   Solanum 
                   lycopersicum 
                 
               
               
                 212275846 
                 NP_001131009.1 
                 
                   Zea 
                   mays 
                 
               
               
                 222619587 
                 EEE55719.1 
                   Oryza   saliva  Japonica Group 
               
               
                 224055535 
                 XP_002298527.1 
                 
                   Populus 
                   trichocarpa 
                 
               
               
                 224101569 
                 XP_002334266.1 
                 
                   Populus 
                   trichocarpa 
                 
               
               
                 224120552 
                 XP_002318358.1 
                 
                   Populus 
                   trichocarpa 
                 
               
               
                 224121288 
                 XP_002330790.1 
                 
                   Populus 
                   trichocarpa 
                 
               
               
                 225444853 
                 XP_002281094 
                 
                   Vitis 
                   vinifera 
                 
               
               
                 225454342 
                 XP_002275850.1 
                 
                   Vitis 
                   vinifera 
                 
               
               
                 225454475 
                 XP_002280923.1 
                 
                   Vitis 
                   vinifera 
                 
               
               
                 225461556 
                 XP_002285222 
                 
                   Vitis 
                   vinifera 
                 
               
               
                 225469540 
                 XP_002270294.1 
                 
                   Vitis 
                   vinifera 
                 
               
               
                 226495389 
                 NP_001148083.1 
                 
                   Zea 
                   mays 
                 
               
               
                 226502400 
                 NP_001147674.1 
                 
                   Zea 
                   mays 
                 
               
               
                 238477377 
                 ACR43489.1 
                 
                   Triticum 
                   aestivum 
                 
               
               
                 240254512 
                 NP_565540.4 
                 
                   Arabidopsis 
                   thaliana 
                 
               
               
                 2501497 
                 Q43716.1 
                 
                   Petunia 
                   x 
                   hybrida 
                 
               
               
                 255555369 
                 XP_002518721.1 
                 
                   Ricinus 
                   communis 
                 
               
               
                 26452040 
                 BAC43110.1 
                 
                   Arabidopsis 
                   thaliana 
                 
               
               
                 296088529 
                 CBI37520.3 
                 
                   Vitis 
                   vinifera 
                 
               
               
                 297611791 
                 NP_001067852.2 
                   Oryza   sativa  Japonica Group 
               
               
                 297795735 
                 XP_002865752.1 
                   Arabidopsis   lyrata  subsp.  lyrata   
               
               
                 297798502 
                 XP_002867135.1 
                   Arabidopsis   lyrata  subsp.  lyrata   
               
               
                 297820040 
                 XP_002877903.1 
                   Arabidopsis   lyrata  subsp.  lyrata   
               
               
                 297832276 
                 XP_002884020.1 
                   Arabidopsis   lyrata  subsp.  lyrata   
               
               
                 302821107 
                 XP_002992218.1 
                 
                   Selaginella 
                   moellendorffii 
                 
               
               
                 30680413 
                 NP_179446.2 
                 
                   Arabidopsis 
                   thaliana 
                 
               
               
                 319759266 
                 ADV71369.1 
                   Pueraria   montana  var.  lobata   
               
               
                 326507826 
                 BAJ86656.1 
                   Hordeum   vulgare  subsp.  Vulgare   
               
               
                 343457675 
                 AEM37036.1 
                   Brassica   rapa  subsp.  oleifera   
               
               
                 350534960 
                 NP_001234680.1 
                 
                   Solanum 
                   lycopersicum 
                 
               
               
                 356501328 
                 XP_003519477.1 
                 
                   Glycine 
                   max 
                 
               
               
                 356522586 
                 XP_003529927.1 
                 
                   Glycine 
                   max 
                 
               
               
                 356535480 
                 XP_003536273.1 
                 
                   Glycine 
                   max 
                 
               
               
                 357445733 
                 XP_003593144.1 
                 
                   Medicago 
                   truncatula 
                 
               
               
                 357452783 
                 XP_003596668.1 
                 
                   Medicago 
                   truncatula 
                 
               
               
                 357474493 
                 XP_003607531.1 
                 
                   Medicago 
                   truncatula 
                 
               
               
                 357500579 
                 XP_003620578.1 
                 
                   Medicago 
                   truncatula 
                 
               
               
                 357504691 
                 XP_003622634.1 
                 
                   Medicago 
                   truncatula 
                 
               
               
                 359477998 
                 XP_003632051.1 
                 
                   Vitis 
                   vinifera 
                 
               
               
                 359487055 
                 XP_002271587 
                 
                   Vitis 
                   vinifera 
                 
               
               
                 359495869 
                 XP_003635104.1 
                 
                   Vitis 
                   vinifera 
                 
               
               
                 387135134 
                 AFJ52948.1 
                 
                   Linum 
                   usitatissimum 
                 
               
               
                 387135176 
                 AFJ52969.1 
                 
                   Linum 
                   usitatissimum 
                 
               
               
                 387135192 
                 AFJ52977.1 
                 
                   Linum 
                   usitatissimum 
                 
               
               
                 387135282 
                 AFJ53022.1 
                 
                   Linum 
                   usitatissimum 
                 
               
               
                 387135302 
                 AFJ53032.1 
                 
                   Linum 
                   usitatissimum 
                 
               
               
                 387135312 
                 AFJ53037.1 
                 
                   Linum 
                   usitatissimum 
                 
               
               
                 388519407 
                 AFK47765.1 
                 
                   Medicago 
                   truncatula 
                 
               
               
                 393887646 
                 AFN26668.1 
                   Barbarea   vulgaris  subsp.  arcuata   
               
               
                 414888074 
                 DAA64088.1 
                 
                   Zea 
                   mays 
                 
               
               
                 42572855 
                 NP_974524.1 
                 
                   Arabidopsis 
                   thaliana 
                 
               
               
                 449440433 
                 XP_004137989.1 
                 
                   Cucumis 
                   sativus 
                 
               
               
                 449446454 
                 XP_004140986.1 
                 
                   Cucumis 
                   sativus 
                 
               
               
                 449449004 
                 XP_004142255.1 
                 
                   Cucumis 
                   sativus 
                 
               
               
                 449451593 
                 XP_004143546.1 
                 
                   Cucumis 
                   sativus 
                 
               
               
                 449515857 
                 XP_004164964.1 
                 
                   Cucumis 
                   sativus 
                 
               
               
                 460382095 
                 XP_004236775.1 
                 
                   Solanum 
                   lycopersicum 
                 
               
               
                 460409128 
                 XP_004249992.1 
                 
                   Solanum 
                   lycopersicum 
                 
               
               
                 460409461 
                 XP_004250157.1 
                 
                   Solanum 
                   lycopersicum 
                 
               
               
                 460409465 
                 XP_004250159.1 
                 
                   Solanum 
                   lycopersicum 
                 
               
               
                 462396388 
                 EMJ02187.1 
                 
                   Prunus 
                   persica 
                 
               
               
                 462402118 
                 EMJ07675.1 
                 
                   Prunus 
                   persica 
                 
               
               
                 462409359 
                 EMJ14693.1 
                 
                   Prunus 
                   persica 
                 
               
               
                 462416923 
                 EMJ21660.1 
                 
                   Prunus 
                   persica 
                 
               
               
                 46806235 
                 BAD17459.1 
                   Oryza   sativa  Japonica Group 
               
               
                 470104266 
                 XP_004288529.1 
                   Fragaria   vesca  subsp.  vesca   
               
               
                 470142008 
                 XP_004306714.1 
                   Fragaria   vesca  subsp.  vesca   
               
               
                 475432777 
                 EMT01232.1 
                 
                   Aegilops 
                   tauschii 
                 
               
               
                 51090402 
                 BAD35324.1 
                   Oryza   sativa  Japonica Group 
               
               
                   
               
             
          
         
       
     
     
       
         
               
               
               
               
             
           
               
                 TABLE 2 
               
               
                   
               
               
                   
                   
                   
                 Internal  
               
               
                 GI number 
                 Accession 
                 Origin 
                 reference 
               
               
                   
               
             
             
               
                 460409128  
                 XP.004249992.1 
                 
                   Solanum 
                   lycopersicum 
                 
                 UGTSL 
               
               
                 460386018  
                 XP.004238697.1 
                 
                   Solanum 
                   lycopersicum 
                 
                 — 
               
               
                 460409134 
                 XP.004249995.1 
                 
                   Solanum 
                   lycopersicum 
                 
                 — 
               
               
                 460410132 
                 XP.004250485.1 
                 
                   Solanum 
                   lycopersicum 
                 
                 UGTSL2 
               
               
                 460410130  
                 XP.004250484.1 
                 
                   Solanum 
                   lycopersicum 
                 
                 — 
               
               
                 460410128  
                 XP.004250483.1 
                 
                   Solanum 
                   lycopersicum 
                 
                 — 
               
               
                 460378310  
                 XP.004234916.1 
                 
                   Solanum 
                   lycopersicum 
                 
                 — 
               
               
                 209954733 
                 BAG80557.1 
                 
                   Lycium 
                   barbarum 
                 
                 UGTLB 
               
               
                 209954725 
                 BAG80553.1 
                 
                   Lycium 
                   barbarum 
                 
                 — 
               
               
                   
               
             
          
         
       
     
     In yet another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside D to form rebaudioside M and/or rebaudioside M2. The UDP-glucosyltransferase may be, for example, UGT76G1. 
     Optionally, the method of the present invention further comprises recycling UDP to provide UDP-glucose. In one embodiment, the method comprises recycling UDP by providing a recycling catalyst, i.e., a biocatalyst capable of UDP-glucose overproduction, and a recycling substrate, such that the conversion of the substrate steviol glycoside to the target steviol glycoside is carried out using catalytic amounts of UDP-glucosyltransferase and UDP-glucose ( FIG. 3 ). 
     In one embodiment, the UDP-glucose recycling catalyst is sucrose synthase. 
     In one embodiment, the recycling substrate is sucrose. 
     In one embodiment the biocatalyst comprises more than one UDP-glucosyltransferase. 
     In embodiment the biocatalyst comprises more than one UDP-glucosyltransferase and UDP-glucose recycling catalyst. 
     The target steviol glycoside is optionally purified from the resulting composition. Purification of the target steviol glycoside from the reaction medium can be achieved by at least one suitable method to provide a highly purified target steviol glycoside composition. Suitable methods include crystallization, separation by membranes, centrifugation, extraction (liquid or solid phase), chromatographic separation, HPLC (preparative or analytical) or a combination of such methods. 
     Compounds and Methods 
     The present invention also provides isolated and highly purified reb D2. Reb D2 is an isomer of reb D and has the following structure: 
     
       
                 
         
             
             
         
      
     
     In another embodiment, the present invention provides reb D2 having a purity greater than about 95% by weight on an anhydrous basis, such as, for example, greater than about 96% by weight, greater than about 97% by weight, greater than about 98% by weight or greater than about 99% by weight. 
     In still another embodiment, the present invention provides reb D2 having a purity greater than about 95% by weight in a steviol glycoside mixture, such as, for example, greater than about 96% by weight, greater than about 97% by weight, greater than about 98% by weight or greater than about 99% by weight. 
     The present invention also provides compositions comprising reb D2. 
     In one embodiment, the present invention provides a method for preparing reb D2 comprising:
         a. contacting a starting composition comprising reb A with an enzyme capable of transforming reb A to reb D2, UDP-glucose, and optionally UDP-glucose recycling enzymes, to produce a composition comprising reb D2; and   b. isolating the composition comprising reb D2.       

     In some embodiments, the enzyme capable of transforming reb A to reb D2 is a UDP-glucosyltransferase, such as, for example, UGT91D2, UGTSL, UGTSL_Sc, UGTSL2 (GI No. 460410132 version XP_004250485.1), GI No. 460409128 (UGTSL) version XP_004249992.1, GI No. 115454819 version NP_001051010.1, GI No. 187373030, version ACD03249.1. GI No. 222619587 version EEE55719.1, GI No. 297795735 version XP_002865752.1 or EUGT11. 
     The enzyme capable of transforming reb A to reb D2 can be immobilized or in a recombinant microorganism. 
     In one embodiment, the enzyme is immobilized. In another embodiment, the enzyme is in a recombinant microorganism. 
     In one embodiment, the microorganism is free. In another embodiment, the microorganism is immobilized. For example, the microorganism may be immobilized to a solid support made from inorganic or organic materials. Non-limiting examples of solid supports suitable to immobilize the microorganism include derivatized cellulose or glass, ceramics, metal oxides or membranes. The microorganism may be immobilized to the solid support, for example, by covalent attachment, adsorption, cross-linking, entrapment or encapsulation. 
     Suitable microorganisms include, but are not limited to,  E. coli, Saccharomyces  sp.,  Aspergillus  sp.,  Pichia  sp.,  Bacillus  sp.,  Yarrowia  sp. 
     In one embodiment the microorganism is in an aqueous medium, comprising water, and various components selected form group including carbon sources, energy sources, nitrogen sources, microelements, vitamins, nucleosides, nucleoside phosphates, nucleoside diphosphates, nucleoside triphosphates, organic and inorganic salts, organic and mineral acids, bases etc. Carbon sources include glycerol, glucose, carbon dioxide, carbonates, bicarbonates. Nitrogen sources can include nitrates, nitrites, amino acids, peptides, peptones, or proteins. 
     In a particular embodiment, the medium comprises buffer. Suitable buffers include, but are not limited to, PIPES buffer, acetate buffer and phosphate buffer. In a particular embodiment, the medium comprises phosphate buffer. 
     In one embodiment the medium can also include an organic solvent. 
     In a particular embodiment, the enzyme is a UDP-glucosyltransferase capable of transforming reb A to reb D2. 
     In a more particular embodiment, the enzyme is selected from UGT91D2, UGTSL, UGTSL_Sc, UGTSL2 (GI No. 460410132 version XP_004250485.1), GI No. 460409128 (UGTSL) version XP_004249992.1, GI No. 115454819 version NP_001051010.1, GI No. 187373030, version ACD03249.1. GI No. 222619587 version EEE55719.1, GI No. 297795735 version XP_002865752.1 or EUGT11 and UGTs having substantial (&gt;85%) sequence identity to these. 
     In a still more particular embodiment, the enzyme is UGTSL2 or its improved variant produced by directed evolution and having higher activity. 
     In one embodiment, the target steviol glycoside can be produced within the microorganism. In another embodiment, the target steviol glycoside can be secreted out in the medium. In one another embodiment, the released steviol glycoside can be continuously removed from the medium. In yet another embodiment, the target steviol glycoside is separated after the completion of the reaction. 
     Isolation of reb D2 from the reaction medium can be achieved by any suitable method to provide a composition comprising reb D2. Suitable methods include, but are not limited to, lysis, crystallization, separation by membranes, centrifugation, extraction (liquid or solid phase), chromatographic separation, HPLC (preparative or analytical) or a combination of such methods. In a particular embodiment, isolation can be achieved by lysis and centrifugation. 
     In some embodiments, isolation may result in a reb D2 purity less than about 95% by weight on an anhydrous basis, and the composition may contain, e.g., steviol glycosides and/or residual reaction products. The composition comprising reb D2 can be further purified to provide highly purified reb D2, i.e. reb D2 having a purity greater than about 95% by weight on an anhydrous basis. In some embodiments, the compositions comprising reb D2 can be further purified to provide reb D2 having a purity greater than about 96%, greater than about 97%, greater than about 98% or greater than about 99% by weight on an anhydrous basis. 
     Purification can be affected by any means known to one of skill in the art including, but not limited to, crystallization, separation by membranes, centrifugation, extraction (liquid or solid phase), chromatographic separation, HPLC (preparative or analytical) or a combination of such methods. In a particular embodiment, HPLC is used to purify reb D2. In a more particular embodiment, semi-preparative HPLC is used to purify reb D2. 
     For example, a two-step semi-preparative HPLC purification can be used. The first step utilizes a C18 column with a mobile phase containing A (25% MeCN in water) and B (30% MeCN in water) with the following gradient: 
     
       
         
               
               
               
             
               
               
               
             
           
               
                   
               
               
                 Time (min) 
                 % A 
                 % B 
               
               
                   
               
             
             
               
                   
               
             
          
           
               
                 0.0-5.0  
                 100 
                 0 
               
               
                 20 
                 20 
                 80 
               
               
                 25 
                 20 
                 80 
               
               
                 30 
                 100 
                 0 
               
               
                   
               
             
          
         
       
     
     The secondary step utilizes the same column and conditions, but with only an isocratic mobile phase: 20% MeCN in water. 
     Those of skill in the art will recognize that the particular column, mobile phases, injection volumes and other HPLC parameters can vary. 
     In one embodiment, the present invention provides isolated and highly purified reb M2. Reb M2 is an isomer of reb M and has the following structure: 
     
       
                 
         
             
             
         
      
     
     In another embodiment, the present invention provides reb M2 having a purity greater than about 95% by weight on an anhydrous basis, such as, for example, greater than about 96% by weight, greater than about 97% by weight, greater than about 98% by weight or greater than about 99% by weight. 
     In still another embodiment, the present invention provides reb M2 having a purity greater than about 95% by weight in a steviol glycoside mixture, such as, for example, greater than about 96% by weight, greater than about 97% by weight, greater than about 98% by weight or greater than about 99% by weight. 
     In yet another embodiment, the present invention provides reb M2 having a purity greater than about 95% by weight in a  stevia  extract, such as, for example, greater than about 96% by weight, greater than about 97% by weight, greater than about 98% by weight or greater than about 99% by weight. 
     The present invention also provides compositions comprising reb M2. 
     It has been found that reb M2 is produced during biotransformation of reb A to reb D. As noted above, biotransformation of reb A to reb D also produces reb D2. Accordingly, in one embodiment, the present invention provides a method for preparing reb M2 comprising:
         a. contacting a starting composition comprising reb A and/or reb D2 with an enzyme capable of transforming reb A and/or reb D2 to reb M2, UDP-glucose, and optionally UDP-glucose recycling enzymes to produce a composition comprising reb M2; and   b. isolating a composition comprising reb M2.       

     Not wishing to be bound by theory, it is currently believed that the pathway begins with transformation of reb A to reb D2, followed by transformation of reb D2 to reb M2. Accordingly, In one embodiment, the present invention provides a method for preparing reb M2 comprising:
         a. contacting a starting composition comprising reb D2 with an enzyme capable of transforming reb D2 to reb M2, UDP-glucose, and optionally UDP-glucose recycling enzymes to produce a composition comprising reb M2; and   b. isolating a composition comprising reb M2.       

     In yet another embodiment, a method for preparing reb M2 comprises:
         a. contacting a starting composition comprising reb A with an enzyme capable of transforming reb A to reb D2, UDP-glucose, and optionally UDP-glucose recycling enzymes to produce a composition comprising reb D2;   b. optionally, isolating a composition comprising reb D2;   c. contacting the composition comprising reb D2 with an enzyme capable of transforming reb D2 to reb M2, UDP-glucose, and optionally UDP-glucose recycling enzymes to produce a composition comprising reb M2; and   d. isolating a composition comprising reb M2.       

     The enzyme can be a UDP-glucosyltransferase, such as, for example, UGT91D2, UGTSL, UGTSL_Sc, UGTSL2 (GI No. 460410132 version XP_004250485.1), GI No. 460409128 (UGTSL) version XP_004249992.1, GI No. 115454819 version NP_001051010.1, GI No. 187373030, version ACD03249.1. GI No. 222619587 version EEE55719.1, GI No. 297795735 version XP_002865752.1 or EUGT11. 
     The enzyme can be immobilized or in a recombinant microorganism. 
     In one embodiment, the enzyme is immobilized. In another embodiment, the enzyme is in a recombinant microorganism. 
     In one embodiment, the microorganism is free. In another embodiment, the microorganism is immobilized. For example, the microorganism may be immobilized to a solid support made from inorganic or organic materials. Non-limiting examples of solid supports suitable to immobilize the microorganism include derivatized cellulose or glass, ceramics, metal oxides or membranes. The microorganism may be immobilized to the solid support, for example, by covalent attachment, adsorption, cross-linking, entrapment or encapsulation. 
     Suitable microorganisms include, but are not limited to,  E. coli, Saccharomyces  sp.,  Aspergillus  sp.,  Pichia  sp.,  Bacillus  sp.,  Yarrowia  sp. 
     In one embodiment the microorganism is in aqueous medium, comprising water, and various components selected form group including carbon sources, energy sources, nitrogen sources, microelements, vitamins, nucleosides, nucleoside phosphates, nucleoside diphosphates, nucleoside triphosphates, organic and inorganic salts, organic and mineral acids, bases etc. Carbon sources include glycerol, glucose, carbon dioxide, carbonates, bicarbonates. Nitrogen sources can include nitrates, nitrites, amino acids, peptides, peptones, or proteins. 
     In a particular embodiment, the medium comprises buffer. Suitable buffers include, but are not limited to, PIPES buffer, acetate buffer and phosphate buffer. In a particular embodiment, the medium comprises phosphate buffer. 
     In one embodiment the medium can also include an organic solvent. 
     In a particular embodiment, the enzyme is a UDP-glucosyltransferase capable of transforming reb A and/or reb D2 to reb M2 and is contained in  E. coli.    
     In a more particular embodiment, the enzyme is selected from UGT91D2, UGTSL, UGTSL_Sc, UGTSL2 (GI No. 460410132 version XP_004250485.1), GI No. 460409128 (UGTSL) version XP_004249992.1, GI No. 115454819 version NP_001051010.1, GI No. 187373030, version ACD03249.1. GI No. 222619587 version EEE55719.1, GI No. 297795735 version XP_002865752.1 or EUGT11. 
     In a still more particular embodiment, the enzyme is UGTSL2 or its improved variant produced by directed evolution and having higher activity. 
     In one embodiment, the target steviol glycoside reb M2 can be produced within the microorganism. In another embodiment, the target steviol glycoside can be secreted out in the medium. In one another embodiment, the released steviol glycoside can be continuously removed from the medium. In yet another embodiment, the target steviol glycoside is separated after the completion of the reaction. 
     Isolation of reb M2 from the reaction medium can be achieved by any suitable method to provide a composition comprising reb M2. Suitable methods include, but are not limited to, lysis, crystallization, separation by membranes, centrifugation, extraction (liquid or solid phase), chromatographic separation, HPLC (preparative or analytical) or a combination of such methods. In a particular embodiment, isolation can be achieved by lysis and centrifugation. 
     In some embodiments, isolation may result in a reb M2 purity less than about 95% by weight on an anhydrous basis, and the composition may contain, e.g., steviol glycosides and/or residual reaction products. 
     The composition comprising reb M2 can be further purified to provide highly purified reb M2, i.e. reb M2 having a purity greater than about 95% by weight on an anhydrous basis. In some embodiments, the compositions comprising reb M2 can be further purified to provide reb M2 having a purity greater than about 96%, greater than about 97%, greater than about 98% or greater than about 99% by weight on an anhydrous basis. 
     Purification can be affected by any means known to one of skill in the art including, but not limited to, crystallization, separation by membranes, centrifugation, extraction (liquid or solid phase), chromatographic separation, HPLC (preparative or analytical) or a combination of such methods. In a particular embodiment, HPLC is used to purify reb M2. In a more particular embodiment, semi-preparative HPLC is used to purify reb M2. 
     For example, a two-step semi-preparative HPLC purification can be used. The first step utilizes a C18 column with a mobile phase containing A (25% MeCN in water) and B (30% MeCN in water) with the following gradient: 
     
       
         
               
               
               
             
               
               
               
             
           
               
                   
               
               
                 Time (min) 
                 % A 
                 % B 
               
               
                   
               
             
             
               
                   
               
             
          
           
               
                 0.0-5.0  
                 100 
                 0 
               
               
                 20 
                 20 
                 80 
               
               
                 25 
                 20 
                 80 
               
               
                 30 
                 100 
                 0 
               
               
                   
               
             
          
         
       
     
     The secondary step utilizes the same column and conditions, but with only an isocratic mobile phase: 20% MeCN in water. 
     Those of skill in the art will recognize that the particular column, mobile phases, injection volumes and other HPLC parameters can vary. 
     Purified steviol glycosides, prepared in accordance with the present invention, may be used in a variety of consumable products including, but not limited to, foods, beverages, pharmaceutical compositions, tobacco products, nutraceutical compositions, oral hygiene compositions, and cosmetic compositions. 
     The high purity reb M obtained in this invention, having a molecular weight of 1291.29, a molecular formula of C 56 H 90 O 33 , CAS registry number 1220616-44-3, and the structure presented in  FIG. 1 , is in the form of a white and odorless powder. The compound is about 200 times sweeter than sugar when compared to a 10% sucrose solution. The infrared absorption spectrum is shown in  FIG. 4 . 
     Other properties of the pure reb M compound include a melting point of 249-250° C., and a specific rotation of [α] D   25  −19.0° in 50% ethanol (C=1.0). The solubility of reb M in water is around 0.3%, and increases with an increase in temperature. 
     Reb M is soluble in diluted solutions of methanol, ethanol, n-propanol, and isopropanol. However, it is insoluble in acetone, benzene, chloroform, and ether. 
     Reb M obtained in accordance with the present invention is heat and pH-stable. 
     Highly purified target glycoside(s) particularly, reb D, reb D2, reb M and/or reb M2 obtained according to this invention can be used “as-is” or in combination with at least one sweetener, flavor, food ingredient and/or combination thereof. 
     Non-limiting examples of flavors include lime, lemon, orange, fruit, banana, grape, pear, pineapple, mango, berry, bitter almond, cola, cinnamon, sugar, cotton candy and vanilla flavors and/or combination thereof. 
     Non-limiting examples of other food ingredients include at least one selected from flavors, acidulants, organic and amino acids, coloring agents, bulking agents, modified starches, gums, texturizers, preservatives, antioxidants, emulsifiers, stabilizers, thickeners and gelling agents and/or combination thereof. 
     Highly purified target glycoside(s) particularly, reb D, reb D2, reb M and/or reb M2 obtained according to this invention can be prepared in various polymorphic forms, including but not limited to hydrates, solvates, anhydrous, amorphous forms and/or combination thereof. 
     Highly purified target steviol glycoside(s), particularly, reb D, reb D2, reb M and/or reb M2 obtained according to this invention may be incorporated as a high intensity natural sweetener in foodstuffs, beverages, pharmaceutical compositions, cosmetics, chewing gums, table top products, cereals, dairy products, toothpastes and other oral cavity compositions, etc. 
     Highly purified target steviol glycoside(s), particularly, reb D, reb D2, reb M and/or reb M2 as a sweetening compound may be employed as the sole sweetener, or it may be used together with at least one naturally occurring high intensity sweeteners such as stevioside, reb A, reb B, reb C, reb D, reb E, reb F, steviolbioside, dulcoside A, rubusoside, mogrosides, brazzein, neohesperidin dihydrochalcone, glycyrrhizic acid and its salts, thaumatin, perillartine, pernandulcin, mukuroziosides, baiyunoside, phlomisoside-I, dimethyl-hexahydrofluorene-dicarboxylic acid, abrusosides, periandrin, carnosiflosides, cyclocarioside, pterocaryosides, polypodoside A, brazilin, hernandulcin, phillodulcin, glycyphyllin, phlorizin, trilobatin, dihydroflavonol, dihydroquercetin-3-acetate, neoastilibin, trans-cinnamaldehyde, monatin and its salts, selligueain A, hematoxylin, monellin, osladin, pterocaryoside A, pterocaryoside B, mabinlin, pentadin, miraculin, curculin, neoculin, chlorogenic acid, cynarin, Luo Han Guo sweetener, mogroside V, siamenoside and/or combination thereof. 
     In a particular embodiment, reb D2 and/or reb M2 can be used together in a sweetener composition comprising a compound selected from the group consisting of reb A, reb B, reb D, NSF-02, Mogroside V, erythritol and/or combinations thereof. 
     Highly purified target steviol glycoside(s), particularly, reb D, reb D2, reb M and/or reb M2 may also be used in combination with synthetic high intensity sweeteners such as sucralose, potassium acesulfame, aspartame, alitame, saccharin, neohesperidin dihydrochalcone, cyclamate, neotame, dulcin, suosan advantame, salts thereof, and the like. 
     Moreover, highly purified target steviol glycoside(s), particularly, reb D, reb D2, reb M and/or reb M2 can be used in combination with natural sweetener suppressors such as gymnemic acid, hodulcin, ziziphin, lactisole, and others. Reb D, reb D2, reb M and/or reb M2 may also be combined with various umami taste enhancers. Reb D, reb D2, reb M and/or reb M2 can be mixed with umami tasting and sweet amino acids such as glutamate, aspartic acid, glycine, alanine, threonine, proline, serine, glutamate, lysine and tryptophan. 
     Highly purified target steviol glycoside(s), particularly, reb D, reb D2, reb M can be used in combination with one or more additive selected from the group consisting of carbohydrates, polyols, amino acids and their corresponding salts, poly-amino acids and their corresponding salts, sugar acids and their corresponding salts, nucleotides, organic acids, inorganic acids, organic salts including organic acid salts and organic base salts, inorganic salts, bitter compounds, flavorants and flavoring ingredients, astringent compounds, proteins or protein hydrolysates, surfactants, emulsifiers, flavonoids, alcohols, polymers and combinations thereof. 
     Highly purified target steviol glycoside(s), particularly, reb D, reb D2, reb M and/or reb M2 may be combined with polyols or sugar alcohols. The term “polyol” refers to a molecule that contains more than one hydroxyl group. A polyol may be a diol, triol, or a tetraol which contain 2, 3, and 4 hydroxyl groups, respectively. A polyol also may contain more than four hydroxyl groups, such as a pentaol, hexaol, heptaol, or the like, which contain 5, 6, or 7 hydroxyl groups, respectively. Additionally, a polyol also may be a sugar alcohol, polyhydric alcohol, or polyalcohol which is a reduced form of carbohydrate, wherein the carbonyl group (aldehyde or ketone, reducing sugar) has been reduced to a primary or secondary hydroxyl group. Examples of polyols include, but are not limited to, erythritol, maltitol, mannitol, sorbitol, lactitol, xylitol, inositol, isomalt, propylene glycol, glycerol, threitol, galactitol, hydrogenated isomaltulose, reduced isomalto-oligosaccharides, reduced xylo-oligosaccharides, reduced gentio-oligosaccharides, reduced maltose syrup, reduced glucose syrup, hydrogenated starch hydrolyzates, polyglycitols and sugar alcohols or any other carbohydrates capable of being reduced which do not adversely affect the taste of the sweetener composition. 
     Highly purified target steviol glycoside(s), particularly, reb D, reb D2, reb M and/or reb M2 may be combined with reduced calorie sweeteners such as D-tagatose, allulose, allose, L-sugars, L-sorbose, L-arabinose, and others. 
     Highly purified target steviol glycoside(s), particularly, reb D, reb D2, reb M and/or reb M2 may also be combined with various carbohydrates. The term “carbohydrate” generally refers to aldehyde or ketone compounds substituted with multiple hydroxyl groups, of the general formula (CH 2 O) n , wherein n is 3-30, as well as their oligomers and polymers. The carbohydrates of the present invention can, in addition, be substituted or deoxygenated at one or more positions. Carbohydrates, as used herein, encompass unmodified carbohydrates, carbohydrate derivatives, substituted carbohydrates, and modified carbohydrates. As used herein, the phrases “carbohydrate derivatives”, “substituted carbohydrate”, and “modified carbohydrates” are synonymous. Modified carbohydrate means any carbohydrate wherein at least one atom has been added, removed, or substituted, or combinations thereof. Thus, carbohydrate derivatives or substituted carbohydrates include substituted and unsubstituted monosaccharides, disaccharides, oligosaccharides, and polysaccharides. The carbohydrate derivatives or substituted carbohydrates optionally can be deoxygenated at any corresponding C-position, and/or substituted with one or more moieties such as hydrogen, halogen, haloalkyl, carboxyl, acyl, acyloxy, amino, amido, carboxyl derivatives, alkylamino, dialkylamino, arylamino, alkoxy, aryloxy, nitro, cyano, sulfo, mercapto, imino, sulfonyl, sulfenyl, sulfonyl, sulfamoyl, carboalkoxy, carboxamido, phosphonyl, phosphinyl, phosphoryl, phosphino, thioester, thioether, oximino, hydrazino, carbamyl, phospho, phosphonato, or any other viable functional group provided the carbohydrate derivative or substituted carbohydrate functions to improve the sweet taste of the sweetener composition. 
     Examples of carbohydrates which may be used in accordance with this invention include, but are not limited to, Psicose, turanose, allulose, allose, D-tagatose, trehalose, galactose, rhamnose, various cyclodextrins, cyclic oligosaccharides, various types of maltodextrins, dextran, sucrose, glucose, ribulose, fructose, threose, arabinose, xylose, lyxose, allose, altrose, mannose, idose, lactose, maltose, invert sugar, isotrehalose, neotrehalose, isomaltulose, erythrose, deoxyribose, gulose, idose, talose, erythrulose, xylulose, psicose, turanose, cellobiose, amylopectin, glucosamine, mannosamine, fucose, glucuronic acid, gluconic acid, glucono-lactone, abequose, galactosamine, beet oligosaccharides, isomalto-oligosaccharides (isomaltose, isomaltotriose, panose and the like), xylo-oligosaccharides (xylotriose, xylobiose and the like), xylo-terminated oligosaccharides, gentio-oligosaccharides (gentiobiose, gentiotriose, gentiotetraose and the like), sorbose, nigero-oligosaccharides, palatinose oligosaccharides, fructooligosaccharides (kestose, nystose and the like), maltotetraol, maltotriol, malto-oligosaccharides (maltotriose, maltotetraose, maltopentaose, maltohexaose, maltoheptaose and the like), starch, inulin, inulo-oligosaccharides, lactulose, melibiose, raffinose, ribose, isomerized liquid sugars such as high fructose corn syrups, coupling sugars, and soybean oligosaccharides. Additionally, the carbohydrates as used herein may be in either the D- or L-configuration. 
     Highly purified target steviol glycoside(s), particularly, reb D, reb D2, reb M and/or reb M2 obtained according to this invention can be used in combination with various physiologically active substances or functional ingredients. Functional ingredients generally are classified into categories such as carotenoids, dietary fiber, fatty acids, saponins, antioxidants, nutraceuticals, flavonoids, isothiocyanates, phenols, plant sterols and stanols (phytosterols and phytostanols); polyols; prebiotics, probiotics; phytoestrogens; soy protein; sulfides/thiols; amino acids; proteins; vitamins; and minerals. Functional ingredients also may be classified based on their health benefits, such as cardiovascular, cholesterol-reducing, and anti-inflammatory. Exemplary functional ingredients are provided in WO2013/096420, the contents of which is hereby incorporated by reference. 
     Highly purified target steviol glycoside(s), particularly, reb D, reb D2, reb M and/or reb M2 obtained according to this invention may be applied as a high intensity sweetener to produce zero calorie, reduced calorie or diabetic beverages and food products with improved taste characteristics. It may also be used in drinks, foodstuffs, pharmaceuticals, and other products in which sugar cannot be used. In addition, highly purified target steviol glycoside(s), particularly, reb D, reb D2, reb M and/or reb M2 can be used as a sweetener not only for drinks, foodstuffs, and other products dedicated for human consumption, but also in animal feed and fodder with improved characteristics. 
     Examples of consumable products in which highly purified target steviol glycoside(s), particularly, reb D, reb D2, reb M and/or reb M2 may be used as a sweetening compound include, but are not limited to, alcoholic beverages such as vodka, wine, beer, liquor, and sake, etc.; natural juices; refreshing drinks; carbonated soft drinks; diet drinks; zero calorie drinks; reduced calorie drinks and foods; yogurt drinks; instant juices; instant coffee; powdered types of instant beverages; canned products; syrups; fermented soybean paste; soy sauce; vinegar; dressings; mayonnaise; ketchups; curry; soup; instant bouillon; powdered soy sauce; powdered vinegar; types of biscuits; rice biscuit; crackers; bread; chocolates; caramel; candy; chewing gum; jelly; pudding; preserved fruits and vegetables; fresh cream; jam; marmalade; flower paste; powdered milk; ice cream; sorbet; vegetables and fruits packed in bottles; canned and boiled beans; meat and foods boiled in sweetened sauce; agricultural vegetable food products; seafood; ham; sausage; fish ham; fish sausage; fish paste; deep fried fish products; dried seafood products; frozen food products; preserved seaweed; preserved meat; tobacco; medicinal products; and many others. In principle it can have unlimited applications. 
     During the manufacturing of products such as foodstuffs, drinks, pharmaceuticals, cosmetics, table top products, and chewing gum, the conventional methods such as mixing, kneading, dissolution, pickling, permeation, percolation, sprinkling, atomizing, infusing and other methods may be used. 
     Moreover, the highly purified target steviol glycoside(s), particularly, reb D, reb D2, reb M and/or reb M2 obtained in this invention may be used in dry or liquid forms. In one embodiment, a tabletop sweetener comprising reb D2 is provided. In another embodiment, a tabletop sweetener comprising reb M2 is provided. 
     The highly purified target steviol glycoside can be added before or after heat treatment of food products. The amount of the highly purified target steviol glycoside(s), particularly, reb D, reb D2, reb M and/or reb M2 depends on the purpose of usage. As discussed above, it can be added alone or in combination with other compounds. 
     The present invention is also directed to sweetness enhancement in beverages using reb D2. The present invention is also directed to sweetness enhancement in beverages using reb M2. Accordingly, the present invention provides a beverage comprising a sweetener and reb D2 and/or reb M2 as a sweetness enhancer, wherein reb D2 and/or reb M2 is present in a concentration at or below their respective sweetness recognition thresholds. 
     As used herein, the term “sweetness enhancer” refers to a compound capable of enhancing or intensifying the perception of sweet taste in a composition, such as a beverage. The term “sweetness enhancer” is synonymous with the terms “sweet taste potentiator,” “sweetness potentiator,” “sweetness amplifier,” and “sweetness intensifier.” 
     The term “sweetness recognition threshold concentration,” as generally used herein, is the lowest known concentration of a sweet compound that is perceivable by the human sense of taste, typically around 1.0% sucrose equivalence (1.0% SE). Generally, the sweetness enhancers may enhance or potentiate the sweet taste of sweeteners without providing any noticeable sweet taste by themselves when present at or below the sweetness recognition threshold concentration of a given sweetness enhancer; however, the sweetness enhancers may themselves provide sweet taste at concentrations above their sweetness recognition threshold concentration. The sweetness recognition threshold concentration is specific for a particular enhancer and can vary based on the beverage matrix. The sweetness recognition threshold concentration can be easily determined by taste testing increasing concentrations of a given enhancer until greater than 1.0% sucrose equivalence in a given beverage matrix is detected. The concentration that provides about 1.0% sucrose equivalence is considered the sweetness recognition threshold. 
     In some embodiments, sweetener is present in the beverage in an amount from about 0.5% to about 12% by weight, such as, for example, about 1.0% by weight, about 1.5% by weight, about 2.0% by weight, about 2.5% by weight, about 3.0% by weight, about 3.5% by weight, about 4.0% by weight, about 4.5% by weight, about 5.0% by weight, about 5.5% by weight, about 6.0% by weight, about 6.5% by weight, about 7.0% by weight, about 7.5% by weight, about 8.0% by weight, about 8.5% by weight, about 9.0% by weight, about 9.5% by weight, about 10.0% by weight, about 10.5% by weight, about 11.0% by weight, about 11.5% by weight or about 12.0% by weight. 
     In a particular embodiment, the sweetener is present in the beverage in an amount from about 0.5% of about 10%, such as for example, from about 2% to about 8%, from about 3% to about 7% or from about 4% to about 6% by weight. In a particular embodiment, the sweetener is present in the beverage in an amount from about 0.5% to about 8% by weight. In another particular embodiment, the sweetener is present in the beverage in an amount from about 2% to about 8% by weight. 
     In one embodiment, the sweetener is a traditional caloric sweetener. Suitable sweeteners include, but are not limited to, sucrose, fructose, glucose, high fructose corn syrup and high fructose starch syrup. 
     In another embodiment, the sweetener is erythritol. 
     In still another embodiment, the sweetener is a rare sugar. Suitable rare sugars include, but are not limited to, D-allose, D-psicose, L-ribose, D-tagatose, L-glucose, L-fucose, L-arbinose, D-turanose, D-leucrose and combinations thereof. 
     It is contemplated that a sweetener can be used alone, or in combination with other sweeteners. 
     In one embodiment, the rare sugar is D-allose. In a more particular embodiment, D-allose is present in the beverage in an amount of about 0.5% to about 10% by weight, such as, for example, from about 2% to about 8%. 
     In another embodiment, the rare sugar is D-psicose. In a more particular embodiment, D-psicose is present in the beverage in an amount of about 0.5% to about 10% by weight, such as, for example, from about 2% to about 8%. 
     In still another embodiment, the rare sugar is D-ribose. In a more particular embodiment, D-ribose is present in the beverage in an amount of about 0.5% to about 10% by weight, such as, for example, from about 2% to about 8%. 
     In yet another embodiment, the rare sugar is D-tagatose. In a more particular embodiment, D-tagatose is present in the beverage in an amount of about 0.5% to about 10% by weight, such as, for example, from about 2% to about 8%. 
     In a further embodiment, the rare sugar is L-glucose. In a more particular embodiment, L-glucose is present in the beverage in an amount of about 0.5% to about 10% by weight, such as, for example, from about 2% to about 8%. 
     In one embodiment, the rare sugar is L-fucose. In a more particular embodiment, L-fucose is present in the beverage in an amount of about 0.5% to about 10% by weight, such as, for example, from about 2% to about 8%. 
     In another embodiment, the rare sugar is L-arabinose. In a more particular embodiment, L-arabinose is present in the beverage in an amount of about 0.5% to about 10% by weight, such as, for example, from about 2% to about 8%. 
     In yet another embodiment, the rare sugar is D-turanose. In a more particular embodiment, D-turanose is present in the beverage in an amount of about 0.5% to about 10% by weight, such as, for example, from about 2% to about 8%. 
     In yet another embodiment, the rare sugar is D-leucrose. In a more particular embodiment, D-leucrose is present in the beverage in an amount of about 0.5% to about 10% by weight, such as, for example, from about 2% to about 8%. 
     The addition of the sweetness enhancer at a concentration at or below its sweetness recognition threshold increases the detected sucrose equivalence of the beverage comprising the sweetener and the sweetness enhancer compared to a corresponding beverage in the absence of the sweetness enhancer. Moreover, sweetness can be increased by an amount more than the detectable sweetness of a solution containing the same concentration of the at least one sweetness enhancer in the absence of any sweetener. 
     Accordingly, the present invention also provides a method for enhancing the sweetness of a beverage comprising a sweetener comprising providing a beverage comprising a sweetener and adding a sweetness enhancer selected from reb D2, reb M2 or a combination thereof, wherein reb D2 and reb M2 are present in a concentration at or below their sweetness recognition thresholds. 
     Addition of reb D2 and/or reb M2 in a concentration at or below the sweetness recognition threshold to a beverage containing a sweetener may increase the detected sucrose equivalence from about 1.0% to about 5.0%, such as, for example, about 1.0%, about 1.5%, about 2.0%, about 2.5%, about 3.0%, about 3.5%, about 4.0%, about 4.5% or about 5.0%. 
     The following examples illustrate preferred embodiments of the invention for the preparation of highly purified target steviol glycoside(s), particularly, reb D, reb D2, reb M and/or reb M2. It will be understood that the invention is not limited to the materials, proportions, conditions and procedures set forth in the examples, which are only illustrative. 
     Example 1 
     In-Vivo Production of UGT76G1 
     NcoI and NdeI restriction sides were added to the original nucleic sequence as described in Genbank accession no. AAR06912.1. After codon optimization the following nucleic sequence was obtained (SEQ ID 1): 
     
       
         
               
             
           
               
                 CCATGGCCCATATGGAAAACAAAACCGAAACCACCGTTCGTCGTCGTCGC 
               
               
                   
               
               
                 CGTATTATTCTGTTTCCGGTTCCGTTTCAGGGTCATATTAATCCGATTCT 
               
               
                   
               
               
                 GCAGCTGGCAAATGTGCTGTATAGCAAAGGTTTTAGCATTACCATTTTTC 
               
               
                   
               
               
                 ATACCAATTTTAACAAACCGAAAACCAGCAATTATCCGCATTTTACCTTT 
               
               
                   
               
               
                 CGCTTTATTCTGGATAATGATCCGCAGGATGAACGCATTAGCAATCTGCC 
               
               
                   
               
               
                 GACACATGGTCCGCTGGCAGGTATGCGTATTCCGATTATTAACGAACATG 
               
               
                   
               
               
                 GTGCAGATGAACTGCGTCGTGAACTGGAACTGCTGATGCTGGCAAGCGAA 
               
               
                   
               
               
                 GAAGATGAAGAAGTTAGCTGTCTGATTACCGATGCACTGTGGTATTTTGC 
               
               
                   
               
               
                 ACAGAGCGTTGCAGATAGCCTGAATCTGCGTCGTCTGGTTCTGATGACCA 
               
               
                   
               
               
                 GCAGCCTGTTTAACTTTCATGCACATGTTAGCCTGCCGCAGTTTGATGAA 
               
               
                   
               
               
                 CTGGGTTATCTGGATCCGGATGATAAAACCCGTCTGGAAGAACAGGCAAG 
               
               
                   
               
               
                 CGGTTTTCCGATGCTGAAAGTGAAAGATATCAAAAGCGCCTATAGCAATT 
               
               
                   
               
               
                 GGCAGATTCTGAAAGAAATTCTGGGCAAAATGATTAAACAGACCAAAGCA 
               
               
                   
               
               
                 AGCAGCGGTGTTATTTGGAATAGCTTTAAAGAACTGGAAGAAAGCGAACT 
               
               
                   
               
               
                 GGAAACCGTGATTCGTGAAATTCCGGCACCGAGCTTTCTGATTCCGCTGC 
               
               
                   
               
               
                 CGAAACATCTGACCGCAAGCAGCAGCAGCCTGCTGGATCATGATCGTACC 
               
               
                   
               
               
                 GTTTTTCAGTGGCTGGATCAGCAGCCTCCGAGCAGCGTTCTGTATGTTAG 
               
               
                   
               
               
                 CTTTGGTAGCACCAGCGAAGTTGATGAAAAAGATTTTCTGGAAATTGCCC 
               
               
                   
               
               
                 GTGGTCTGGTTGATAGCAAACAGAGCTTTCTGTGGGTTGTTCGTCCGGGT 
               
               
                   
               
               
                 TTTGTTAAAGGTAGCACCTGGGTTGAACCGCTGCCGGATGGTTTTCTGGG 
               
               
                   
               
               
                 TGAACGTGGTCGTATTGTTAAATGGGTTCCGCAGCAAGAAGTTCTGGCAC 
               
               
                   
               
               
                 ACGGCGCAATTGGTGCATTTTGGACCCATAGCGGTTGGAATAGCACCCTG 
               
               
                   
               
               
                 GAAAGCGTTTGTGAAGGTGTTCCGATGATTTTTAGCGATTTTGGTCTGGA 
               
               
                   
               
               
                 TCAGCCGCTGAATGCACGTTATATGAGTGATGTTCTGAAAGTGGGTGTGT 
               
               
                   
               
               
                 ATCTGGAAAATGGTTGGGAACGTGGTGAAATTGCAAATGCAATTCGTCGT 
               
               
                   
               
               
                 GTTATGGTGGATGAAGAAGGTGAATATATTCGTCAGAATGCCCGTGTTCT 
               
               
                   
               
               
                 GAAACAGAAAGCAGATGTTAGCCTGATGAAAGGTGGTAGCAGCTATGAAA 
               
               
                   
               
               
                 GCCTGGAAAGTCTGGTTAGCTATATTAGCAGCCTGTAATAACTCGAG 
               
             
          
         
       
     
     After synthesis of the gene and subcloning into pET30A+ vector using NdeI and XhoI cloning sites, the UGT76G1_pET30a+ plasmid was introduced in  E. coli  Bl21(DE3) and  E. coli  EC100 by electroporation. The obtained cells were grown in petri-dishes in the presence of Kanamycin and suitable colonies were selected and allowed to grow in liquid LB medium (erlenmeyer flasks). Glycerol was added to the suspension as cryoprotectant and 400 μL aliquots were stored at −20° C. and at −80° C. 
     The storage aliquots of  E. coli  BL21(DE3) containing the pET30A+_UGT76G1 plasmid were thawed and added to 30 mL of LBGKP medium (20 g/L Luria Broth Lennox; 50 mM PIPES buffer pH 7.00; 50 mM Phosphate buffer pH 7.00; 2.5 g/L glucose and 50 mg/L of Kanamycin). This culture was allowed to shake at 135 rpm at 30° C. for 8 h. 
     The production medium contained 60 g/L of overnight express instant TB medium (Novagen), 10 g/L of glycerol and 50 mg/L of Kanamycin. The medium was allowed to stir at 20° C. while taking samples to measure the OD and pH. The cultures gave significant growth and a good OD was obtained. After 40 h, the cells were harvested by centrifugation and frozen to yield 12.7 g of cell wet weight. 
     Lysis was performed by addition of Bugbuster Master mix (Novagen) and the lysate was recovered by centrifugation and kept frozen. Activity tests were performed with thawed lysate. 
     Example 2 
     In-Vitro Production of UGT76G1 
     The S30 T7 High Yield Protein expression system kit from Promega was used. 4 μg of UGT76G1_pET30a+ plasmid from  E. coli  EC100 was mixed with 80 μL of S30 premix plus and 72 μL of S30 T7 extract was added. Nuclease-free water was added in order to obtain a total volume of 200 μL and the resulting solution was incubated for 2 h at 30° C. 180 μL was used in the catalytic test reaction. 
     Example 3 
     In-Vitro Production of UGT91D2 
     NcoI and NdeI restriction sides were added to the original nucleic sequence as described in Genbank accession no. ACE87855.1. After codon optimization the following nucleic sequence was obtained (SEQ ID 2): 
     
       
         
               
             
           
               
                 CCATGGCACATATGGCAACCAGCGATAGCATTGTTGATGATCGTAAACAG 
               
               
                   
               
               
                 CTGCATGTTGCAACCTTTCCGTGGCTGGCATTTGGTCATATTCTGCCGTA 
               
               
                   
               
               
                 TCTGCAGCTGAGCAAACTGATTGCAGAAAAAGGTCATAAAGTGAGCTTTC 
               
               
                   
               
               
                 TGAGCACCACCCGTAATATTCAGCGTCTGAGCAGCCATATTAGTCCGCTG 
               
               
                   
               
               
                 ATTAATGTTGTTCAGCTGACCCTGCCTCGTGTTCAAGAACTGCCGGAAGA 
               
               
                   
               
               
                 TGCCGAAGCAACCACCGATGTTCATCCGGAAGATATTCCGTATCTGAAAA 
               
               
                   
               
               
                 AAGCAAGTGATGGTCTGCAGCCGGAAGTTACCCGTTTTCTGGAACAGCAT 
               
               
                   
               
               
                 AGTCCGGATTGGATCATCTATGATTATACCCATTATTGGCTGCCGAGCAT 
               
               
                   
               
               
                 TGCAGCAAGCCTGGGTATTAGCCGTGCACATTTTAGCGTTACCACCCCGT 
               
               
                   
               
               
                 GGGCAATTGCATATATGGGTCCGAGCGCAGATGCAATGATTAATGGTAGT 
               
               
                   
               
               
                 GATGGTCGTACCACCGTTGAAGATCTGACCACCCCTCCGAAATGGTTTCC 
               
               
                   
               
               
                 GTTTCCGACCAAAGTTTGTTGGCGTAAACATGATCTGGCACGTCTGGTTC 
               
               
                   
               
               
                 CGTATAAAGCACCGGGTATTAGTGATGGTTATCGTATGGGTCTGGTTCTG 
               
               
                   
               
               
                 AAAGGTAGCGATTGTCTGCTGAGCAAATGCTATCATGAATTTGGCACCCA 
               
               
                   
               
               
                 GTGGCTGCCGCTGCTGGAAACCCTGCATCAGGTTCCGGTTGTTCCGGTGG 
               
               
                   
               
               
                 GTCTGCTGCCTCCGGAAGTTCCGGGTGATGAAAAAGATGAAACCTGGGTT 
               
               
                   
               
               
                 AGCATCAAAAAATGGCTGGATGGTAAACAGAAAGGTAGCGTGGTTTATGT 
               
               
                   
               
               
                 TGCACTGGGTAGCGAAGTTCTGGTTAGCCAGACCGAAGTTGTTGAACTGG 
               
               
                   
               
               
                 CACTGGGTCTGGAACTGAGCGGTCTGCCGTTTGTTTGGGCATATCGTAAA 
               
               
                   
               
               
                 CCGAAAGGTCCGGCAAAAAGCGATAGCGTTGAACTGCCGGATGGTTTTGT 
               
               
                   
               
               
                 TGAACGTACCCGTGATCGTGGTCTGGTTTGGACCAGCTGGGCACCTCAGC 
               
               
                   
               
               
                 TGCGTATTCTGAGCCATGAAAGCGTTTGTGGTTTTCTGACCCATTGTGGT 
               
               
                   
               
               
                 AGCGGTAGCATTGTGGAAGGTCTGATGTTTGGTCATCCGCTGATTATGCT 
               
               
                   
               
               
                 GCCGATTTTTGGTGATCAGCCGCTGAATGCACGTCTGCTGGAAGATAAAC 
               
               
                   
               
               
                 AGGTTGGTATTGAAATTCCGCGTAATGAAGAAGATGGTTGCCTGACCAAA 
               
               
                   
               
               
                 GAAAGCGTTGCACGTAGCCTGCGTAGCGTTGTTGTTGAAAAAGAAGGCGA 
               
               
                   
               
               
                 AATCTATAAAGCCAATGCACGTGAACTGAGCAAAATCTATAATGATACCA 
               
               
                   
               
               
                 AAGTGGAAAAAGAATATGTGAGCCAGTTCGTGGATTATCTGGAAAAAAAC 
               
               
                   
               
               
                 ACCCGTGCAGTTGCCATTGATCACGAAAGCTAATGACTCGAG 
               
             
          
         
       
     
     After synthesis of the gene and subcloning into pET30A+ vector using NcoI and XhoI cloning sites, the UGT91D2_pET30a+ plasmid was introduced into  E. coli  EC100 by electroporation. The obtained cells were grown in the presence of Kanamycin and suitable colonies were selected and allowed to grow in liquid LB medium (erlenmeyer flasks). Glycerol was added to the suspension as cryoprotectant and 400 μL aliquots were stored at −20° C. and at −80° C. 
     The S30 T7 High Yield Protein expression system kit from Promega was used for the in-vitro synthesis of the protein. 
     4 μg of UGT91D2_pET30a+ plasmid was mixed with 80 μL of S30 premix plus and 72 μL of S30 T7 extract was added. Nuclease-free water was added in order to obtain a total volume of 200 μL and the resulting solution was incubated for 2 h at 30° C. 5 μL was used for SDS-page analysis while the remaining 45 μL was used in the catalytic test reaction. 
     Example 4 
     Catalytic Reaction with In-Vivo Produced UGT76G1 
     The total volume of the reaction was 5.0 mL with the following composition: 50 mM sodium phosphate buffer pH 7.2, 3 mM MgCl 2 , 2.5 mM UDP-glucose, 0.5 mM Stevioside and 500 μL of UGT76G1 thawed lysate. The reactions were run at 30° C. on an orbitary shaker at 135 rpm. For each sample, 460 μL of the reaction mixture was quenched with 40 μL of 2N H 2 SO 4  and 420 μL of methanol/water (6/4). The samples were immediately centrifuged and kept at 10° C. before analysis by HPLC (CAD). HPLC indicated almost complete conversion of stevioside to rebaudioside A as seen in  FIG. 40 . 
     Example 5 
     Catalytic Reaction with In-Vitro Produced UGT91D2 
     The total volume of the reaction was 0.5 mL with the following composition: 50 mM sodium phosphate buffer pH 7.2, 3 mM MgCl 2 , 3.8 mM UDP-glucose, 0.1 mM Rebaudioside A and 180 μL of in-vitro produced UGT91D2. The reactions were run at 30° C. on an orbitary shaker at 135 rpm. For each sample, 450 μL of reaction mixture was quenched with 45 μL of 2N H 2 SO 4  and 405 μL of 60% MeOH. After centrifugation, the supernatant was analyzed by HPLC (CAD). HPLC indicated a 4.7% conversion of rebaudioside A to rebaudioside D after 120 h. 
     Example 6 
     Catalytic Reaction with In-Vitro Produced UGT76G1 
     The total volume of the reaction was 2 mL with the following composition: 50 mM sodium phosphate buffer pH 7.2, 3 mM MgCl 2 , 3.8 mM UDP-glucose, 0.5 mM Rebaudioside D and 180 μL of in-vitro produced UGT76G1. The reactions were run at 30° C. on an orbitary shaker at 135 rpm. For each sample, 400 μL of reaction mixture was quenched with 40 μL of 2N H 2 SO 4  and 360 μL of 60% MeOH. After centrifugation, the supernatant was analyzed by HPLC (CAD). HPLC indicated 80% conversion of rebaudioside D to rebaudioside M after 120 h as seen in  FIG. 41 . 
     For examples 7 to 12, the following abbreviations were used: 
     LBGKP medium: 20 g/L Luria Broth Lennox; 50 mM PIPES buffer pH 7.00; 50 mM Phosphate buffer pH 7.00; 2.5 g/L glucose and 50 mg/L of Kanamycin or Ampicillin LB medium: (20 g/L Luria Broth Lennox) 
     Example 7 
     Preparation and Activity of UGT76G1 Prepared by pET30a+ Plasmid and BL21 (DE3) Expression Strain 
     The pET30a+_UGT76G1 plasmid was transformed into BL21(DE3) expression strain (Lucigen E. Cloni® EXPRESS Electrocompetent Cells). The obtained cells were grown on LB Agar medium in petri-dishes in the presence of Kanamycin. Suitable colonies were selected and allowed to grow in liquid LBGKP medium containing Kanamycin. Glycerol was added and 400 μL aliquots were stored at −20° C. and at −80° C. 
     A storage aliquot was thawed and added to 30 mL of LBGKP medium. This culture was allowed to shake at 30° C. for 8 h. and subsequently used to inoculate 400 mL of production medium containing 60 g/L of “Overnight express instant TB medium” (Novagen, reference 71491-5), 10 g/L of glycerol and 50 mg/L of Kanamycin. The medium was allowed to stir at 20° C. while taking samples to measure the OD (600 nm) and pH. After 40 h, the cells were harvested by centrifugation and frozen. The obtained cell wet weight was 10.58 g. 
     3.24 g of obtained pellet was lysed by addition of 8.1 mL of “Bugbuster Master mix” (Novagen, reference 71456) and 3.5 mL of water. The lysate was recovered by centrifugation and kept frozen. 
     Example 8 
     Preparation and Activity of UGT76G1 Prepared by pET30a+ Plasmid and Tuner (DE3) Expression Strain 
     The pET30a+_UGT76G1 plasmid was transformed into Tuner (DE3) expression strain (Novagen Tuner™ (DE3) Competent cells) by heat shock treatment. The obtained cells were grown on LB Agar medium in petri-dishes in the presence of Kanamycin. Suitable colonies were selected and allowed to grow in liquid LBGKP medium containing Kanamycin). Glycerol was added and 400 μL aliquots were stored at −20° C. and at −80° C. 
     A storage aliquot was thawed and added to 100 mL of LB medium containing 50 mg/L of Kanamycin. This culture allowed to shake at 30° C. for 15 h. 4.4 mL of this culture was used to inoculate 200 mL of production medium containing LB. This medium was allowed to stir at 37° C. until an OD (600 nm) of 0.9 was obtained, after which 400 μL of a 100 mM IPTG solution was added and the medium was allowed to stir at 30° C. for 4 h. The cells were harvested by centrifugation and frozen. The obtained cell wet weight was 1.38 g. 
     The obtained pellet was lysed by addition of 4.9 mL of “Bugbuster Master mix” (Novagen, reference 71456) and 2.1 mL of water. The lysate was recovered by centrifugation and kept frozen. 
     Example 9 
     Preparation and Activity of UGT76G1 Prepared by pMAL Plasmid and BL21 Expression Strain 
     After subcloning the synthetic UGT76G1 gene into the pMAL plasmid using NdeI and SalI cloning sites, the pMAL_UGT76G1 plasmid was transformed into BL21 expression strain (New England Biolabs BL21 Competent  E. coli ) by heat shock treatment. The obtained cells were grown on LB Agar medium in petri-dishes in the presence of Ampicillin. Suitable colonies were selected and allowed to grow in liquid LBGKP medium containing Ampicillin). Glycerol was added and 400 μL aliquots were stored at −20° C. and at −80° C. 
     A storage aliquot was thawed and added to 30 mL of LBGKP medium. This culture was allowed to shake at 30° C. for 8 h. and subsequently used to inoculate 400 mL of production medium containing 60 g/L of “Overnight express instant TB medium” (Novagen, reference 71491-5), 10 g/L of glycerol and 50 mg/L of Ampicillin. The medium was allowed to stir at 20° C. while taking samples to measure the OD and pH. After 40 h, the cells were harvested by centrifugation and frozen. The obtained cell wet weight was 5.86 g. 
     2.74 g of obtained pellet was lysed by addition of 9.6 mL of “Bugbuster Master Mix” (Novagen, reference 71456) and 4.1 mL of water. The lysate was recovered by centrifugation and kept frozen. 
     Example 10 
     Preparation and Activity of UGT76G1 Prepared by pMAL Plasmid and ArcticExpress Expression Strain 
     The pMAL_UGT76G1 plasmid was transformed into ArticExpress expression strain (Agilent ArcticExpress competent cells) by heat shock treatment. The obtained cells were grown on LB Agar medium in petri-dishes in the presence of Ampicillin and Geneticin. Suitable colonies were selected and allowed to grow in liquid LBGKP medium containing of Ampicillin and Geneticin. Glycerol was added and 400 μL aliquots were stored at −20° C. and at −80° C. 
     A storage aliquot was thawed and added to 30 mL of LBGKP medium (containing Ampicillin and Geneticin). This culture was allowed to shake at 30° C. for 8 h. and subsequently used to inoculate 400 mL of production medium containing 60 g/L of “Overnight express instant TB medium” (Novagen, reference 71491-5), 10 g/L of glycerol and 50 mg/L of Ampicillin. The medium was allowed to stir at 12° C. while taking samples to measure the OD (600 nm) and pH. After 68 h, the cells were harvested by centrifugation and frozen. The obtained cell wet weight was 8.96 g. 
     2.47 g of the obtained pellet was lysed by addition of 8.73 mL of “Bugbuster Master Mix” (Novagen, reference 71456) and 3.79 mL of water. The lysate was recovered by centrifugation and kept frozen. 
     Example 11 
     Preparation and Activity of UGT76G1 Prepared by pCOLDIII Plasmid and ArcticExpress Expression Strain 
     After subcloning the synthetic UGT76G1 gene into the pCOLDIII plasmid using Nde1 and Xho1 cloning sites, the pCOLDIII_UGT76G1 plasmid was transformed into ArcticExpress expression strain (Agilent ArcticExpress competent cells) by heat shock treatment. The obtained cells were grown on LB Agar medium in petri-dishes in the presence of Ampicillin and Geneticin. Suitable colonies were selected and allowed to grow in liquid LBGKP medium containing Ampicillin and Geneticin. Glycerol was added and 400 μL aliquots were stored at −20° C. and at −80° C. 
     A storage aliquot was thawed and added to 30 mL of LBGKP medium (containing Ampicillin and Geneticin). This culture was allowed to shake at 30° C. for 8 h. and subsequently used to inoculate 400 mL of production medium containing 60 g/L of “Overnight express instant TB medium” (Novagen, reference 71491-5), 10 g/L of glycerol and 50 mg/L of Kanamycin. The medium was allowed to stir at 12° C. while taking samples to measure the OD (600 nm) and pH. After 63 h, the cells were harvested by centrifugation and frozen. The obtained cell wet weight was 6.54 g. 
     2.81 g of the obtained pellet was lysed by addition of 9.8 mL of “Bugbuster Master Mix” (Novagen, reference 71456) and 4.2 mL of water. The lysate was recovered by centrifugation and kept frozen. 
     Example 12 
     Preparation and Activity of UGT76G1 Prepared by pCOLDIII Plasmid and Origami2 (DE3) Expression Strain 
     The pCOLDIII_UGT76G1 plasmid was transformed into Origami2 (DE3) expression strain (Novagen Origami™2 (DE3) Competent Cells) by heat shock treatment. The obtained cells were grown on LB Agar medium in petri-dishes in the presence of Ampicillin. Suitable colonies were selected and allowed to grow in liquid LBGKP medium containing Ampicillin. Glycerol was added and 400 μL aliquots were stored at −20° C. and at −80° C. 
     A storage aliquot was thawed and added to 30 mL of LBGKP medium (containing Ampicillin). This culture was allowed to shake at 30° C. for 8 h. and subsequently used to inoculate 400 mL of production medium containing 60 g/L of “Overnight express instant TB medium” (Novagen, reference 71491-5), 10 g/L of glycerol and 50 mg/L of Kanamycin. The medium was allowed to stir at 12° C. while taking samples to measure the OD (600 nm) and pH. After 68 h, the cells were harvested by centrifugation and frozen. The obtained cell wet weight was 2.53 g. 
     1.71 g of the obtained pellet was lysed by addition of 6.0 mL of “Bugbuster Master mix” (Novagen, reference 71456) and 1.9 mL of water. The lysate was recovered by centrifugation and kept frozen. 
     Example 13 
     Determination of Activity 
     Activity tests were performed on a 5 mL scale with 500 μL of thawed lysate for the transformation of Stevioside to Rebaudioside A and Rebaudioside D to Rebaudioside M using 0.5 mM of substrate, 2.5 mM of UDP-Glucose and 3 mM MgCl 2  in 50 mM Sodium Phosphate buffer at pH 7.2. Samples were taken and analyzed by HPLC. The results for the different preparations of UGT76G1 are summarized in the following table. 
     
       
         
               
               
               
               
             
               
               
               
               
               
             
               
               
               
               
               
             
           
               
                   
               
               
                   
                   
                   
                 Transformation activity* 
               
             
          
           
               
                   
                   
                 Expression 
                 Stevioside to 
                 Rebaudioside D 
               
               
                 Example 
                 Plasmid 
                 strain 
                 Rebaudioside A 
                 to Rebaudioside M 
               
               
                   
               
             
          
           
               
                 7 
                 pET30a+ 
                 BL21 (DE3) 
                 29 U mL −1   
                 0.31 U mL −1   
               
               
                 8 
                 pET30a+ 
                 Tuner (DE3) 
                 33 U mL −1   
                 0.40 U mL −1   
               
               
                 9 
                 pMAL 
                 BL21 
                 20 U mL −1   
                 0.15 U mL −1   
               
               
                 10 
                 pMAL 
                 ArticExpress 
                 15 U mL −1   
                 0.25 U mL −1   
               
               
                 11 
                 pCOLDIII 
                 ArticExpress 
                 15 U mL −1   
                 0.11 U mL −1   
               
               
                 12 
                 pCOLDIII 
                 Origami2 (DE3) 
                 37 U mL −1   
                 0.20 U mL −1   
               
               
                   
               
               
                 * Note 
               
               
                 The activities for the transformation of Stevioside and Rebaudioside M are mentioned per mL of lysate. 1 U will transform 1 μmol of substrate in 1 hour at 30° C. and pH 7.2 
               
             
          
         
       
     
     Example 14 
     50 mL Scale Reaction for the Transformation of Rebaudioside D to Rebaudioside M 
     5 mL of the lysate of Example 12 was used to transform Rebaudioside D to Rebaudioside M on a 50 mL scale. The reaction medium consisted of 50 mM Sodium Phosphate buffer pH 7.2, 3 mM of MgCl 2 , 2.5 mM of UDP-Glucose and 0.5 mM of Rebaudioside D. After allowing the reaction to be shaken at 30° C. for 90 h. 50 mL of ethanol was added and the resulting mixture was allowed to stir at −20° C. for 1 h. After centrifugation at 5000 g for 10 min. the supernatant was purified via ultrafiltration (Vivaflow MWCO 30000). 78 mL of permeate was obtained and the 9 mL of retentate was diluted with 9 mL of ethanol and resubjected to Ultrafiltration (Vivaflow MWCO 30000). Another 14 mL of filtrate was obtained, which was combined with the first permeate. The combined permeates were concentrated under reduced pressure at 30° C. until 32 mL of a clear solution was obtained. 
     The HPLC trace of the product mixture is shown in  FIG. 5 . HPLC was carried out on an Agilent 1200 series equipped with a binary pump, auto sampler, and thermostat column compartment. The method was isocratic, with a mobile phase composed of 70% water (0.1% formic acid): 30% acetonitrile. The flow rate was 0.1 μL/min. The column used was Phenomenex Prodigy 5μ ODS (3) 100 A; 250×2 mm. The column temperature was maintained at 40° C. The injection volume was 20-40 μl. 
     Example 15 
     Preparation of UGT91D2 Using pMAL Plasmid and BL21 Expression Strain 
     After subcloning the synthetic UGT91D2 gene into the pMAL plasmid using NdeI and Sal1 cloning sites, the pMAL_UGT91D2 plasmid was transformed into BL21 expression strain (New England Biolabs BL21 Competent  E. coli ) by heat shock treatment. The obtained cells were grown on LB Agar medium in petri-dishes in the presence of Ampicillin. Suitable colonies were selected and allowed to grow in liquid LBGKP medium containing Ampicillin). Glycerol was added and 400 μl, aliquots were stored at −20° C. and at −80° C. 
     A storage aliquot was thawed and added to 30 mL of LBGKP medium. This culture was allowed to shake at 30° C. for 8 h. and subsequently used to inoculate 400 mL of production medium containing 60 g/L of “Overnight express instant TB medium” (Novagen, reference 71491-5), 10 g/L of glycerol and 50 mg/L of Ampicillin. The medium was allowed to stir at 20° C. while taking samples to measure the OD and pH. After 40 h, the cells were harvested by centrifugation and frozen. The obtained cell wet weight is 12.32 g. 
     2.18 g of obtained pellet was lysed by addition of 7.7 mL of “Bugbuster Master Mix” (Novagen, reference 71456) and 3.2 mL of water. The lysate was recovered by centrifugation and used directly for activity testing. 
     Example 16 
     Preparation of UGT91D2 Using pMAL Plasmid and ArcticExpress Expression Strain 
     The pMAL_UGT91D2 plasmid was transformed into ArcticExpress expression strain (Agilent ArcticExpress competent cells) by heat shock treatment. The obtained cells were grown on LB Agar medium in petri-dishes in the presence of Ampicillin and Geneticin. Suitable colonies were selected and allowed to grow in liquid LBGKP medium containing Ampicillin and Geneticin. Glycerol was added and 400 μL aliquots were stored at −20° C. and at −80° C. 
     A storage aliquot was thawed and added to 30 mL of LBGKP medium (containing Ampicillin and Geneticin). This culture was allowed to shake at 30° C. for 8 h. and subsequently used to inoculate 400 mL of production medium containing 60 g/L of “Overnight express instant TB medium” (Novagen, reference 71491-5), 10 g/L of glycerol and 50 mg/L of Ampicillin. The medium was allowed to stir at 20° C. for 16 h. followed by another 50 h. at 12° C. while taking samples to measure the OD (600 nm) and pH. The cells were harvested by centrifugation and frozen. The obtained cell wet weight is 15.77 g. 
     2.57 g of the obtained pellet was lysed by addition of 9.0 mL of “Bugbuster Master Mix” (Novagen, reference 71456) and 3.8 mL of water. The lysate was recovered by centrifugation and used directly for activity testing. 
     Example 17 
     Preparation of UGT91D2 Using pET30a+ Plasmid and Tuner (DE3) Expression Strain 
     The pET30a+_UGT91D2 plasmid was transformed into Tuner (DE3) expression strain (Novagen Tuner™ (DE3) Competent cells) by heat shock treatment. The obtained cells were grown on LB Agar medium in petri-dishes in the presence of Kanamycin. Suitable colonies were selected and allowed to grow in liquid LBGKP medium (containing Kanamycin). Glycerol was added and 400 μL aliquots were stored at −20° C. and at −80° C. 
     A storage aliquot was thawed and added to 100 mL of LB medium containing 50 mg/L of Kanamycin. This culture allowed to shake at 30° C. for 15 h. 6.2 mL of this culture was used to inoculate 500 mL of production medium containing LB. This medium was allowed to stir at 37° C. until an OD (600 nm) of 0.9 was obtained after which 500 μL of a 100 mM IPTG solution was added (IPTG concentration in medium is 100 μM) and the medium was allowed to stir at 30° C. for 4 h, the cells were harvested by centrifugation and frozen. The obtained cell wet weight is 4.02 g. 
     1.92 g of the obtained pellet was lysed by addition of 6.8 mL of “Bugbuster Master mix” (Novagen, reference 71456) and 2.8 mL of water. The lysate was recovered by centrifugation and tested directly for activity. 
     Example 18 
     Preparation of UGT91D2 Using pET30a+ Plasmid and ArcticExpress Expression Strain 
     The pET30a+_UGT91D2 plasmid was transformed into ArcticExpress (DE3) expression strain (Agilent ArcticExpress competent cells) by heat shock treatment. The obtained cells were grown on LB Agar medium in petri-dishes in the presence of Kanamycin and Geneticin. Suitable colonies were selected and allowed to grow in liquid LBGKP medium containing of Kanamycin and Geneticin. Glycerol was added and 400 μL aliquots were stored at −20° C. and at −80° C. 
     A storage aliquot was thawed and added to 30 mL of LBGKP medium (containing Kanamycin and Geneticin). This culture was allowed to shake at 30° C. for 8 h. and subsequently used to inoculate 400 mL of production medium containing 60 g/L of “Overnight express instant TB medium” (Novagen, reference 71491-5), 10 g/L of glycerol and 50 mg/L of Ampicillin. The medium was allowed to stir at 20° C. for 16 h. followed by another 50 h. at 12° C. while taking samples to measure the OD (600 nm) and pH. After 60 h, the cells were harvested by centrifugation and frozen. The obtained cell wet weight is 16.07 g. 
     3.24 g of the obtained pellet was lysed by addition of 11.4 mL of “Bugbuster Master Mix” (Novagen, reference 71456) and 4.8 mL of water. The lysate was recovered by centrifugation and used directly for activity testing. 
     Example 19 
     Determination of Activity of In-Vivo Preparations of UGT91D2 
     Activity tests were performed at 5 mL scale with 1000 μL of lysate for the transformation of Rubusoside to Stevioside using 0.5 mM of substrate, 2.5 mM of UDP-Glucose and 3 mM MgCl 2  in 50 mM Sodium Phosphate buffer at pH 7.2. Samples were taken and analyzed by HPLC. The results for the different preparations of UGT91D2 are summarized in the following table. 
     
       
         
               
               
               
               
             
               
               
               
               
             
           
               
                   
               
               
                   
                   
                   
                 Transformation activity* 
               
               
                 Example 
                 Plasmid 
                 Expression strain 
                 Rubusoside to Stevioside 
               
               
                   
               
             
             
               
                   
               
             
          
           
               
                 15 
                 pMAL 
                 BL21 
                  9 mU mL −1   
               
               
                 16 
                 pMAL 
                 ArcticExpress 
                 60 mU mL −1   
               
               
                 17 
                 pET30a+ 
                 Tuner (DE3) 
                 28 mU mL −1   
               
               
                 18 
                 pET30a+ 
                 ArcticExpress (DE3) 
                 21 mU mL −1   
               
               
                   
               
               
                 * Note: 
               
               
                 The activities are mentioned per mL of lysate. 1 U will transform 1 μmol of substrate in 1 hour at 30° C. and pH 7.2 
               
             
          
         
       
     
     Example 20 
     Other Enzymes for Rebaudioside A to Rebaudioside D Conversion 
     The following genes of UDP-glucosyltransferases were identified from public databases, synthesized by DNA2.0 and subsequently subcloned in pET30a+ vector. 
     
       
         
               
               
               
               
               
             
               
               
               
               
               
             
           
               
                   
               
               
                   
                   
                   
                   
                 Con- 
               
               
                   
                   
                   
                   
                 version 
               
               
                 Micro- 
                   
                   
                 Internal  
                 RebA to  
               
               
                 plate 
                 Position 
                 Gene Name 
                 reference 
                 RebD 
               
               
                   
               
             
             
               
                   
               
             
          
           
               
                 C908201 
                 A1 
                 gi115454819_NP_001051010.1 
                 S115N01  
                 Active 
               
               
                   
                   
                   
                 A1 
                   
               
               
                 C908201 
                 G2 
                 gi187373030_ACD03249.1 
                 S115N01  
                 Active 
               
               
                   
                   
                   
                 G2 
                   
               
               
                 C908201 
                 A7 
                 gi460409128_XP_004249992.1 
                 S115N05  
                 Active 
               
               
                   
                   
                   
                 A7 
                   
               
               
                 C912666 
                 E1 
                 gi222619587_EEE55719.1 
                 S115N06  
                 Active 
               
               
                   
                   
                   
                 E1 
                   
               
               
                 C912666 
                 C2 
                 gi297795735_XP_002865752.1 
                 S115N06  
                 Active 
               
               
                   
                   
                   
                 C2 
               
               
                   
               
             
          
         
       
     
     The aminoacid sequences are as follows: 
     
       
         
               
             
           
               
                 SEQ ID 3 
               
               
                 &gt;gi|115454819|ref|NP_001051010.1|Os03g0702500 
               
               
                 [ Oryza sativa  Japonica Group] 
               
               
                 MDDAHSSQSPLHVVIFPWLAFGHLLPCLDLAERLAARGHRVSFVSTPRNL 
               
               
                   
               
               
                 ARLPPVRPELAELVDLVALPLPRVDGLPDGAEATSDVPFDKFELHRKAFD 
               
               
                   
               
               
                 GLAAPFSAFLDTACAGGKRPDWVLADLMHHWVALASQERGVPCAMILPCS 
               
               
                   
               
               
                 AAVVASSAPPTESSADQREAIVRSMGTAAPSFEAKRATEEFATEGASGVS 
               
               
                   
               
               
                 IMTRYSLTLQRSKLVAMRSCPELEPGAFTILTRFYGKPVVPFGLLPPRPD 
               
               
                   
               
               
                 GARGVSKNGKHDAIMQWLDAQPAKSVVYVALGSEAPMSADLLRELAHGLD 
               
               
                   
               
               
                 LAGTRFLWAMRKPAGVDADSVLPAGFLGRTGERGLVTTRWAPQVSILAHA 
               
               
                   
               
               
                 AVCAFLTHCGWGSVVEGLQFGHPLIMLPILGDQGPNARILEGRKLGVAVP 
               
               
                   
               
               
                 RNDEDGSFDRGGVAGAVRAVVVEEEGKTFFANARKLQEIVADREREERCI 
               
               
                   
               
               
                 DEFVQHLTSWNELKNNSDGQYP 
               
               
                   
               
               
                 SEQ ID 4 
               
               
                 &gt;gi|187373030|gb|ACD03249.1|UDP-glycosyltrans- 
               
               
                 ferase [ Avena strigosa ] 
               
               
                 MAVKDEQQSPLHILLFPFLAPGHLIPIADMAALFASRGVRCTILTTPVNA 
               
               
                   
               
               
                 AIIRSAVDRANDAFRGSDCPAIDISVVPFPDVGLPPGVENGNALTSPADR 
               
               
                   
               
               
                 LKFFQAVAELREPFDRFLADNHPDAVVSDSFFHWSTDAAAEHGVPRLGFL 
               
               
                   
               
               
                 GSSMFAGSCNESTLHNNPLETAADDPDALVSLPGLPHRVELRRSQMMDPK 
               
               
                   
               
               
                 KRPDHWALLESVNAADQKSFGEVFNSFHELEPDYVEHYQTTLGRRTWLVG 
               
               
                   
               
               
                 PVALASKDMAGRGSTSARSPDADSCLRWLDTKQPGSVVYVSFGTLIRFSP 
               
               
                   
               
               
                 AELHELARGLDLSGKNFVWVLGRAGPDSSEWMPQGFADLITPRGDRGFII 
               
               
                   
               
               
                 RGWAPQMLILNHRALGGFVTHCGWNSTLESVSAGVPMVTWPRFADQFQNE 
               
               
                   
               
               
                 KLIVEVLKVGVSIGAKDYGSGIENHDVIRGEVIAESIGKLMGSSEESDAI 
               
               
                   
               
               
                 QRKAKDLGAEARSAVENGGSSYNDVGRLMDELMARRSSVKVGEDIIPTND 
               
               
                   
               
               
                 GL 
               
               
                   
               
               
                 SEQ ID 5 
               
               
                 &gt;gi|460409128|ref|XP_004249992.1| PREDICTED: 
               
               
                 cyanidin-3-O-glucoside 2-O-glucuronosyltrans- 
               
               
                 ferase-like [ Solanum lycopersicum ] 
               
               
                 MSPKLHKELFFHSLYKKTRSNHTMATLKVLMFPFLAYGHISPYLNVAKKL 
               
               
                   
               
               
                 ADRGFLIYFCSTPINLKSTIEKIPEKYADSIHLIELHLPELPQLPPHYHT 
               
               
                   
               
               
                 TNGLPPNLNQVLQKALKMSKPNFSKILQNLKPDLVIYDILQRWAKHVANE 
               
               
                   
               
               
                 QNIPAVKLLTSGAAVFSYFFNVLKKPGVEFPFPGIYLRKIEQVRLSEMMS 
               
               
                   
               
               
                 KSDKEKELEDDDDDDDLLVDGNMQIMLMSTSRTIEAKYIDFCTALTNWKV 
               
               
                   
               
               
                 VPVGPPVQDLITNDVDDMELIDWLGTKDENSTVFVSFGSEYFLSKEDMEE 
               
               
                   
               
               
                 VAFALELSNVNFIWVARFPKGEERNLEDALPKGFLERIGERGRVLDKFAP 
               
               
                   
               
               
                 QPRILNHPSTGGFISHCGWNSAMESIDFGVPIIAMPMHLDQPMNARLIVE 
               
               
                   
               
               
                 LGVAVEIVRDDDGKIHRGEIAETLKGVITGKTGEKLRAKVRDISKNLKTI 
               
               
                   
               
               
                 RDEEMDAAAEELIQLCRNGN 
               
               
                   
               
               
                 SEQ ID 6 
               
               
                 &gt;gi|222619587|gb|EEE55719.1| hypothetical protein 
               
               
                 OsJ_04191 [ Oryza sativa  Japonica Group] 
               
               
                 MHVVMLPWLAFGHILPFAEFAKRVARQGHRVTLFSTPRNTRRLIDVPPSL 
               
               
                   
               
               
                 AGRIRVVDIPLPRVEHLPEHAEATIDLPSNDLRPYLRRAYDEAFSRELSR 
               
               
                   
               
               
                 LLQETGPSRPDWVLADYAAYWAPAAASRHGVPCAFLSLFGAAALCFFGPA 
               
               
                   
               
               
                 ETLQGRGPYAKTEPAHLTAVPEYVPFPTTVAFRGNEARELFKPSLIPDES 
               
               
                   
               
               
                 GVSESYRFSQSIEGCQLVAVRSNQEFEPEWLELLGELYQKPVIPIGMFPP 
               
               
                   
               
               
                 PPPQDVAGHEETLRWLDRQEPNSVVYAAFGSEVKLTAEQLQRIALGLEAS 
               
               
                   
               
               
                 ELPFIWAFRAPPDAGDGDGLPGGFKERVNGRGVVCRGWVPQVKFLAHASV 
               
               
                   
               
               
                 GGFLTHAGWNSIAEGLANGVRLVLLPLMFEQGLNARQLAEKKVAVEVARD 
               
               
                   
               
               
                 EDDGSFAANDIVDALRRVMVGEEGDEFGVKVKELAKVFGDDEVNDRYVRD 
               
               
                   
               
               
                 FLKCLSEYKMQRQG 
               
               
                   
               
               
                 SEQ ID 7 
               
               
                 &gt;gi|297795735|ref|XP_002865752.1| UDP-gluco- 
               
               
                 ronosyl/UDP-glucosyl transferase family protein 
               
               
                 [ Arabidopsis lyrata  subsp.  lyrata ] 
               
               
                 MDDKKEEVMHIAMFPWLAMGHLLPFLRLSKLLAQKGHKISFISTPRNILR 
               
               
                   
               
               
                 LPKLPSNLSSSITFVSFPLPSISGLPPSSESSMDVPYNKQQSLKAAFDLL 
               
               
                   
               
               
                 QPPLTEFLRLSSPDWIIYDYASHWLPSIAKELGISKAFFSLFNAATLCFM 
               
               
                   
               
               
                 GPSSSLIEESRSTPEDFTVVPPWVPFKSTIVFRYHEVSRYVEKTDEDVTG 
               
               
                   
               
               
                 VSDSVRFGYTIDGSDAVFVRSCPEFEPEWFSLLQDLYRKPVFPIGFLPPV 
               
               
                   
               
               
                 IEDDDDDTTWVRIKEWLDKQRVNSVVYVSLGTEASLRREELTELALGLEK 
               
               
                   
               
               
                 SETPFFWVLRNEPQIPDGFEERVKGRGMVHVGWVPQVKILSHESVGGFLT 
               
               
                   
               
               
                 HCGWNSVVEGIGFGKVPIFLPVLNEQGLNTRLLQGKGLGVEVLRDERDGS 
               
               
                   
               
               
                 FGSDSVADSVRLVMIDDAGEEIREKVKLMKGLFGNMDENIRYVDELVGFM 
               
               
                   
               
               
                 RNDESSQLKEEEEEDDCSDDQSSEVSSETDEKELNLDLKEEKRRISVYKS 
               
               
                   
               
               
                 LSSEFDDYVANEKMG 
               
             
          
         
       
     
     The tested plasmids were received in a microtiterplate containing a plasmid as freeze-dried solid in each separate well. 
     Suspension of Plasmids. 
     To each well was added 24 μL of ultra-pure sterile water and the microtiter plate was shaken for 30 minutes at Room Temperature. Subsequently, the plate was incubated at 4° C. for 1 hour. The content of each well were further mixed by pipetting up and down. The plasmid quantification was performed by Qubit2.0 analysis using 1 μL of suspension. Determined quantities of plasmids were: 
     
       
         
               
               
               
               
               
             
           
               
                   
                   
               
               
                   
                 Microtiter plate 
                 Position 
                 Internal reference 
                 [Plasmid] ng/μL 
               
               
                   
                   
               
             
             
               
                   
                 C908201 
                 A1 
                 S115N01 A1 
                 32.8 
               
               
                   
                 C908201 
                 G2 
                 S115N01 G2 
                 41.0 
               
               
                   
                 C908201 
                 A7 
                 S115N05 A7 
                 56.6 
               
               
                   
                 C912666 
                 E1 
                 S115N06 E1 
                 64.0 
               
               
                   
                 C912666 
                 C2 
                 S115N06 C2 
                 31.4 
               
               
                   
                   
               
             
          
         
       
     
     Transformation of Competent Cells with Plasmids. 
     Aliquots of chemically competent EC100 cells were taken from freezer at −80° C. and stored on ice. The cells were allowed to thaw on ice for 10 minutes. 10 μL of a dilution of above described plasmid solution was added to a sterile microtube of 1.5 mL (in order to transform each cell with 50 pg of DNA) and stored on ice. 100 μL of chemically competent cells was added to each microtube. After incubation of the chemically competent cells plasmid mixtures on ice for 20 min a thermal shock of 30 seconds at 42° C. was performed. 
     Further incubation was performed on ice for 2 minutes. To each microtube 300 μL of SOC medium was added and the resulting mixture was transferred to a sterile 15 mL tube. After incubate for 1 hour at 37° C. while shaking at 135 rpm, the mixture is spread on solid Luria Broth medium containing Kanamycin 50 μg/mL. The petri-dishes are allowed to incubate for 16 hours at 37° C. 
     Preparation of Stock Solutions in Glycerol and Purification of Plasmids. 
     To a 50 mL sterile Falcon Tube 10 mL of Luria Broth medium containing 50 μg/mL of Kanamycin was added. The medium was seeded with an isolated colony from the above described Petri dish and the cultures were allowed to incubate for 16 hours at 37° C. while shaking at 135 rpm. 
     To sterile microtube of 1.5 mL containing 300 μL of a 60% sterile glycerol solution, 600 μL of the culture was added. The stock solution was stored at −80° C. 
     The remainder of the culture was centrifuged at 5,525 g for 10 minutes at 10° C. and after removal of the supernatant, the pellet was stored on ice. The produced plasmids were purified according to the Qiagen Qiaprep Spin Miniprep kit (ref: 27106) and the plasmid yield was measured at 260 nm. The plasmid solution was stored at 4° C. Plasmid quantities were determined as follows: 
     
       
         
               
               
               
               
             
               
               
               
               
             
           
               
                   
               
               
                 Microtiter plate 
                 Position 
                 Internal reference of test 
                 [Plasmid] ng/μL 
               
               
                   
               
             
             
               
                   
               
             
          
           
               
                 C908201 
                 A1 
                 S115N01 A1 
                 115.7 
               
               
                 C908201 
                 G2 
                 S115N01 G2 
                 120.4 
               
               
                 C908201 
                 A7 
                 S115N05 A7 
                 293.8 
               
               
                 C912666 
                 E1 
                 S115N06 E1 
                 126.1 
               
               
                 C912666 
                 C2 
                 S115N06 C2 
                 98.8 
               
               
                   
               
             
          
         
       
     
     In-Vitro Expression of Enzymes. 
     18 μL of plasmid solution (containing approximately 1.5 μg of plasmid) was used for in-vitro expression according to the Promega S30 T7 High-Yield Protein Expression System (ref: L1110) kit. The expression medium was produced as follows: 
     
       
         
               
               
               
               
             
           
               
                   
               
               
                   
                 S30 Premix Plus 
                 T7 S30 Extract 
                 Total 
               
               
                   
               
             
             
               
                 Trials 
                 30 μL 
                 27 μL 
                 57 μL 
               
               
                 reference 
                 20 μL 
                 18 μL 
                 38 μL 
               
               
                   
               
             
          
         
       
     
     The prepared expression medium mix was added to the plasmid solution and the solution was allowed to incubate at 30° C. for 3 hours while mixing the mixture every 45 minutes. 5 μL of the mixture was frozen whereas the remainder was used for the catalytic test for the conversion of Rebaudioside A to Rebaudioside D. 
     Catalytic Test for Transformation of Rebaudioside A to Rebaudioside D. 
     430 μL of a reaction mixture containing 0.5 mM Rebaudioside A, 3 mM MgCl 2 , 50 mM phosphate buffer (pH7.2) and 2.5 mM UDP-glucose was added to a 1.5 mL sterile microtube. 52 μL of the enzyme expression medium was added and the resulting mixture was allowed to react at 30° C. for 24 hours. 125 μL samples were taken after 2 hours, 16 hours and 24 hours and added to a 115 μL of 60% methanol and 10 μL of 2 N H 2 SO 4 . The quenched sample was centrifuged at 18,000 g for 2 minutes at RT. 200 μL was transferred to an HPLC vial and analyzed. 
     HPLC Analysis 
     The HPLC assay was performed as follows: 
     Apparatus 
                                         Equipment   Supplier   Reference   Lot#                   Elite   Hitachi   L-2130   NA       Photodiode Array   Hitachi   L-2455   NA       Corona CAD detector   ESA   70-6186A   CO-2044       Injector 100 μL   Hitachi       NA       Column Synergy 4u Hydro-RP    Phenomenex   00G-4375-E0   588582-12       80A (250 × 4.60 mm)                    
Instrument Conditions
 
                                     Column Temperature   55° C.       Detection   UV 205 nm; bw 400 nm CAD detection       Analysis duration   15 min       Injected volume   10 μL       Flow rate   1 mL/min                    
Mobile Phase Gradient Program
 
     
       
         
               
               
               
               
             
               
               
               
               
             
           
               
                   
                   
               
               
                   
                 Time (min) 
                 % Water containing 0.04% acetic acid 
                 % methanol 
               
               
                   
                   
               
             
             
               
                   
               
             
          
           
               
                   
                 0 
                 40 
                 60 
               
               
                   
                 8 
                 25 
                 75 
               
               
                   
                 10 
                 25 
                 75 
               
               
                   
                 11 
                 40 
                 60 
               
               
                   
                 15 
                 40 
                 60 
               
               
                   
                   
               
             
          
         
       
     
     The HPLC assay results are provided below: 
     
       
         
               
               
             
               
               
               
               
             
               
               
               
               
             
           
               
                   
               
               
                 Internal 
                 Steviol glycoside conversion in reaction mixture (% area) 
               
             
          
           
               
                 reference  
                 Reb D 
                 Reb UNK 
                 Reb A 
               
               
                   
               
             
          
           
               
                 S115N01 A1 
                 2.1 
                 ND 
                 96.7 
               
               
                 S115N01 G2 
                 0.6 
                 ND 
                 99.4 
               
               
                 S115N05 A7 
                 22.4 
                 23.3 
                 46.7 
               
               
                 S115N06 E1 
                 0.14 
                 7.0 
                 92.8 
               
               
                 S115N06 C2 
                 0.28 
                 3.9 
                 95.8 
               
               
                   
               
             
          
         
       
     
     The enzyme S115N05 A7 had the highest activity for Reb A to Reb D conversion (ca. 22.4%) 
     At least three enzymes produced a significant amount of an unknown glycoside (marked as Reb UNK; later identified as reb D2) along with reb D, as seen in  FIGS. 42-46 . 
     The below table accompanies  FIG. 42 . 
     
       
         
               
             
               
               
               
             
           
               
                   
               
             
             
               
                 Sample: 12400 S115N01A1 T24h 13062 lABA 
               
               
                 gi|115454819|ref|NP_001051010.1| Os03g0702500  
               
               
                 [ Oryza saliva  Japonica Group] 
               
               
                 Filename: 130621_12400_011.dat 
               
               
                   
               
               
                 CAD Ch 1 Results 
               
             
          
           
               
                 Compound 
                 Retention time 
                 Integration (area) 
               
               
                   
               
               
                 Rebaudioside D 
                 5.797 
                  13,532,277 
               
               
                 Unknown@RT7.890 
                 7.890 
                  7,094,778 
               
               
                 Rebaudioside A 
                 9.157 
                 613,483,011 
               
               
                 Total 
                   
                 634,110,066 
               
               
                   
               
             
          
         
       
     
     The below table accompanies  FIG. 43 . 
     
       
         
               
               
             
               
               
               
               
             
           
               
                   
                   
               
             
             
               
                   
                 Sample: 12400 S115NOIG2 T24h 130621ABA 
               
               
                   
                 &gt;gi|187373030|gb|ACD03249.1| UDP- 
               
               
                   
                 glycosyltransferase [ Avena strigosa ] 
               
               
                   
                 Filename: 130621_12400_020.dat 
               
               
                   
                   
               
               
                   
                 CAD Ch 1 Results 
               
             
          
           
               
                   
                 Compound 
                 Retention time 
                 Integration (area) 
               
               
                   
                   
               
               
                   
                 Rebaudioside D 
                 5.788 
                  3,547,834 
               
               
                   
                 Rebaudioside A 
                 9.148 
                 585,285,463 
               
               
                   
                 Total 
                   
                 588,833,297 
               
               
                   
                   
               
             
          
         
       
     
     The below table accompanies  FIG. 44 . 
     
       
         
               
             
               
               
               
             
           
               
                   
               
             
             
               
                 Sample: 12400 S115N05A7 T24h 130627ABA 
               
               
                 &gt;gi|460409128|ref|XP_004249992.1| PREDICTED:  
               
               
                 cyanidin-3-O-glucoside 2-O-glucuronosyltransferase- 
               
               
                 like [ Solanum lycopersicum ] 
               
               
                 Filename: 130627_12400_027.dat 
               
               
                   
               
               
                 CAD Ch 1 Results 
               
             
          
           
               
                 Compound 
                 Retention time 
                 Integration (area) 
               
               
                   
               
               
                 Unknown@RT4.508 
                 4.508 
                  64,361,822 
               
               
                 Rebaudioside D 
                 5.761 
                 191,273,935 
               
               
                 Rebaudioside UNK 
                 6.685 
                 198,934,644 
               
               
                 Rebausioside A 
                 9.106 
                 398,115,681 
               
               
                 Total 
                   
                 852,686,082 
               
               
                   
               
             
          
         
       
     
     The below table accompanies  FIG. 45 . 
     
       
         
               
             
               
               
               
             
           
               
                   
               
             
             
               
                 Sample: 12400 S115N06E1 T24h 130627ABA 
               
               
                 &gt;gi|222619587|gb|EEE55719.1| hypothetical 
               
               
                 protein OsJ_04191 ( Oryza saliva  Japonica Group] 
               
               
                 Filename: 130627_12400_046.dat 
               
               
                   
               
               
                 CAD Ch 1 Results 
               
             
          
           
               
                 Compound 
                 Retention time 
                 Integration (area) 
               
               
                   
               
               
                 Rebaudioside D 
                 5.737 
                 964,715 
               
               
                 Rebaudioside UNK 
                 6.685 
                 46,027,361 
               
               
                 Rebausioside A 
                 9.113 
                 606,312,523 
               
               
                 Total 
                   
                 653,304,599 
               
               
                   
               
             
          
         
       
     
     The below table accompanies  FIG. 46 . 
     
       
         
               
             
               
               
               
             
           
               
                   
               
             
             
               
                 Sample: 12400 S115N06C2 T24h 130627ABA 
               
               
                 &gt;gi|297795735|ref|XP_002865752.1| UDP-glucoronosyl/ 
               
               
                 UDP-glucosyl transferase family protein 
               
               
                 [ Arabidopsis lyrata  subsp. lyrata] 
               
               
                 Filename: 130627_12400_052.dat 
               
               
                   
               
               
                 CAD Ch 1 Results 
               
             
          
           
               
                 Compound 
                 Retention time 
                 Integration (area) 
               
               
                   
               
               
                 Rebaudioside D 
                 5.757 
                  1,852,407 
               
               
                 Rebaudioside UNK 
                 6.708 
                  26,033,636 
               
               
                 Rebausioside A 
                 9.136 
                 633,014,654 
               
               
                 Total 
                   
                 660,900,697 
               
               
                   
               
             
          
         
       
     
     Example 21 
     Activity of In-Vitro Produced EUGT11 
     EUGT11 gene as was described in the Patent application WO/2013/022989A2 was synthesized by DNA2.0 and subsequently subcloned in pET30a+ vector. 
     
       
         
               
               
               
               
               
               
             
           
               
                   
               
               
                   
                   
                   
                   
                   
                 Conversion 
               
               
                 Micro- 
                   
                 GI  
                   
                 Internal  
                 RebA to  
               
               
                 plate 
                 Position 
                 number 
                 Version 
                 reference 
                 RebD 
               
               
                   
               
             
             
               
                 C912666 
                 G4 
                 41469452 
                 AAS07253.1 
                 S115N08 G4 
                 Active 
               
               
                   
               
             
          
         
       
     
     The amino-acid sequence is as follows: 
     
       
         
               
             
           
               
                 SEQ ID 8 
               
               
                 &gt;gi|41469452|gb|AAS07253.1| putative UDP-gluco- 
               
               
                 ronosyl and UDP-glucosyl transferase [ Oryza sativa   
               
               
                 Japonica Group] EUGT11 enzyme from patent 
               
               
                 application WO/2013/022989A2 
               
               
                 MHVVICPLLAFGHLLPCLDLAQRLACGHRVSFVSTPRNISRLPPVRPSLA 
               
               
                   
               
               
                 PLVSFVALPLPRVEGLPNGAESTHNVPHDRPDMVELHLRAFDGLAAPFSE 
               
               
                   
               
               
                 FLGTACADWVMPTSSAPRQTLSSNIHRNSSRPGTPAPSGRLLCPITPHSN 
               
               
                   
               
               
                 TLERAAEKLVRSSRQNARARSLLAFTSPPLPYRDVFRSLLGLQMGRKQLN 
               
               
                   
               
               
                 IAHETNGRRTGTLPLNLCRWMWKQRRCGKLRPSDVEFNTSRSNEAISPIG 
               
               
                   
               
               
                 ASLVNLQSIQSPNPRAVLPIASSGVRAVFIGRARTSTPTPPHAKPARSAA 
               
               
                   
               
               
                 PRAHRPPSSVMDSGYSSSYAAAAGMHVVICPWLAFGHLLPCLDLAQRLAS 
               
               
                   
               
               
                 RGHRVSFVSTPRNISRLPPVRPALAPLVAFVALPLPRVEGLPDGAESTND 
               
               
                   
               
               
                 VPHDRPDMVELHRRAFDGLAAPFSEFLGTACADWVIVDVFHHWAAAAALE 
               
               
                   
               
               
                 HKVPCAMMLLGSAHMIASIADRRLERAETESPAAAGQGRPAAAPTFEVAR 
               
               
                   
               
               
                 MKLIRTKGSSGMSLAERFSLTLSRSSLVVGRSCVEFEPETVPLLSTLRGK 
               
               
                   
               
               
                 PITFLGLMPPLHEGRREDGEDATVRWLDAQPAKSVVYVALGSEVPLGVEK 
               
               
                   
               
               
                 VHELALGLELAGTRFLWALRKPTGVSDADLLPAGFEERTRGRGVVATRWV 
               
               
                   
               
               
                 PQMSILAHAAVGAFLTHCGWNSTIEGLMFGHPLIMLPIFGDQGPNARLIE 
               
               
                   
               
               
                 AKNAGLQVARNDGDGSFDREGVAAAIRAVAVEEESSKVFQAKAKKLQEIV 
               
               
                   
               
               
                 ADMACHERYIDGFIQQLRSYKD 
               
             
          
         
       
     
     The tested plasmid was received in a microtiterplate containing a plasmid as freeze-dried solid in a separate well. 
     Suspension of Plasmid 
     To the well was added 24 μL of ultra-pure sterile water and the microtiter plate was shaken for 30 minutes at Room Temperature. Subsequently, the plate was incubated at 4° C. for 1 hour. The content of the well was further mixed by pipetting up and down. The plasmid quantification was performed by Qubit2.0 analysis using 1 μL of suspension. Plasmid quantity was determined as follows: 
     
       
         
               
               
               
               
             
           
               
                   
               
               
                 Microtiter plate 
                 Position 
                 Internal reference of test 
                 [Plasmid] ng/μL 
               
               
                   
               
             
             
               
                 C912666 
                 G4 
                 S115N08 G4 
                 19.2 
               
               
                   
               
             
          
         
       
     
     Transformation of Competent Cells with Plasmid. 
     An aliquot of chemically competent EC100 cells was taken from freezer at −80° C. and stored on ice. The cells were allowed to thaw on ice for 10 minutes. 10 μL of a dilution of above described plasmid solution was added to a sterile microtube of 1.5 mL (in order to transform each cell with 50 pg of DNA) and stored on ice. 100 μL of chemically competent cells was added to the microtube. After incubation of the chemically competent cells/plasmid mixture on ice for 20 min a thermal shock of 30 seconds at 42° C. was performed. 
     Further incubation was performed on ice for 2 minutes. To the microtube 300 of SOC medium was added and the resulting mixture was transferred to a sterile 15 mL tube. After incubate for 1 hour at 37° C. while shaking at 135 rpm, the mixture is spread on solid Luria Broth medium containing Kanamycin 50 μg/mL. The Petri dish is allowed to incubate for 16 hours at 37° C. 
     Preparation of Stock Solutions in Glycerol and Purification of Plasmid. 
     To a 50 mL sterile Falcon Tube 10 mL of Luria Broth medium containing 50 μg/mL of Kanamycin was added. The medium was seeded with an isolated colony from the above described Petri dish and the cultures were allowed to incubate for 16 hours at 37° C. while shaking at 135 rpm. 
     To sterile microtube of 1.5 mL containing 300 μL of a 60% sterile glycerol solution, 600 μL of the culture was added. The stock solution was stored at −80° C. 
     The remainder of the culture was centrifuged at 5,525 g for 10 minutes at 10° C. and after removal of the supernatant, the pellet was stored on ice. The produced plasmids were purified according to the Qiagen Qiaprep Spin Miniprep kit (ref: 27106) and the plasmid yield was measured at 260 nm. The plasmid solution was stored at 4° C. Plasmid quantity was determined as follows: 
     
       
         
               
               
               
               
             
           
               
                   
               
               
                 Microtiter plate 
                 Position 
                 Internal reference of test 
                 [Plasmid] ng/μL 
               
               
                   
               
             
             
               
                 C912666 
                 G4 
                 S115N08 G4 
                 38.4 
               
               
                   
               
             
          
         
       
     
     In-Vitro Expression of EUGT11. 
     18 μL of a diluted plasmid solution (containing approximately 1.5 μg of plasmid) was used for in-vitro expression according to the Promega S30 T7 High-Yield Protein Expression System (ref: L1110) kit. The expression medium was produced as follows: 
     
       
         
               
               
               
               
               
             
           
               
                   
               
               
                   
                 S30 Premix Plus 
                 T7 S30 Extract 
                 DNA template 
                 Total 
               
               
                   
               
             
             
               
                 Trials 
                 30 μL 
                 27 μL 
                 18 μL (~1.8 μg) 
                 75 μL 
               
               
                 reference  
                 20 μL 
                 18 μL 
                 12 μL (~1.0 μg) 
                 50 μL 
               
               
                   
               
             
          
         
       
     
     The prepared expression medium mix was added to the plasmid solution and the solution was allowed to incubate at 30° C. for 3 hours while mixing the mixture every 45 minutes. 5 μL of the mixture was frozen whereas the remainder was used for the catalytic test for the conversion of Rebaudioside A to Rebaudioside D. 
     Catalytic Test for Transformation of Rebaudioside A to Rebaudioside D. 
     430 μL of a reaction mixture containing 0.5 mM Rebaudioside A, 3 mM MgCl 2 , 50 mM phosphate buffer (pH7.2) and 2.5 mM UDP-glucose was added to a 1.5 mL sterile microtube. 52 μL of the enzyme expression medium was added and the resulting mixture was allowed to react at 30° C. for 24 hours. 125 μL samples were taken after 2 hours, 16 hours and 24 hours and added to a 115 μL of 60% methanol and 10 μL of 2 N H 2 SO 4 . The quenched sample was centrifuged at 18,000 g for 2 minutes at RT. 200 μL was transferred to HPLC vial and analyzed as seen in  FIG. 47 . 
     HPLC Analysis. 
     The HPLC assay was performed as described in EXAMPLE 20. 
     The HPLC assay results are provided below: 
     
       
         
               
             
               
               
               
             
           
               
                   
               
             
             
               
                 Sample: 12400 S115N08G4 T24h 130702CJA 
               
               
                 &gt;gi|41469452|gb|AAS07253.1| putative UDP-glucoronosyl a  
               
               
                 and UDP-glucosyl transferase [ Oryza sativ  Japonica Group]  
               
               
                 (EUGT11 enzyme from patent application WO/2013/022989A2) 
               
               
                 Filename: 130702_12400_026.dat 
               
               
                   
               
               
                 CAD Ch 1 Results 
               
             
          
           
               
                 Compound 
                 Retention time 
                 Integration (area) 
               
               
                   
               
               
                 Rebaudioside D 
                 5.797 
                  54,654,810 
               
               
                 Rebaudioside A 
                 9.157 
                 633,926,835 
               
               
                 Total 
                   
                 688,581,645 
               
               
                   
               
             
          
         
       
     
     Example 22 
     In-Vivo Production of Enzymes 
     The enzymes described in EXAMPLE 20 were produced in vivo. 
     The pET30A+ vector containing the gene corresponding to the enzyme was introduced in  E. coli  BL21(DE3) by heat shock. The obtained cells were grown in Petri dishes in the presence of Kanamycin and suitable colonies were selected and allowed to grow in liquid LB medium (Erlenmeyer flasks). Glycerol was added to the suspension as cryoprotector and 400 μL aliquots were stored at −20° C. and at −80° C. 
     The storage aliquots of  E. coli  BL21(DE3) containing the pET30A+_UGT plasmids were thawed and added to 30 mL of LBGKP medium (20 g/L Luria Broth Lennox; 50 mM PIPES buffer pH 7.00; 50 mM Phosphate buffer pH 7.00; 2.5 g/L glucose and 50 mg/L of Kanamycine). This culture was allowed to shake at 135 rpm at 30° C. for 8 hrs. 
     The production medium contained 60 g/L of overnight express instant TB medium (Novagen), 10 g/L of glycerol and 50 mg/L of Kanamycine. The preculture was added to 400 mL of this medium and the solution was allowed to stir at 20° C. while taking samples to measure the OD and pH. The cultures gave significant growth and a good OD was obtained. After 40 hrs, the cells were harvested by centrifugation and frozen. The following yields of cell wet weights (CWW) are mentioned below. 
     
       
         
               
               
               
             
           
               
                   
               
               
                 GI number 
                 Version 
                 CWW 
               
               
                   
               
             
             
               
                 115454819 
                 NP_001051010.1 
                 9.2 g 
               
               
                 187373030 
                 ACD03249.1 
                 7.4 g 
               
               
                 460409128 
                 XP_004249992.1 
                 6.8 g 
               
               
                 222619587 
                 EEE55719.1 
                 7.5 g 
               
               
                 297795735 
                 XP_002865752.1 
                 8.8 g 
               
               
                   
               
             
          
         
       
     
     Lysis was performed by addition of Bugbuster Master mix (Novagen) and the lysate was recovered by centrifugation and used fresh. 
     Determination of Activity. 
     Activity tests were performed at 5 mL scale with 1,000 μL of thawed lysate for the transformation of Rebaudioside A using 0.5 mM of substrate, 2.5 mM of UDP-Glucose and 3 mM MgCl 2  in 50 mM Sodium Phosphate buffer at pH 7.2. Samples were taken and analyzed by HPLC as seen in  FIGS. 48-52 . 
     HPLC Analysis. 
     The HPLC assay was performed as described in EXAMPLE 20. 
     The results for the different enzymes are provided below. 
     
       
         
               
               
               
               
             
               
               
               
               
             
           
               
                   
               
               
                   
                   
                 Conversion after  
                   
               
               
                 GI Number 
                 Version 
                 45 hrs.  
                 Reb D selectivity 
               
               
                   
               
             
             
               
                   
               
             
          
           
               
                 115454819 
                 NP_001051010.1 
                 1.1% 
                  100% 
               
               
                 187373030 
                 ACD03249.1 
                 0.8% 
                  100% 
               
               
                 460409128 
                 XP_004249992.1 
                 62.1% 
                 43.6% 
               
               
                 222619587 
                 EEE55719.1 
                 2.9% 
                 Reb D Not detected 
               
               
                 297795735 
                 XP_002865752.1 
                 0.0% 
                 Reb D Not detected 
               
               
                   
               
             
          
         
       
     
     The below table accompanies  FIG. 48 . 
     
       
         
               
             
               
               
               
             
           
               
                   
               
             
             
               
                 SAMPLE: 12400 S129N01 T45h 130712ABA 
               
               
                 &gt;gi115454819 / NP_001051010.1 
               
               
                 Filename: 130712_12400_003.dat 
               
               
                   
               
               
                 CAD Ch 1 Results 
               
             
          
           
               
                 Compound 
                 Retention time 
                 Integration (area) 
               
               
                   
               
               
                 Rebaudioside D 
                 5.775 
                 3,264,475 
               
               
                 Unknown@RT6.986 
                 6.986 
                 4,110,607 
               
               
                 Unknown@RT7.330 
                 7.330 
                 564,033,104 
               
               
                 Unknown@RT7.700 
                 7.700 
                 328,710,539 
               
               
                 Unknown@RT8.158 
                 8.158 
                 6,344,796 
               
               
                 Rebaudioside A 
                 9.135 
                 673,271,863 
               
               
                 Unknown@RT9.653 
                 9.653 
                 616,489,141 
               
               
                 Total 
                   
                 2,196,224,525 
               
               
                   
               
             
          
         
       
     
     The below table accompanies  FIG. 49 . 
     
       
         
               
             
               
               
               
             
           
               
                   
               
             
             
               
                 Sample: 12400 S129N02 T45h 130712ABA 
               
               
                 &gt;gi187373030 / ACD03249.1 
               
               
                 Filename: 130712_12400_004.dat 
               
               
                   
               
               
                 CAD Ch 1 Results 
               
             
          
           
               
                 Compound 
                 Retention time 
                 Integration (area) 
               
               
                   
               
               
                 Rebaudioside D 
                 5.772 
                 1,997,401 
               
               
                 Unknown@RT6.977 
                 6.977 
                 3,341,419 
               
               
                 Unknown@RT7.252 
                 7.252 
                 10,576,676 
               
               
                 Unknown@RT7.687 
                 7.687 
                 298,862,034 
               
               
                 Rebaudioside A 
                 9.117 
                 675,210,845 
               
               
                 Unknown@RT9.639 
                 9.639 
                 874,680,345 
               
               
                 Total 
                   
                 1,864,668,720 
               
               
                   
               
             
          
         
       
     
     The below table accompanies  FIG. 50 . 
     
       
         
               
             
               
               
               
             
           
               
                   
               
             
             
               
                 Sample: 12400 S129N04 T45h 130712ABA 
               
               
                 &gt;gi460409128 / XP_004249992.1 
               
               
                 Filename: 130712_12400_006.dat 
               
               
                   
               
               
                 CAD Ch 1 Results 
               
             
          
           
               
                 Compound 
                 Retention time 
                 Integration (area) 
               
               
                   
               
               
                 Unknown@RT4.526 
                 4.526 
                 89,809,997 
               
               
                 Rebaudioside D 
                 5.777 
                 217,830,913 
               
               
                 Rebaudioside UNK 
                 6.711 
                 192,129,243 
               
               
                 Unknown@RT6.986 
                 6.986 
                 10,241,417 
               
               
                 Unknown@RT7.331 
                 7.331 
                 41,195,765 
               
               
                 Unknown@RT7.701 
                 7.701 
                 310,640,254 
               
               
                 Unknown@RT8.162 
                 8.162 
                 7,950,609 
               
               
                 Rebaudioside A 
                 9.137 
                 304,611,760 
               
               
                 Unknown@RT9.656 
                 9.656 
                 863,496,704 
               
               
                 Total 
                   
                 2,037,906,662 
               
               
                   
               
             
          
         
       
     
     The below table accompanies  FIG. 51 . 
     
       
         
               
             
               
               
               
             
           
               
                   
               
             
             
               
                 Sample: 12400 S129N05 T45h 130712ABA 
               
               
                 &gt;gi222619587 / EEE55719.1 
               
               
                 Filename: 130712_12400_007.dat 
               
               
                   
               
               
                 CAD Ch 1 Results 
               
             
          
           
               
                 Compound 
                 Retention time 
                 Integration (area) 
               
               
                   
               
               
                 Rebaudioside UNK 
                 6.708 
                   20,047,847 
               
               
                 Unknown@RT6.999 
                 6.999 
                   598,924,958 
               
               
                 Unknown@RT7.699 
                 7.699 
                   303,182,042 
               
               
                 Rebaudioside A 
                 9.133 
                   672,777,773 
               
               
                 Unknown@RT9.655 
                 9.655 
                   606,371,969 
               
               
                 Total 
                   
                 2,201,304,589 
               
               
                   
               
             
          
         
       
     
     The below table accompanies  FIG. 52 . 
     
       
         
               
             
               
               
               
             
           
               
                   
               
             
             
               
                 Sample: 12400 S129N06 T45h 130712ABA 
               
               
                 &gt;gi297795735 / XP_002865752.1 
               
               
                 Filename: 130712_12400_008.dat 
               
               
                   
               
               
                 CAD Ch 1 Results 
               
             
          
           
               
                 Compound 
                 Retention time 
                 Integration (area) 
               
               
                   
               
               
                 Unknown@RT6.998 
                 6.998 
                   920,620,332 
               
               
                 Unknown@RT7.696 
                 7.696 
                   314,421,575 
               
               
                 Rebaudioside A 
                 9.128 
                   688,195,594 
               
               
                 Unknown@RT9.645 
                 9.645 
                   308,115,680 
               
               
                 Total 
                   
                 2,231,353,181 
               
               
                   
               
             
          
         
       
     
     Example 23 
     Identification of Glycosides 
     The reaction mixtures representing GI No. 460409128, particularly the sample “12400 S115N05A7 T24 h 130627ABA” of EXAMPLE 20 (hereinafter S115N05A7), and the sample “12400 S129N04 T45h 130712ABA” of EXAMPLE 22 (hereinafter S129N04) were additionally assayed by LC-MS to identify the unknown glycosides. An Agilent 1200 series HPLC system, equipped with binary pump (G1312B), autosampler (G1367D), thermostatted column compartment (G1316B), DAD detector (G1315C), connected with Agilent 6110A MSD, and interfaced with “LC/MSD Chemstation” software, was used. 
     Instrument Conditions 
                                                 Column   Phenomenex Kinetex 2.6u C18 100A,                4.6 mm × 150 mm, 2.6 μm           Column Temperature   55° C.           Detection   DAD at 210 nm bw 360 nm               MSD (Scan and SIM mode)               Mode: ES-API, Negative Polarity               Drying gas flow: 13.0 L/min               Nebulizer pressure: 30 psig               Drying gas temperature: 270° C.           Analysis duration    25 min           Injected volume   2 μL           Flow rate   1 mL/min                        
Mobile Phase Gradient Program
 
     
       
         
               
               
               
             
               
               
               
             
           
               
                   
               
               
                 Time (min) 
                 A (%): Formic acid 0.1% 
                 B (%): Acetonitrile 
               
               
                   
               
             
             
               
                   
               
             
          
           
               
                 0 
                 75 
                 25 
               
               
                 8.5 
                 75 
                 25 
               
               
                 10.0 
                 71 
                 29 
               
               
                 16.5 
                 70 
                 30 
               
               
                   
               
             
          
         
       
     
     The compound observed on LCMS system at 3.5 min, corresponds to compound “Unknown@4.508” in sample “S115N05A7” (EXAMPLE 20), and compound “Unknown@RT4.526” in sample “S129N04” (EXAMPLE 22). The LCMS data suggests that this compound has six glucosidic residues (C 56 H 90 O 33 ) in its structure, and was found to be an isomer form of reb M, namely reb M2 (see Example 40 for discussion). 
     Whereas the compound observed on LCMS system at 7.6 min, corresponds with compound “reb UNK” in sample “S115N05A7” (EXAMPLE 20), and compound “reb UNK” in sample “S129N04” (EXAMPLE 22), The LCMS data suggests that “reb UNK” has five glucosidic residues (C 50 H 80 O 28 ) in its structure, and was found to be an isomer form of reb D, namely reb D2 (see Example 39 for discussion). The ratio of these compounds and the LCMS chromatograms are provided below and as shown in  FIGS. 53-54 . 
     
       
         
               
               
             
               
               
               
               
               
             
           
               
                   
               
               
                   
                 Steviol glycoside conversion in reaction mixture (% area) 
               
             
          
           
               
                 Sample 
                 Unknown@RT 3.5 
                 Reb D 
                 Reb UNK 
                 Reb A 
               
               
                   
               
               
                 S115N05A7 
                 6.47 
                 20.35 
                 19.93 
                 53.24 
               
               
                 S129N04 
                 6.05 
                 23.73 
                 21.22 
                 49.00 
               
               
                   
               
             
          
         
       
     
     The below table accompanies  FIG. 53 . 
     
       
         
               
             
               
               
               
               
             
               
               
               
               
             
           
               
                   
               
               
                 Sample: 12400 S115N05A7 T24h 130627ABA 
               
               
                 &gt;gi|460409128/XP_004249992.1 
               
               
                 MSD SIM Results 
               
             
          
           
               
                 Compound 
                 Retention time 
                 MW 
                 Integration (area) 
               
               
                   
               
             
          
           
               
                 Unknown@RT3.567 
                 3.567 
                 1,291 
                 79,060 
               
               
                 Rebaudioside D 
                 5.654 
                 1,129 
                 248,604 
               
               
                 Rebaudioside UNK 
                 7.659 
                 1,129 
                 243,469 
               
               
                 Rebausioside A 
                 13.793 
                 967 
                 650,372 
               
               
                 Total 
                   
                   
                 1,221,505 
               
               
                   
               
             
          
         
       
     
     The below table accompanies  FIG. 54 . 
     
       
         
               
             
               
               
               
               
             
               
               
               
               
             
           
               
                   
               
               
                 Sample: 12400 S129N04 T45h 130712ABA &gt; 
               
               
                 gi460409128/XP_004249992.1 
               
               
                 MSD SIM Results 
               
             
          
           
               
                 Compound 
                 Retention time 
                 MW 
                 Integration (area) 
               
               
                   
               
             
          
           
               
                 Unknown@RT3.550 
                 3.550 
                 1,291 
                 151,414 
               
               
                 Rebaudioside D 
                 5.633 
                 1,129 
                 593,709 
               
               
                 Rebaudioside UNK 
                 7.638 
                 1,129 
                 530,836 
               
               
                 Rebaudioside A 
                 13.782 
                 967 
                 1,225,970 
               
               
                 Total 
                   
                   
                 2,501,929 
               
               
                   
               
             
          
         
       
     
     Example 24 
     Identification of Glycosides 
     The reaction mixture representing GI No. 460409128, particularly the sample “12400 S129N04 T45h 130712ABA” of EXAMPLE 22 (hereinafter S129N04) were additionally assayed by LC-MS, as seen in  FIGS. 55-56 , along with  Stevia rebaudiana  Bertoni leaf extract “MLD1” produced by PureCircle Sdn Bhd (Malaysia) to determine the occurrence of S129N04 glycosides in nature. 
     The below table accompanies  FIG. 55 . 
     
       
         
               
             
               
               
               
             
           
               
                   
               
               
                 Samples: 
               
               
                 1) 12400 S129N04 T45h 130712ABA &gt;  
               
               
                 gi460409128/XP_004249992.1 
               
               
                 2) MLD1  Stevia   rebaudiana  Bertoni extract 
               
               
                 MSD SIM 1,129 Results 
               
             
          
           
               
                   
                 Compound 
                 MW 
               
               
                   
                   
               
               
                   
                 Rebaudioside D 
                 1,129 
               
               
                   
                 Rebaudioside UNK 
                 1,129 
               
               
                   
                   
               
             
          
         
       
     
     The below table accompanies  FIG. 56 . 
     
       
         
               
             
               
               
               
             
           
               
                   
               
               
                 Samples: 
               
               
                 1) 12400 S129N04 T45h 130712ABA &gt; 
               
               
                 gi460409128/XP_004249992.1 
               
               
                 2) MLD1  Stevia   rebaudiana  Bertoni extract 
               
               
                 MSD SIM 1,291 Results 
               
             
          
           
               
                   
                 Compound 
                 MW 
               
               
                   
                   
               
               
                   
                 Unknown@RT3.550 
                 1,291 
               
               
                   
                 Rebaudioside M 
                 1,291 
               
               
                   
                   
               
             
          
         
       
     
     The assay shows that the compound observed on LCMS system at 3.5 min, in EXAMPLE 23 (C 56 H 90 O 33 ; later confirmed as reb M2), and the compound observed on LCMS system at 7.6 min, in EXAMPLE 23 (C 50 H 80 O 28 , reb UNK; later confirmed as reb D2) occur in the extract of  Stevia rebaudiana  Bertoni plant. 
     Example 25 
     Conversion of Rebaudioside E to Rebaudioside D 
     The total volume of the reaction was 5.0 mL with the following composition: 100 mM potassium phosphate buffer pH 7.5, 3 mM MgCl 2 , 2.5 mM UDP-glucose, 0.5 mM Rebaudioside E and 500 μL of UGT76G1 thawed lysate (UGT76G1 gene was cloned in pET30a+ vector and expressed in  E. coli  BL21 (DE3)). The reactions were run at 30° C. on an orbitary shaker at 135 rpm. For sampling 300 μL of the reaction mixture was quenched with 30 μl of 2N H 2 SO 4  and 270 μL of methanol/water (6/4). The samples were immediately centrifuged and kept at 10° C. before analysis by HPLC (CAD detection). The following reaction profile was obtained corresponding to a complete conversion of Rebaudioside E to Rebaudioside D as seen in  FIG. 57 . 
     Example 26 
     Directed Evolution of UGT76G1 for the Conversion of Rebaudioside D to Rebaudioside M 
     Starting from the amino acid sequence of UGT76G1, as is described in Genbank (AAR06912.1), different mutations at various amino acid positions were identified that could alter the activity of the enzyme for the transformation of Rebaudioside D (Reb D) to Rebaudioside M (Reb M). This list of mutations, designed by DNA2.0 ProteinGPS™ strategy, was subsequently used to synthesize 96 variant genes that contained 3, 4 or 5 of these mutations that were codon-optimized for expression in  E. coli . The genes were subcloned in the pET30a+ plasmid and used for transformation of  E. coli  BL21 (DE3) chemically competent cells. The obtained cells were grown in Petri-dishes on solid LB medium in the presence of Kanamycin. Suitable colonies were selected and allowed to grow in liquid LB medium in tubes. Glycerol was added to the suspension as cryoprotectant and 400 μL aliquots were stored at −20° C. and at −80° C. 
     These storage aliquots of  E. coli  BL21(DE3) containing the pET30a+_UGT76G1var plasmids were thawed and added to LBGKP medium (20 g/L Luria Broth Lennox; 50 mM PIPES buffer pH 7.00; 50 mM Phosphate buffer pH 7.00; 2.5 g/L glucose and 50 mg/L of Kanamycine). This culture was allowed to shake in a 96 microtiter plate at 135 rpm at 30° C. for 8 h. 
     3.95 mL of production medium containing 60 g/L of Overnight Express™ Instant TB medium (Novagen®), 10 g/L of glycerol and 50 mg/L of Kanamycin was inoculated with 50 μL of above described culture. In a 48 deepwell plate the resulting culture was allowed to stir at 20° C. The cultures gave significant growth and a good OD (600 nm; 1 cm) was obtained. After 44 h, the cells were harvested by centrifugation and frozen. 
     Lysis was performed by addition of Bugbuster® Master mix (Novagen®) to the thawed cells and the lysate was recovered by centrifugation. Activity tests were performed with 100 μL of fresh lysate that was added to a solution of Rebaudioside D (final concentration 0.5 mM), MgCl 2  (final concentration 3 mM) and UDP-Glucose (final concentration 2.5 mM) in 50 mM phosphate buffer pH 7.2. 
     The reaction was allowed to run at 30° C. and samples were taken after 2, 4, 7 and 24 h. to determine conversion and initial rate by HPLC (CAD detection) using the analytical method that was described above for the transformation of Rebaudioside D to Rebaudioside M. The results are depicted in the following table. 
     
       
         
               
               
               
               
             
               
               
               
               
             
           
               
                   
               
               
                   
                   
                 conversion Reb D  
                   
               
               
                   
                   
                 to Reb M 
                 initial rate 
               
               
                   
                   
                 after 24 h 
                 (Reb M 
               
               
                 Clone 
                 Mutations* 
                 (%) 
                 area/min) 
               
               
                   
               
             
             
               
                   
               
             
          
           
               
                 UGT76G1var1 
                 E224A_F314S_R334K 
                 51.8 
                 5.5E+07 
               
               
                 UGT76G1var2 
                 S274G_T284I_L379G 
                 49.3 
                 4.7E+07 
               
               
                 UGT76G1var3 
                 I295T_S357C_V366I 
                 9.6 
                 1.6E+06 
               
               
                 UGT76G1var4 
                 E224D_E231A_F265I 
                 14.7 
                 8.6E+06 
               
               
                 UGT76G1var5 
                 F22Y_I373L_P382M 
                 3.5 
                 2.3E+06 
               
               
                 UGT76G1var6 
                 Q266S_S357N_I373L 
                 0.5 
                 1.8E+06 
               
               
                 UGT76G1var7 
                 F22L_I43V_A239V 
                 0.2 
                 −6.0E+04   
               
               
                 UGT76G1var8 
                 E224A_Q266S_Q342E 
                 0.5 
                 2.3E+04 
               
               
                 UGT76G1var9 
                 E231A_D301N_G348P 
                 52.0 
                 4.9E+07 
               
               
                 UGT76G1var10 
                 A33G_L246F_Q342E 
                 0.3 
                 −7.7E+02   
               
               
                 UGT76G1var11 
                 F22L_A33G_V310I 
                 0.4 
                 3.8E+04 
               
               
                 UGT76G1var12 
                 L243P_K303G_A352G 
                 0.5 
                 8.7E+04 
               
               
                 UGT76G1var13 
                 L243A_S357C_A385T 
                 0.2 
                 −3.3E+04   
               
               
                 UGT76G1var14 
                 A239I_F265I_V396F 
                 5.3 
                 1.5E+06 
               
               
                 UGT76G1var15 
                 F41L_L246F_Q425E 
                 5.6 
                 1.5E+06 
               
               
                 UGT76G1var16 
                 F265I_P272A_I335V 
                 18.6 
                 5.8E+06 
               
               
                 UGT76G1var17 
                 F265L_Q266E_Q342K 
                 0.7 
                 7.2E+05 
               
               
                 UGT76G1var18 
                 L243P_S274G_N409R 
                 1.9 
                 5.0E+05 
               
               
                 UGT76G1var19 
                 E224D_E229A_Q432E 
                 10.5 
                 5.5E+06 
               
               
                 UGT76G1var20 
                 S375M_K393G_Y397E 
                 1.8 
                 1.9E+06 
               
               
                 UGT76G1var21 
                 A239V_V300A_K303G 
                 41.9 
                 3.3E+07 
               
               
                 UGT76G1var22 
                 E231A_V310I_R334K 
                 34.4 
                 2.4E+07 
               
               
                 UGT76G1var23 
                 T263S_G348P_A352G 
                 47.8 
                 4.1E+07 
               
               
                 UGT76G1var24 
                 A239I_P272A_Q425E 
                 31.0 
                 2.1E+07 
               
               
                 UGT76G1var25 
                 T284L_Q342K_Y397Q 
                 0.9 
                 6.3E+04 
               
               
                 UGT76G1var26 
                 S241I_F265L_F377C 
                 1.8 
                 7.5E+05 
               
               
                 UGT76G1var27 
                 A239I_L379A_V394I 
                 29.0 
                 1.5E+07 
               
               
                 UGT76G1var28 
                 L243A_S274G_P382M 
                 6.1 
                 2.4E+06 
               
               
                 UGT76G1var29 
                 F22Y_V279I_N409R 
                 41.0 
                 2.9E+07 
               
               
                 UGT76G1var30 
                 I43V_E224A_S241I 
                 13.6 
                 5.6E+06 
               
               
                 UGT76G1var31 
                 E224D_L243P_V300A 
                 0.4 
                 2.4E+05 
               
               
                 UGT76G1var32 
                 A239V_L243A_S375M 
                 0.0 
                 −4.4E+04   
               
               
                 UGT76G1var33 
                 A33G_R334H_Y397Q 
                 1.0 
                 7.5E+06 
               
               
                 UGT76G1var34 
                 I43V_T284I_I295T 
                 3.4 
                 1.5E+06 
               
               
                 UGT76G1var35 
                 T284L_F314S_S357N 
                 0.5 
                 1.8E+05 
               
               
                 UGT76G1var36 
                 F265L_L379A_V396F 
                 20.0 
                 8.8E+06 
               
               
                 UGT76G1var37 
                 E229A_L379G_I407V 
                 39.1 
                 2.8E+07 
               
               
                 UGT76G1var38 
                 F41L_I295M_F377C 
                 8.2 
                 3.7E+06 
               
               
                 UGT76G1var39 
                 F22Y_F41L_V366I 
                 7.2 
                 3.3E+06 
               
               
                 UGT76G1var40 
                 T263S_Q266E_S375R 
                 47.6 
                 3.3E+07 
               
               
                 UGT76G1var41 
                 L246F_A385T_K393G 
                 0.8 
                 1.4E+06 
               
               
                 UGT76G1var42 
                 T263S_Q266S_R334H 
                 34.6 
                 2.2E+07 
               
               
                 UGT76G1var43 
                 S241I_P272A_V279I 
                 19.9 
                 9.4E+06 
               
               
                 UGT76G1var44 
                 I335V_S375R_I407V 
                 35.3 
                 2.3E+07 
               
               
                 UGT76G1var45 
                 V279I_D301N_S389E 
                 38.6 
                 2.3E+07 
               
               
                 UGT76G1var46 
                 F22L_Q266E_I295M 
                 0.6 
                 9.8E+05 
               
               
                 UGT76G1var47 
                 E229A_T284I_S389E 
                 4.8 
                 2.7E+06 
               
               
                 UGT76G1var48 
                 V394I_Y397E_Q432E 
                 47.6 
                 3.8E+07 
               
               
                 UGT76G1var49 
                 F41L_Q266E_T284I_Y397Q 
                 2.6 
                 1.1E+06 
               
               
                 UGT76G1var50 
                 F22Y_V310I_S375M_F377C 
                 1.9 
                 −7.9E+05   
               
               
                 UGT76G1var51 
                 K303G_S357C_S389E_V396F 
                 18.7 
                 9.5E+06 
               
               
                 UGT76G1var52 
                 D301N_I373L_F377C_I407V 
                 12.9 
                 4.6E+06 
               
               
                 UGT76G1var53 
                 R334K_A352G_P382M_S389E 
                 9.3 
                 4.1E+06 
               
               
                 UGT76G1var54 
                 E229A_T284L_R334K_Q342E 
                 0.7 
                 4.3E+05 
               
               
                 UGT76G1var55 
                 I295M_Q342E_V366I_N409R 
                 1.0 
                 2.2E+05 
               
               
                 UGT76G1var56 
                 L246F_A352G_S357N_Q432E 
                 0.4 
                 4.1E+04 
               
               
                 UGT76G1var57 
                 S241I_T263S_L379G_A385T 
                 0.8 
                 1.5E+05 
               
               
                 UGT76G1var58 
                 S357C_S375M_N409R_Q425E 
                 7.5 
                 2.2E+06 
               
               
                 UGT76G1var59 
                 I335V_K393G_V394I_Y397Q 
                 33.0 
                 2.7E+07 
               
               
                 UGT76G1var60 
                 E231A_L243A_V279I_S357N 
                 0.5 
                 9.5E+04 
               
               
                 UGT76G1var61 
                 I43V_F265I_Q266S_L379A 
                 6.4 
                 2.0E+06 
               
               
                 UGT76G1var62 
                 L243P_P272A_V394I_V396F 
                 0.1 
                 3.4E+04 
               
               
                 UGT76G1var63 
                 F314S_R334H_Q342K_L379G 
                 3.4 
                 1.2E+06 
               
               
                 UGT76G1var64 
                 F22L_A239I_R334H_I407V 
                 0.3 
                 3.1E+04 
               
               
                 UGT76G1var65 
                 A33G_A239V_P382M_Q425E 
                 1.2 
                 3.3E+05 
               
               
                 UGT76G1var66 
                 F265L_V310I_V366I_A385T 
                 0.8 
                 3.7E+05 
               
               
                 UGT76G1var67 
                 E224D_F314S_S375R_Y397E 
                 −2.1 
                 −5.6E+05   
               
               
                 UGT76G1var68 
                 Q342K_G348P_I373L_Y397E 
                 −1.4 
                 −1.1E+05   
               
               
                 UGT76G1var69 
                 S274G_I295T_I335V_L379A 
                 24.7 
                 8.3E+06 
               
               
                 UGT76G1var70 
                 E224A_I295T_V300A_G348P 
                 24.0 
                 8.4E+06 
               
               
                 UGT76G1var71 
                 I295M_V300A_K393G_Q432E 
                 42.9 
                 2.1E+07 
               
               
                 UGT76G1var72 
                 T284L_D301N_K303G_S375R 
                 19.2 
                 9.1E+06 
               
               
                 UGT76G1var73 
                 F22Y_D301N_R334H_Q342E_V396F 
                 0.8 
                 8.7E+05 
               
               
                 UGT76G1var74 
                 I295T_I373L_S375R_Y397Q_Q432E 
                 0.6 
                 9.6E+04 
               
               
                 UGT76G1var75 
                 F41L_A239I_Q266S_S375M_P382M 
                 0.8 
                 −1.3E+05   
               
               
                 UGT76G1var76 
                 F22Y_A239I_L246F_I295M_R334K 
                 2.6 
                 7.2E+05 
               
               
                 UGT76G1var77 
                 A239V_F265I_I295T_D301N_K393G 
                 1.9 
                 4.4E+05 
               
               
                 UGT76G1var78 
                 V279I_V300A_V310I_I335V_S357C 
                 3.2 
                 8.2E+05 
               
               
                 UGT76G1var79 
                 E224D_T284I_V366I_I373L_K393G 
                 8.5 
                 3.8E+06 
               
               
                 UGT76G1var80 
                 L243P_L379A_S389E_Q425E_Q432E 
                 1.0 
                 2.1E+05 
               
               
                 UGT76G1var81 
                 A33G_T263S_S274G_V279I_Y397E 
                 15.0 
                 6.5E+06 
               
               
                 UGT76G1var82 
                 E224D_L243A_F265L_R334H_A352G 
                 1.1 
                 2.5E+05 
               
               
                 UGT76G1var83 
                 I43V_Q342E_S357N_S375R_L379G 
                 0.5 
                 4.3E+04 
               
               
                 UGT76G1var84 
                 F22L_Q266S_F314S_A352G_S357C 
                 1.2 
                 2.3E+05 
               
               
                 UGT76G1var85 
                 T284L_G348P_F377C_P382M_N409R 
                 1.8 
                 4.0E+05 
               
               
                 UGT76G1var86 
                 E224A_T284L_V396F_Y397E_I407V 
                 1.6 
                 3.8E+05 
               
               
                 UGT76G1var87 
                 S241I_L243A_V300A_F314S_N409R 
                 35.7 
                 2.1E+07 
               
               
                 UGT76G1var88 
                 A239V_T284I_V310I_Q342K_L379A 
                 1.6 
                 3.8E+05 
               
               
                 UGT76G1var89 
                 F41L_E229A_E231A_F265L_P272A 
                 1.2 
                 2.1E+05 
               
               
                 UGT76G1var90 
                 E231A_S241I_S274G_Y397Q_Q425E 
                 34.5 
                 1.9E+07 
               
               
                 UGT76G1var91 
                 E224A_L246F_T263S_F265I_Q342K 
                 1.2 
                 2.3E+05 
               
               
                 UGT76G1var92 
                 K303G_S357N_V366I_V394I_I407V 
                 1.6 
                 3.6E+05 
               
               
                 UGT76G1var93 
                 I43V_Q266E_S375M_S389E_V394I 
                 1.8 
                 4.5E+05 
               
               
                 UGT76G1var94 
                 Q266E_P272A_R334K_G348P_L379G 
                 72.0 
                 7.9E+07 
               
               
                 UGT76G1var95 
                 A33G_I295M_K303G_I335V_A385T 
                 −1.3 
                 −1.7E+05   
               
               
                 UGT76G1var96 
                 F22L_E229A_L243P_F377C_A385T 
                 1.2 
                 2.7E+05 
               
               
                   
               
               
                 *Mutations are noted as follows: original amino acid-position-new amino acid: For example the mutation of an alanine at position 33 to a glycine is noted as A33G. 
               
             
          
         
       
     
     Example 27 
     In-Vivo Production of UGTSL2 
     
       
         
               
             
           
               
                 SEQ ID 9 
               
               
                 UGTSL2 (GI_460410132 / XP_004250485.1) amino acid 
               
               
                 sequence: 
               
               
                 MATNLRVLMFPWLAYGHISPFLNIAKQLADRGFLIYLCSTRINLESIIKK 
               
               
                   
               
               
                 IPEKYADSIHLIELQLPELPELPPHYHTTNGLPPHLNPTLHKALKMSKPN 
               
               
                   
               
               
                 FSRILQNLKPDLLIYDVLQPWAEHVANEQNIPAGKLLTSCAAVFSYFFSF 
               
               
                   
               
               
                 RKNPGVEFPFPAIHLPEVEKVKIREILAKEPEEGGRLDEGNKQMMLMCTS 
               
               
                   
               
               
                 RTIEAKYIDYCTELCNWKVVPVGPPFQDLITNDADNKELIDWLGTKHENS 
               
               
                   
               
               
                 TVFVSFGSEYFLSKEDMEEVAFALELSNVNFIWVARFPKGEERNLEDALP 
               
               
                   
               
               
                 KGFLERIGERGRVLDKFAPQPRILNHPSTGGFISHCGWNSAMESIDFGVP 
               
               
                   
               
               
                 IIAMPIHNDQPINAKLMVELGVAVEIVRDDDGKIHRGEIAETLKSVVTGE 
               
               
                   
               
               
                 TGEILRAKVREISKNLKSIRDEEMDAVAEELIQLCRNSNKSK 
               
             
          
         
       
     
     The pET30A+ vector containing the UGTSL2 gene was introduced in  E. coli  B121(DE3) by heat shock. The obtained cells were grown in petri-dishes in the presence of Kanamycin and suitable colonies were selected and allowed to grow in liquid LB medium (erlenmeyer flasks). Glycerol was added to the suspension as cryoprotecteur and 400 μL aliquots were stored at −20° C. and at −80° C. 
     The storage aliquots of  E. coli  BL21(DE3) containing the pET30A+_UGTSL2 plasmids were thawed and added to 30 mL of LBGKP medium (20 g/L Luria Broth Lennox; 50 mM PIPES buffer pH 7.00; 50 mM Phosphate buffer pH 7.00; 2.5 g/L glucose and 50 mg/L of Kanamycin). This culture was allowed to shake at 135 rpm at 30° C. for 8 h. 
     The production medium contained 60 g/L of overnight express instant TB medium (Novagen), 10 g/L of glycerol and 50 mg/L of Kanamycin. The preculture was added to 200 mL of this medium and the solution was allowed to stir at 20° C. while taking samples to measure the OD and pH. The culture gave significant growth and a good OD was obtained. After 40 h, the cells were harvested by centrifugation and frozen to obtain 6.22 g of cell wet weight. 
     Lysis was performed on 1.4 g of cells by addition of Bugbuster Master mix (Novagen) and the lysate was recovered by centrifugation and used fresh. 
     Example 28 
     Determination of Activity for Stevioside to Rebaudioside E Conversion with UGTSL and UGTSL2 
     UGTSL was prepared according to EXAMPLE 22, and UGTSL2 was prepared according to EXAMPLE 27. 
     Activity tests were performed at 3 mL scale with 600 μL of lysate for the transformation of Stevioside using 0.5 mM of substrate, 2.5 mM of UDP-Glucose and 3 mM MgCl 2  in 50 mM Sodium Phosphate buffer at pH 7.2. Samples were taken and analyzed by HPLC. HPLC Analysis as shown in  FIGS. 58-59 . The HPLC assay was performed as described in EXAMPLE 20. 
     The results for the different enzymes and the corresponding chromatograms are provided below. 
     
       
         
               
               
               
               
               
             
               
               
               
               
               
             
           
               
                   
               
               
                   
                   
                   
                 Stevioside  
                   
               
               
                 Enzyme 
                   
                   
                 conv. 1   
                 Rebaudioside 
               
               
                 internal 
                   
                   
                 (reaction  
                 E 
               
               
                 reference 
                 GI Number 
                 Version 
                 time) 
                 formation 1   
               
               
                   
               
             
             
               
                   
               
             
          
           
               
                 UGTSL 
                 460409128 
                 XP_004249992.1 
                 74% (22 h.) 
                 46% 
               
               
                 UGTSL2 
                 460410132 
                 XP_004250485.1 
                 77% (2 h.)  
                 50% 
               
               
                   
               
               
                 Note: 
               
               
                   1 Based on initial concentration of Stevioside 
               
             
          
         
       
     
     The below table accompanies  FIG. 58 . 
     
       
         
               
             
               
               
               
             
               
               
               
             
           
               
                   
               
               
                 SAMPLE: 12400 S151N33 T22h 130926ABA 
               
               
                 Gene references: UGTSL (XP_004249992.1) 
               
               
                 Filename: 130926_12400_042.dat 
               
               
                 CAD Ch 1 Results 
               
             
          
           
               
                 Compound 
                 Retention time 
                 Integration (area) 
               
               
                   
               
             
          
           
               
                 Unknown@RT4.27 
                 4.270 
                 45,634,692 
               
               
                 Rebaudioside E 
                 5.398 
                 215,079,800 
               
               
                 Unknown@RT6.79 
                 6.790 
                 11,0326,212 
               
               
                 Unknown@RT7.32 
                 7.320 
                 33,855,010 
               
               
                 Unknown@RT7.69 
                 7.689 
                 271,186,269 
               
               
                 Unknown@RT8.18 
                 8.178 
                 6,003,490 
               
               
                 Unknown@RT8.78 
                 8.779 
                 20,739,231 
               
               
                 Stevioside 
                 9.201 
                 114,734,548 
               
               
                 Unknown@RT9.65 
                 9.648 
                 779,225,521 
               
               
                 Total 
                   
                 1,596,784,773 
               
               
                   
               
             
          
         
       
     
     The below table accompanies  FIG. 59 . 
     
       
         
               
             
               
               
               
             
               
               
               
             
           
               
                   
               
               
                 SAMPLE: 12400 S151N26 T2h 130927ABA 
               
               
                 Gene references: UGTSL2 (XP_004250485.1) 
               
               
                 Filename: 130927_12400_093.dat 
               
               
                 CAD Ch 1 Results 
               
             
          
           
               
                 Compound 
                 Retention time 
                 Integration (area) 
               
               
                   
               
             
          
           
               
                 Unknown@RT3.84 
                 3.841 
                 16,182,482 
               
               
                 Unknown@RT4.25 
                 4.255 
                 20,078,830 
               
               
                 Unknown@RT4.91 
                 4.910 
                 27,630,795 
               
               
                 Rebaudioside E 
                 5.389 
                 203,768,956 
               
               
                 Unknown@RT5.75 
                 5.751 
                 8,018,638 
               
               
                 Unknown@RT6.82 
                 6.817 
                 200,959,602 
               
               
                 Unknown@RT7.31 
                 7.310 
                 370188401 
               
               
                 Unknown@RT7.68 
                 7.680 
                 294,963,186 
               
               
                 Stevioside 
                 9.186 
                 101,729,292 
               
               
                 Unknown@RT9.63 
                 9.635 
                 727,903,255 
               
               
                 Total 
                   
                 1,971,423,437 
               
               
                   
               
             
          
         
       
     
     Example 29 
     Determination of Activity for Rubusoside to Rebaudioside E Conversion with UGTSL and UGTSL2 
     UGTSL was prepared according to EXAMPLE 22, and UGTSL2 was prepared according to EXAMPLE 27. 
     Activity tests were performed at 3 mL scale with 600 μL of lysate for the transformation of Rubusoside using 0.5 mM of substrate, 2.5 mM of UDP-Glucose and 3 mM MgCl 2  in 50 mM Sodium Phosphate buffer at pH 7.2. Samples were taken and analyzed by HPLC as shown in  FIGS. 60-61 . The HPLC assay was performed as described in EXAMPLE 20. 
     The results for the different enzymes and the corresponding chromatograms are provided below. 
     
       
         
               
               
               
               
               
             
               
               
               
               
               
             
           
               
                   
               
               
                   
                   
                   
                 Rubusoside  
                   
               
               
                 Enzyme 
                   
                   
                 conv. 1   
                 Rebaudioside  
               
               
                 internal 
                   
                   
                 (reaction  
                 E 
               
               
                 reference 
                 GI Number 
                 Version 
                 time) 
                 formation 1   
               
               
                   
               
             
             
               
                   
               
             
          
           
               
                 UGTSL 
                 460409128 
                 XP_004249992.1 
                 70% (45 h.) 
                 27% 
               
               
                 UGTSL2 
                 460410132 
                 XP_004250485.1  
                 80% (2 h.)  
                 55% 
               
               
                   
               
               
                 Note: 
               
               
                   1 Based on initial concentration of Rubusoside 
               
             
          
         
       
     
     The below table accompanies  FIG. 60 . 
     
       
         
               
             
               
               
               
             
               
               
               
             
           
               
                   
               
               
                 SAMPLE: 12400 S151N22 T45h 130927ABA 
               
               
                 Gene references: UGTSL (XP_004249992.1) 
               
               
                 Filename: 130927_12400_092.dat 
               
               
                 CAD Ch 1 Results 
               
             
          
           
               
                 Compound 
                 Retention time 
                 Integration (area) 
               
               
                   
               
             
          
           
               
                 Rebaudioside E 
                 5.499 
                 135,984,743 
               
               
                 Unknown@RT7.03 
                 7.027 
                 54,448,761 
               
               
                 Unknown@RT7.30 
                 7.302 
                 41,308,528 
               
               
                 Unknown@RT7.68 
                 7.682 
                 283,852,603 
               
               
                 Unknown@RT8.14 
                 8.145 
                 5,484,731 
               
               
                 Unknown@RT8.74 
                 8.742 
                 290,946,055 
               
               
                 Stevioside 
                 9.178 
                 8,774,098 
               
               
                 Unknown@RT9.64 
                 9.637 
                 761,299,117 
               
               
                 Unknown@RT10.54 
                 10.542 
                 18,276,224 
               
               
                 Rubusoside 
                 11.233 
                 155,492,389 
               
               
                 Total 
                   
                 1,755,867,249 
               
               
                   
               
             
          
         
       
     
     The below table accompanies  FIG. 61 . 
     
       
         
               
             
               
               
               
             
               
               
               
             
           
               
                   
               
               
                 SAMPLE: 12400 S151N15 T2h 130927ABA 
               
               
                 Gene references: UGTSL2 (XP_004250485.1) 
               
               
                 Filename: 130927_12400_080.dat 
               
               
                 CAD Ch 1 Results 
               
             
          
           
               
                 Compound 
                 Retention time 
                 Integration (area) 
               
               
                   
               
             
          
           
               
                 Unknown@RT5.14 
                 5.138 
                 5,555,472 
               
               
                 Rebaudioside E 
                 5.505 
                 278,529,547 
               
               
                 Unknown@RT6.64 
                 6.643 
                 23,812,633 
               
               
                 Unknown@RT7.01 
                 7.012 
                 84,543,823 
               
               
                 Unknown@RT7.31 
                 7.315 
                 283,724,517 
               
               
                 Unknown@RT7.69 
                 7.687 
                 264,400,008 
               
               
                 Unknown@RT8.78 
                 8.767 
                 188,634,123 
               
               
                 Stevioside 
                 9.193 
                 9,365,107 
               
               
                 Unknown@RT9.64 
                 9.643 
                 700,878,865 
               
               
                 Rubusoside 
                 11.238 
                 102,484,386 
               
               
                 Totals 
                   
                 1,941,928,481 
               
               
                   
               
             
          
         
       
     
     Example 30 
     Determination of Activity for Rebaudioside A to Rebaudioside D Conversion with UGTSL2 
     UGTSL2 was prepared according to EXAMPLE 27. 
     Activity tests were performed at 3 mL scale with 60 μL of lysate for the transformation of Rebaudioside A using 0.5 mM of substrate, 2.5 mM of UDP-Glucose and 3 mM MgCl 2  in 50 mM Sodium Phosphate buffer at pH 7.2. Samples were taken and analyzed by HPLC as shown in  FIG. 62 . The HPLC assay was performed as described in EXAMPLE 20. 
     The result after 23 h. of reaction and the corresponding chromatogram is provided below. 
     
       
         
               
               
               
               
               
             
           
               
                   
               
               
                   
                   
                   
                 Rebaudioside  
                   
               
               
                 Enzyme 
                   
                   
                 A conv. 1   
                 Rebaudioside  
               
               
                 internal 
                   
                   
                 (reaction  
                 D 
               
               
                 reference 
                 GI Number 
                 Version 
                 time) 
                 formation 1   
               
               
                   
               
             
             
               
                 UGTSL2 
                 460410132 
                 XP_004250485.1 
                 78% (23 h.) 
                 75% 
               
               
                   
               
               
                 Note: 
               
               
                   1 Based on initial concentration of Rebaudioside A 
               
             
          
         
       
     
     The below table accompanies  FIG. 62 . 
     
       
         
               
             
               
               
               
             
               
               
               
             
           
               
                   
               
               
                 SAMPLE: 12400 S154N14 T23h 131003ABA 
               
               
                 Gene references: UGTSL2 (XP_004250485.1) 
               
               
                 Filename: 131003_12400_086.dat 
               
               
                 CAD Ch 1 Results 
               
             
          
           
               
                 Compound 
                 Retention time 
                 Integration (area) 
               
               
                   
               
             
          
           
               
                 Unknown@RT4.53 
                 4.530 
                 55,894,278 
               
               
                 Rebaudioside D 
                 5.788 
                 461,768,318 
               
               
                 Unknown@RT6.71 
                 6.713 
                 7,942,480 
               
               
                 Unknown@RT6.99 
                 6.993 
                 11,192,896 
               
               
                 Unknown@RT7.33 
                 7.327 
                 120,255,606 
               
               
                 Unknown@RT7.70 
                 7.700 
                 38,994,186 
               
               
                 Rebaudioside A 
                 9.140 
                 137,037,966 
               
               
                 Unknown@RT9.65 
                 9.652 
                 314,468,535 
               
               
                 Total 
                   
                 1,147,554,265 
               
               
                   
               
             
          
         
       
     
     Example 31 
     Identification of Glycosides 
     The reaction mixtures prepared according to EXAMPLE 30 and incubated for 45 hrs was analyzed by LC-MS, along with  Stevia rebaudiana  Bertoni leaf extract “MLD1” produced by PureCircle Sdn Bhd (Malaysia), to determine the occurrence of formed glycosides in nature. 
     An Agilent 1200 series HPLC system, equipped with binary pump (G1312B), autosampler (G1367D), thermostatted column compartment (G1316B), DAD detector (G1315C), connected with Agilent 6110A MSD, and interfaced with “LC/MSD Chemstation” software, was used, and the chromatogram is shown in  FIG. 63 . 
     Instrument Conditions 
                                           Instrument conditions                                    Column   Phenomenex Prodigy 3u C18 100A,                4.6 mm × 250 mm, 3 μm           Column Temperature   55° C.           Detection   DAD at 210 nm bw 360 nm               MSD (Scan and SIM mode)               Mode: ES-API, Negative Polarity               Drying gas flow: 13.0 L/min               Nebulizer pressure: 30 psig               Drying gas temperature: 270° C.           Analysis duration   75 min           Injected volume   10 μL           Flow rate   0.5 mL/min                        
Mobile Phase Gradient Program
 
     
       
         
               
               
               
             
           
               
                   
               
               
                 Time (min) 
                 A (%): Formic acid 0.1% 
                 B (%): Acetonitrile 
               
               
                   
               
             
             
               
                  0 
                 75 
                 25 
               
               
                 30 
                 75 
                 25 
               
               
                 33 
                 68 
                 32 
               
               
                 75 
                 68 
                 32 
               
               
                   
               
             
          
         
       
     
     The assay shows that the compound observed on LC-MS system at 11.77 min is the same as the compound at 3.5 min, in EXAMPLE 23 (C 56 H 90 O 33 ; later confirmed as reb M2), and the compound observed at 26.64 min is the same as the compound at 7.6 min, in EXAMPLE 23 (C 50 H 80 O 28 , reb UNK; later confirmed as reb D2). Other isomers of reb M were observed at 13.96 min and also another isomer form of reb D was observed at 25.06 min. All observed compounds occurred in the extract of  Stevia rebaudiana  Bertoni plant. 
     The below table accompanies  FIG. 63 . 
     
       
         
               
             
               
               
               
               
             
               
               
               
               
             
           
               
                   
               
               
                 SAMPLE: UGTSL2 T45h 
               
               
                 Gene references: UGTSL2 (XP_004250485.1) 
               
               
                 MSD SIM Results 
               
             
          
           
               
                   
                 Compound 
                 Retention time 
                 MW 
               
               
                   
                   
               
             
          
           
               
                   
                 Unknown@RT11.77 
                 11.775 
                 1,291 
               
               
                   
                 Unknown@RT13.96 
                 13.965 
                 1,291 
               
               
                   
                 Rebaudioside D 
                 19.598 
                 1,129 
               
               
                   
                 Unknown@RT25.06 
                 25.061 
                 1,129 
               
               
                   
                 Unknown@RT26.64 
                 26.637 
                 1,129 
               
               
                   
                 Rebausioside A 
                 52.258 
                 967 
               
               
                   
                   
               
             
          
         
       
     
     Example 32 
     In Vivo Preparation and Activity Determination of UGTLB 
     
       
         
               
             
           
               
                 SEQ ID 10 
               
               
                 UGTLB (GI_209954733 / BAG80557.1) amino acid 
               
               
                 sequence 
               
               
                 MGTEVTVHKNTLRVLMFPWLAYGHISPFLNVAKKLVDRGFLIYLCSTAIN 
               
               
                   
               
               
                 LKSTIKKIPEKYSDSIQLIELHLPELPELPPHYHTTNGLPPHLNHTLQKA 
               
               
                   
               
               
                 LKMSKPNFSKILQNLKPDLVIYDLLQQWAEGVANEQNIPAVKLLTSGAAV 
               
               
                   
               
               
                 LSYFFNLVKKPGVEFPFPAIYLRKNELEKMSELLAQSAKDKEPDGVDPFA 
               
               
                   
               
               
                 DGNMQVMLMSTSRIIEAKYIDYFSGLSNWKVVPVGPPVQDPIADDADEME 
               
               
                   
               
               
                 LIDWLGKKDENSTVFVSFGSEYFLSKEDREEIAFGLELSNVNFIWVARFP 
               
               
                   
               
               
                 KGEEQNLEDALPKGFLERIGDRGRVLDKFAPQPRILNHPSTGGFISHCGW 
               
               
                   
               
               
                 NSVMESVDFGVPIIAMPIHLDQPMNARLIVELGVAVEIVRDDYGKIHREE 
               
               
                   
               
               
                 IAEILKDVIAGKSGENLKAKMRDISKNLKSIRDEEMDTAAEELIQLCKNS 
               
               
                   
               
               
                 PKLK 
               
             
          
         
       
     
     The pET30A+ vector containing the UGTLB gene was introduced in  E. coli  Bl21(DE3) by heat shock. The obtained cells were grown in petri-dishes in the presence of Kanamycin and suitable colonies were selected and allowed to grow in liquid LB medium (erlenmeyer flasks). Glycerol was added to the suspension as cryoprotecteur and 400 μL aliquots were stored at −20° C. and at −80° C. 
     The storage aliquots of  E. coli  BL21(DE3) containing the pET30A+_UGTLB plasmids were thawed and added to 30 mL of LBGKP medium (20 g/L Luria Broth Lennox; 50 mM PIPES buffer pH 7.00; 50 mM Phosphate buffer pH 7.00; 2.5 g/L glucose and 50 mg/L of Kanamycine). This culture was allowed to shake at 135 rpm at 30° C. for 8 h. 
     The production medium contained 60 g/L of overnight express instant TB medium (Novagen), 10 g/L of glycerol and 50 mg/L of Kanamycine. The preculture was added to 200 mL of this medium and the solution was allowed to stir at 20° C. while taking samples to measure the OD and pH. The culture gave significant growth and a good OD was obtained. After 40 h, the cells were harvested by centrifugation and frozen to obtain 5.7 g of cell wet weight. 
     Lysis was performed on 1.2 g of cells by addition of 6 mL Bugbuster Master mix (Novagen) and the lysate was recovered by centrifugation and used fresh. 
     Determination of Activity for Stevioside to Rebaudioside E Conversion with UGTLB 
     Activity tests were performed at 3 mL scale with 600 μL of lysate for the transformation of Stevioside using 0.5 mM of substrate, 2.5 mM of UDP-Glucose and 3 mM MgCl 2  in 50 mM Sodium Phosphate buffer at pH 7.2. Samples were taken and analyzed by HPLC as shown in  FIGS. 64-66 . The corresponding chromatograms are depicted in  FIGS. 64-66 . 
     
       
         
               
               
               
               
               
             
           
               
                   
               
               
                   
                   
                   
                 Stevioside  
                   
               
               
                 Enzyme  
                   
                   
                 conv. 1   
                 Rebaudioside  
               
               
                 internal 
                   
                   
                 (reaction  
                 E 
               
               
                 reference 
                 GI Number 
                 Version 
                 time) 
                 formation 1   
               
               
                   
               
             
             
               
                 UGTLB 
                 209954733 
                 BAG80557.1 
                 89% (22 h.) 
                 3% 
               
               
                   
               
               
                 Note: 
               
               
                   1 Based on initial concentration of Stevioside 
               
             
          
         
       
     
     The below table accompanies  FIG. 64 . 
                                                                 SAMPLE: 12400 S151N28 T22h 130926ABA       Gene references: UGTLB (BAG80557.1)       Filename: 130926_12400_037.dat       CAD Ch 1 Results                Compound   Retention time   Integration (area)                            Unknown@4.27   4.270   101,580,340           Unknown@4.88   4.884   2,979,482           Rebaudioside E   5.397   13,747,837           Unknown@6.80   6.796   378,936,196           Unknown@7.32   7.319   54,838,779           Unknown@7.69   7.693   291,189,747           Unknown@8.78   8.784   21,079,018           Stevioside   9.200   50,143,248           Unknown@9.65   9.650   888,211,556           Unknown@10.70   10.697   5,878,160           Totals       1,808,584,363                        
Determination of Activity for Rubusoside to Rebaudioside E Conversion with UGTLB
 
     Activity tests were performed at 3 mL scale with 600 μL of lysate for the transformation of Rubusoside using 0.5 mM of substrate, 2.5 mM of UDP-Glucose and 3 mM MgCl 2  in 50 mM Sodium Phosphate buffer at pH 7.2. Samples were taken and analyzed by HPLC. The corresponding chromatogram is depicted in  FIG. 65 . 
     
       
         
               
               
               
               
               
             
           
               
                   
               
               
                   
                   
                   
                 Rubusoside  
                   
               
               
                 Enzyme  
                   
                   
                 conv. 1   
                 Rebaudioside  
               
               
                 internal 
                   
                   
                 (reaction  
                 E 
               
               
                 reference 
                 GI Number 
                 Version 
                 time) 
                 formation 1   
               
               
                   
               
             
             
               
                 UGTLB 
                 209954733 
                 BAG80557.1 
                 65% (5 h.) 
                 4% 
               
               
                   
               
               
                 Note: 
               
               
                   1 Based on initial concentration of Rubusoside 
               
             
          
         
       
     
     The below table accompanies  FIG. 65 . 
                                                                 SAMPLE: 12400 S151N17 T5h 130927ABA       Gene references: UGTLB (BAG80557.1)       Filename: 130927_12400_084.dat       CAD Ch 1 Results                Compound   Retention time   Integration (area)                            Rebaudioside E   5.491   21921232           Unknown@7.01   7.010   9764063           Unknown@7.29   7.295   12510947           Unknown@7.68   7.677   283386906           Unknown@8.73   8.728   402240506           Unknown@9.63   9.630   878990745           Rubusoside   11.227   176000085           Totals       1784814484                        
Determination of Activity for Rebaudioside A to Rebaudioside D Conversion with UGTLB
 
     Activity tests were performed at 3 mL scale with 600 μL of lysate for the transformation of Rebaudioside A using 0.5 mM of substrate, 2.5 mM of UDP-Glucose and 3 mM MgCl 2  in 50 mM Sodium Phosphate buffer at pH 7.2. Samples were taken and analyzed by HPLC. The corresponding chromatogram after 23 h. of reaction is depicted in  FIG. 66 . 
     
       
         
               
               
               
               
               
             
           
               
                   
               
               
                   
                   
                   
                 Rebaudioside  
                   
               
               
                 Enzyme  
                   
                   
                 A 
                 Rebaudioside 
               
               
                 internal 
                   
                   
                 conv. 1    
                 D 
               
               
                 reference 
                 GI Number 
                 Version 
                 (reaction time) 
                 formation 1   
               
               
                   
               
             
             
               
                 UGTLB 
                 209954733 
                 BAG80557.1 
                 72% (22 h.) 
                 10% 
               
               
                   
               
               
                 Note: 
               
               
                   1 Based on initial concentration of Rebaudioside A 
               
             
          
         
       
     
     The below table accompanies  FIG. 66 . 
     
       
         
               
             
               
               
               
               
             
               
               
               
               
             
           
               
                   
               
               
                 SAMPLE: 12400 S154N6 T22h 130926ABA 
               
               
                 Gene references: UGTLB (BAG80557.1) 
               
               
                 Filename: 130926_12400_015.dat 
               
               
                 CAD Ch 1 Results 
               
             
          
           
               
                   
                 Compound 
                 Retention time 
                 Integration (area) 
               
               
                   
                   
               
             
          
           
               
                   
                 Unknown@4.42 
                 4.522 
                 137,916,950 
               
               
                   
                 Unknown@4.90 
                 4.903 
                 2,015,271 
               
               
                   
                 Rebaudioside D 
                 5.762 
                 59,876,764 
               
               
                   
                 Unknown@6.69 
                 6.689 
                 364,185,331 
               
               
                   
                 Unknown@6.97 
                 6.973 
                 26,368,965 
               
               
                   
                 Unknown@7.32 
                 7.318 
                 110,284,197 
               
               
                   
                 Unknown@7.69 
                 7.689 
                 294,579,799 
               
               
                   
                 Unknown@8.29 
                 8.293 
                 7,867,452 
               
               
                   
                 Unknown@8.78 
                 8.779 
                 15,928,550 
               
               
                   
                 Rebausioside A 
                 9.118 
                 165,602,247 
               
               
                   
                 Unknown@9.64 
                 9.642 
                 868,327,712 
               
               
                   
                 Totals 
                   
                 2,052,953,238 
               
               
                   
                   
               
             
          
         
       
     
     Example 33 
     Determination of Reaction Products for Rubusoside and Stevioside Conversion with UGTSL, UGTSL2, and UGTLB 
     Conversion of stevioside with UGTSL and UGTSL2 was conducted in similar manner to Example 28, and the conversion of rubusoside with UGTSL and UGTSL2 was conducted similarly to Example 29. Conversions of rubusoside and stevioside with UGTLB was conducted similarly to Example 32. 
     The reaction mixtures were analyzed by LCMS to determine all reaction products. 
     
       
         
               
             
               
               
               
             
               
               
               
               
               
               
               
               
               
             
               
               
               
               
               
               
               
               
               
             
           
               
                   
               
               
                 Rubusoside conversion products 
               
             
          
           
               
                   
                   
                 LC-MS, peak area ratio (%) 
               
             
          
           
               
                   
                   
                   
                   
                   
                   
                 Unknown peak  
                 Unknown peak 
                 Unknown peak 
               
               
                 Sample 
                 UGT 
                   
                   
                   
                   
                 #1 (MW804) 
                 #2 (MW804) 
                 #3 (MW804) 
               
               
                 ID 
                 (reaction time) 
                 Rub 
                 Stev 
                 Reb E 
                 Reb D 
                 RT 30.70 min 
                 RT 49.50 min 
                 RT 50.40 min 
               
               
                   
               
             
          
           
               
                 S151N15 
                 UGTSL2 (2 hrs) 
                 3.54 
                 2.12 
                 52.88 
                 6.73 
                 12.02 
                 9.94 
                 12.77 
               
               
                 S151N17 
                 UGTLB (5 hrs) 
                 13.49 
                 ND 
                 9.21 
                 1.29 
                 4.07 
                 66.67 
                 5.27 
               
               
                 S151N22 
                 UGTSL (45 hrs) 
                 7.82 
                 2.37 
                 35.88 
                 3.45 
                 20.38 
                 27.75 
                 2.35 
               
               
                   
               
             
          
         
       
     
     
       
         
               
             
               
               
               
             
               
               
               
               
               
               
               
               
             
               
               
               
               
               
               
               
               
             
           
               
                   
               
               
                 Stevioside conversion products 
               
             
          
           
               
                   
                   
                 LC-MS, peak area ratio (%) 
               
             
          
           
               
                   
                   
                   
                   
                   
                 Unknown peak  
                 Unknown peak 
                 Unknown peak 
               
               
                 Sample  
                 UGT  
                   
                   
                   
                 #1 (MW966) 
                 #2 (MW966) 
                 #3 (MW966) 
               
               
                 ID 
                 (reaction time) 
                 Stev 
                 Reb E 
                 Reb D 
                 RT = 22.60 min 
                 RT = 26.50 min 
                 RT = 29.50 min 
               
               
                   
               
             
          
           
               
                 S151N26 
                 UGTSL2 (2 hrs) 
                 20.01 
                 42.56 
                 1.70 
                 4.48 
                 5.56 
                 25.70 
               
               
                 S151N28 
                 UGTLB (2 hrs)  
                 43.11 
                 3.12 
                 ND 
                 ND 
                 53.78 
                 ND 
               
               
                 S151N33 
                 UGTSL (22 hrs) 
                 25.24 
                 49.68 
                 0.54 
                 3.97 
                 20.56 
                 ND 
               
               
                   
               
             
          
         
       
     
     It can be seen that amongst Rubusoside conversion products, besides Stevioside, Reb E and Reb D, there are at least 3 additional compounds with Molecular Weight of 804. The retention time of these compounds do not match with Reb B which is known to have same Molecular Weight as Stevioside. Since these compounds have same molecular weight with Stevioside it can be assumed that these novel steviol glycosides are isomers of Stevioside. On the other hand amongst Stevioside conversion products, besides Reb E and Reb D, there are at least 3 additional compounds with Molecular Weight of 966. The retention time of these compounds do not match with Reb A which is known to have same Molecular Weight as Reb E. Since these compounds have same molecular weight with Reb A and Reb E it can be assumed that these novel steviol glycosides are isomers of Reb A (Reb E). 
     Example 34 
     In Vivo Production of UGT76G1 in  S. cerevisiae   
     
       
         
               
             
           
               
                 SEQ ID 11 
               
               
                 UGT76G1 [ Stevia rebaudiana ] (gi_37993653 /gb_ 
               
               
                 AAR06912.1) 
               
               
                 MENKTETTVRRRRRIILFPVPFQGHINPILQLANVLYSKGFSITIFHTNF 
               
               
                   
               
               
                 NKPKTSNYPHFTFRFILDNDPQDERISNLPTHGPLAGMRIPIINEHGADE 
               
               
                   
               
               
                 LRRELELLMLASEEDEEVSCLITDALWYFAQSVADSLNLRRLVLMTSSLF 
               
               
                   
               
               
                 NFHAHVSLPQFDELGYLDPDDKTRLEEQASGFPMLKVKDIKSAYSNWQIL 
               
               
                   
               
               
                 KEILGKMIKQTKASSGVIWNSFKELEESELETVIREIPAPSFLIPLPKHL 
               
               
                   
               
               
                 TASSSSLLDHDRTVFQWLDQQPPSSVLYVSFGSTSEVDEKDFLEIARGLV 
               
               
                   
               
               
                 DSKQSFLWVVRPGFVKGSTWVEPLPDGFLGERGRIVKWVPQQEVLAHGAI 
               
               
                   
               
               
                 GAFWTHSGWNSTLESVCEGVPMIFSDFGLDQPLNARYMSDVLKVGVYLEN 
               
               
                   
               
               
                 GWERGEIANAIRRVMVDEEGEYIRQNARVLKQKADVSLMKGGSSYESLES 
               
               
                   
               
               
                 LVSYISSL 
               
             
          
         
       
     
     The above mentioned amino acid sequence was codon optimized for expression in  S. cerevisiae . Furthermore the yeast consensus sequence AACACA was added before the ATG start codon. The synthetic gene was subcloned in the pYES2 vector using Hind III and Xba I restriction sites. The pYES2_UGT76G1_Sc vector was used to transform chemically competent  S. cerevisiae  INVSc1 cells (Invitrogen). 
     The cells were grown on a solid synthetic minimal medium containing 2% glucose lacking Uracil and a single colony was picked and allowed to grow in liquid synthetic minimal medium lacking Uracil (SC-U containing 2% glucose). After centrifugation, the cells were suspended with SC-U (containing 2% glucose) and 60% glycerol/water. Aliquots were stored at −80° C. and one aliquot was used to start a culture in SC-U (containing 2% glucose) for 43 h at 30° C. Part of this culture was centrifuged and suspended in induction medium (SC-U containing 2% galactose) for 19 h30 at 30° C. 
     Cells were obtained by centrifugation and lysis with five volumes of CelLytic™ Y Cell Lysis Reagent (Sigma). The lysates were used directly for activity testing (UGT76G1_Sc). 
     Example 35 
     Determination of Activity of UGT76G1_Sc for the Conversion of Rebaudioside D to Rebaudioside M 
     UGT76G1_Sc was prepared according to EXAMPLE 34. Activity tests were performed at 2 mL scale with 200 μL of lysate for the transformation of Rebaudioside D using 0.5 mM of substrate, 2.5 mM of UDP-Glucose and 3 mM MgCl 2  in 50 mM Sodium Phosphate buffer at pH 7.2. Samples were taken and analyzed by HPLC as shown in  FIG. 67 . The corresponding chromatogram is depicted in  FIG. 67 . 
     
       
         
               
               
               
               
             
           
               
                   
                   
               
               
                   
                 Enzyme  
                 Rebaudioside D  
                   
               
               
                   
                 internal 
                 conv. 1   
                 Rebaudioside 
               
               
                   
                 reference 
                 (reaction time) 
                 M selectivity 1   
               
               
                   
                   
               
             
             
               
                   
                 UGT76G1_Sc 
                 85% (21 h.) 
                 100% 
               
               
                   
                   
               
               
                   
                 Note: 
               
               
                   
                   1 Based on initial concentration of Rebaudioside D 
               
             
          
         
       
     
     The below table accompanies  FIG. 67 . 
     
       
         
               
             
               
               
               
               
             
               
               
               
               
             
           
               
                   
               
               
                 SAMPLE: 12400 S169N10 T21h 131119CJA 
               
               
                 Gene references: UGT76G1_Sc 
               
               
                 Filename: 131122_12400_238.dat 
               
               
                 CAD Ch 1 Results 
               
             
          
           
               
                   
                 Compound 
                 Retention time 
                 Integration (area) 
               
               
                   
                   
               
             
          
           
               
                   
                 Rebaudioside D 
                 5.750 
                 112,094,430 
               
               
                   
                 Unknown@6.23 
                 6.235 
                 17,886,043 
               
               
                   
                 Rebaudioside M 
                 6.700 
                 616,583,935 
               
               
                   
                 Rebaudioside A 
                 9.095 
                 11,183,884 
               
               
                   
                 Unknown@10.27 
                 10.272 
                 62,863,156 
               
               
                   
                 Unknown@11.31 
                 11.310 
                 35,839,478 
               
               
                   
                 Total 
                   
                 856,450,926 
               
               
                   
                   
               
             
          
         
       
     
     Example 36 
     In Vivo Production of UGTSL in  S. cerevisiae   
     
       
         
               
             
           
               
                 SEQ ID 12 
               
               
                 UGTSL [ Solanum lycopersicum ] (gi_460409128 / XP_ 
               
               
                 004249992.1 
               
               
                 MSPKLHKELFFHSLYKKTRSNHTMATLKVLMFPFLAYGHISPYLNVAKKL 
               
               
                   
               
               
                 ADRGFLIYFCSTPINLKSTIEKIPEKYADSIHLIELHLPELPQLPPHYHT 
               
               
                   
               
               
                 TNGLPPNLNQVLQKALKMSKPNFSKILQNLKPDLVIYDILQRWAKHVANE 
               
               
                   
               
               
                 QNIPAVKLLTSGAAVFSYFFNVLKKPGVEFPFPGIYLRKIEQVRLSEMMS 
               
               
                   
               
               
                 KSDKEKELEDDDDDDDLLVDGNMQIMLMSTSRTIEAKYIDFCTALTNWKV 
               
               
                   
               
               
                 VPVGPPVQDLITNDVDDMELIDWLGTKDENSTVFVSFGSEYFLSKEDMEE 
               
               
                   
               
               
                 VAFALELSNVNFIWVARFPKGEERNLEDALPKGFLERIGERGRVLDKFAP 
               
               
                   
               
               
                 QPRILNHPSTGGFISHCGWNSAMESIDFGVPIIAMPMHLDQPMNARLIVE 
               
               
                   
               
               
                 LGVAVEIVRDDDGKIHRGEIAETLKGVITGKTGEKLRAKVRDISKNLKTI 
               
               
                   
               
               
                 RDEEMDAAAEELIQLCRNGN 
               
             
          
         
       
     
     The above mentioned amino acid sequence was codon optimized for expression in  S. cerevisiae . Furthermore the yeast consensus sequence AACACA was added before the ATG start codon. The synthetic gene was subcloned in the pYES2 vector using Hind III and Xba I restriction sites. The pYES2_UGTSL_Sc vector was used to transform chemically competent  S. cerevisiae  INVSc1 cells (Invitrogen). 
     The cells were grown on a solid synthetic minimal medium containing 2% glucose, lacking Uracil and a single colony was picked and allowed to grow in liquid synthetic minimal medium lacking Uracil (SC-U containing 2% glucose). After centrifugation, the cells were suspended with SC-U (containing 2% glucose) and 60% glycerol/water. Aliquots were stored at −80° C. and one aliquot was used to start a culture in SC-U (containing 2% glucose) for 43 h at 30° C. Part of this culture was centrifuged and suspended in induction medium (SC-U containing 2% galactose) for 19 h30 at 30° C. 
     Cells were obtained by centrifugation and lysis with five volumes of CelLytic™ Y Cell Lysis Reagent (Sigma). The lysates were used directly for activity testing (UGTSL_Sc). 
     Example 37 
     Determination of Activity of UGTSL_Sc for the Conversion of Rebaudioside A to Rebaudioside D 
     UGTSL_Sc was prepared according to EXAMPLE 36. Activity tests were performed at 2 mL scale with 200 μL of lysate for the transformation of Rebaudioside A using 0.5 mM of substrate, 2.5 mM of UDP-Glucose and 3 mM MgCl 2  in 50 mM Sodium Phosphate buffer at pH 7.2. Samples were taken and analyzed by HPLC as shown in  FIG. 68 . The corresponding chromatogram is depicted in  FIG. 68 . 
     
       
         
               
               
               
               
             
           
               
                   
                   
               
               
                   
                 Enzyme  
                 Rebaudioside A  
                   
               
               
                   
                 internal  
                 conv. 1    
                 Rebaudioside  
               
               
                   
                 reference 
                 (reaction time) 
                 D selectivity 1   
               
               
                   
                   
               
             
             
               
                   
                 UGTSL_Sc 
                 46% (4 h) 
                 42% 
               
               
                   
                   
               
               
                   
                 Note: 
               
               
                   
                   1 Based on initial concentration of Rebaudioside A 
               
             
          
         
       
     
     The below table accompanies  FIG. 68 . 
     
       
         
               
             
               
               
               
               
             
               
               
               
               
             
           
               
                   
               
               
                 SAMPLE: 12400 S169N02 T4h 131119CJA 
               
               
                 Gene references: UGTSL_Sc 
               
               
                 Filename: 131122_12400_203.dat 
               
               
                 CAD Ch 1 Results 
               
             
          
           
               
                   
                 Compound 
                 Retention time 
                 Integration (area) 
               
               
                   
                   
               
             
          
           
               
                   
                 Unknown@4.50 
                 4.500 
                 75,046,986 
               
               
                   
                 Rebaudioside D 
                 5.731 
                 223,409,643 
               
               
                   
                 Unknown@6.66 
                 6.658 
                 228,651,278 
               
               
                   
                 Rebaudioside A 
                 9.084 
                 404,642,305 
               
               
                   
                 Unknown@10.08 
                 10.079 
                 43,992,253 
               
               
                   
                 Unknown@11.21 
                 11.211 
                 29,776,761 
               
               
                   
                 Unknown@11.90 
                 11.905 
                 2,185,316 
               
               
                   
                 Total 
                   
                 1,007,704,542 
               
               
                   
                   
               
             
          
         
       
     
     Example 38 
     Isolation of Rebaudioside M 
     The amount of the product mixture of Example 14 was not large enough to separate via preparative HPLC methods. Accordingly, analytical HPLC with a series of injections was used to separate the components of the mixture. Separation was conducted according to the method described above in Example 14 to provide two fractions corresponding to the two main peaks in the HPLC trace of  FIG. 5 : Fraction A (retention time 24.165 minutes) and Fraction B (retention time 31.325 minutes). 
     The retention time of Fraction A was consistent with reb D, indicating unreacted starting material from the biotransformation reaction. 
     The retention time of purified Fraction B ( FIG. 6 ) was consistent with reb M, indicating successful biotransformation from reb D. The identity of the material collected in Fraction B as reb M was confirmed by co-injection of purified Fraction B with a reb M standard (available from PureCircle, HPLC trace of reb M standard shown in  FIG. 7 ). Both Fraction B and the reb M standard were found to elute at the same retention time ( FIG. 8 ), indicating Fraction B was reb M. 
     The identity of Fraction B as reb M was also separately confirmed by NMR and HRMS. For sampling, Fraction B was concentrated under rotary evaporator, freeze dried and dried for 40 h at 40° C. 
     The NMR sample was dissolved in deuterated pyridine (C 5 D 5 N) and spectra were acquired on a Varian Unity Plus 600 MHz instrument using standard pulse sequences. The NMR spectra of Fraction B was compared to the NMR spectra of reb M. An overlay of the two spectra ( FIG. 9 ) showed consistency of peaks of Fraction B with reb M. A table of the NMR assignments for reb M is shown below: 
     
       
         
               
             
               
               
               
               
             
               
               
               
               
             
           
               
                   
               
               
                   1 H and  13 C NMR spectral data for Rebaudioside M in C 5 D 5 N  a-c . 
               
             
          
           
               
                   
                 Position 
                   13 C NMR 
                   1 H NMR 
               
               
                   
                   
               
             
          
           
               
                   
                 1 
                 40.3 
                 0.75 t (13.2) 
               
               
                   
                   
                   
                 1.76 m 
               
               
                   
                 2 
                 19.6 
                 1.35 m 
               
               
                   
                   
                   
                 2.24 m 
               
               
                   
                 3 
                 38.4 
                 1.01 m 
               
               
                   
                   
                   
                 2.30 d (13.3) 
               
               
                   
                 4 
                 44.3 
                 — 
               
               
                   
                 5 
                 57.4 
                 1.06 d (12.8) 
               
               
                   
                 6 
                 23.5 
                 2.23 m 
               
               
                   
                   
                   
                 2.41 q (13.2) 
               
               
                   
                 7 
                 42.6 
                 1.41 m 
               
               
                   
                   
                   
                 1.80 m 
               
               
                   
                 8 
                 41.2 
                 — 
               
               
                   
                 9 
                 54.3 
                 0.91 d (7.7) 
               
               
                   
                 10 
                 39.7 
                 — 
               
               
                   
                 11 
                 20.2 
                 1.65 m 
               
               
                   
                   
                   
                 1.75 m 
               
               
                   
                 12 
                 38.5 
                 1.86 m 
               
               
                   
                   
                   
                 2.73 m 
               
               
                   
                 13 
                 87.6 
                 — 
               
               
                   
                 14 
                 43.3 
                 2.02 m 
               
               
                   
                   
                   
                 2.74 m 
               
               
                   
                 15 
                 46.5 
                 1.88 d (16.4) 
               
               
                   
                   
                   
                 2.03 m 
               
               
                   
                 16 
                 153.3 
                 — 
               
               
                   
                 17 
                 104.9 
                 4.90 s 
               
               
                   
                   
                   
                 5.69 s 
               
               
                   
                 18 
                 28.2 
                 1.32 s 
               
               
                   
                 19 
                 176.9 
                 — 
               
               
                   
                 20 
                 16.8 
                 1.38 s 
               
               
                   
                 1′ 
                 94.9 
                 6.39 d (8.2) 
               
               
                   
                 2′ 
                 76.9 
                 4.51 t (8.5) 
               
               
                   
                 3′ 
                 88.6 
                 5.09 t (8.5) 
               
               
                   
                 4′ 
                 70.1 
                 4.18 m 
               
               
                   
                 5′ 
                 78.4 
                 4.13 m 
               
               
                   
                 6′ 
                 61.8 
                 4.20 m 
               
               
                   
                   
                   
                 4.31 m 
               
               
                   
                 1″ 
                 96.2 
                 5.46 d (7.1) 
               
               
                   
                 2″ 
                 81.4 
                 4.13 m 
               
               
                   
                 3″ 
                 87.9 
                 4.98 t (8.5) 
               
               
                   
                 4″ 
                 70.4 
                 4.07 t (9.6) 
               
               
                   
                 5″ 
                 77.7 
                 3.94 m 
               
               
                   
                 6″ 
                 62.6 
                 4.19 m 
               
               
                   
                   
                   
                 4.32 m 
               
               
                   
                 1′″ 
                 104.8 
                 5.48 d (7.7) 
               
               
                   
                 2′″ 
                 75.8 
                 4.15 m 
               
               
                   
                 3′″ 
                 78.6 
                 4.13 m 
               
               
                   
                 4′″ 
                 73.2 
                 3.98 m 
               
               
                   
                 5′″ 
                 77.6 
                 3.74 ddd (2.8, 6.4, 9.9) 
               
               
                   
                 6′″ 
                 64.0 
                 4.27 m 
               
               
                   
                   
                   
                 4.51 m 
               
               
                   
                 1″″ 
                 103.9 
                 5.45 d (7.5) 
               
               
                   
                 2″″ 
                 75.6 
                 3.98 m 
               
               
                   
                 3″″ 
                 77.8 
                 4.50 t (7.8) 
               
               
                   
                 4″″ 
                 71.3 
                 4.14 m 
               
               
                   
                 5″″ 
                 78.0 
                 3.99 m 
               
               
                   
                 6″″ 
                 62.1 
                 4.20 m 
               
               
                   
                   
                   
                 4.32 m 
               
               
                   
                 1′″″ 
                 104.2 
                 5.81 d (7.2) 
               
               
                   
                 2′″″ 
                 75.5 
                 4.20 m 
               
               
                   
                 3′″″ 
                 78.4 
                 4.20 m 
               
               
                   
                 4′″″ 
                 73.6 
                 4.10 m 
               
               
                   
                 5′″″ 
                 77.8 
                 3.90 ddd (2.8, 6.4, 9.9) 
               
               
                   
                 6′″″ 
                 64.0 
                 4.32 m 
               
               
                   
                   
                   
                 4.64 d (10.3) 
               
               
                   
                 1″″″ 
                 104.1 
                 5.31 d (8.0) 
               
               
                   
                 2″″″ 
                 75.5 
                 3.95 m 
               
               
                   
                 3″″″ 
                 78.0 
                 4.37 t (9.1) 
               
               
                   
                 4″″″ 
                 71.1 
                 4.10 m 
               
               
                   
                 5″″″ 
                 78.1 
                 3.85 ddd (1.7, 6.1, 9.9) 
               
               
                   
                 6″″″ 
                 62.1 
                 4.10 m 
               
               
                   
                   
                   
                 4.32 m 
               
               
                   
                   
               
               
                   
                   a  assignments made on the basis of COSY, HMQC and HMBC correlations; 
               
               
                   
                   b  Chemical shift values are in δ (ppm); 
               
               
                   
                   c  Coupling constants are in Hz. 
               
             
          
         
       
     
     HRMS ( FIG. 10 ) was generated with a Waters Premier Quadropole Time-of-Flight (Q-TOF) mass spectrometer equipped with an electrospray ionization source operated in the positive-ion mode. The sample was dissolved in methanol and eluted in 2:2:1 methanol: acetonitrile: water and introduced via infusion using the onboard syringe pump. The presence of reb M was confirmed by a [M+Na] +  adduct at m/z 1313.5265, which corresponds to a molecular formula of C 56 H 90 O 33   
     
       
                 
         
             
             
         
      
     
     Example 39 
     Isolation and Characterization of Reb D2 
     Crude Reaction Sample. 
     The sample, Lot CB-2977-106, used for isolation, was prepared according to Example 22 with UGTSL (GI #460409128). 
     HPLC Analysis. 
     Preliminary HPLC analyses of samples were performed using a Waters 2695 Alliance System with the following method: Phenomenex Synergi Hydro-RP, 4.6×250 mm, 4 μm (p/n 00G-4375-E0); Column Temp: 55° C.; Mobile Phase A: 0.0284% ammonium acetate (NH 4 OAc) and 0.0116% acetic acid (HOAc) in water; Mobile Phase B: Acetonitrile (MeCN); Flow Rate: 1.0 mL/min; Injection volume: 10 μL. Detection was by UV (210 nm) and CAD. 
     Gradient: 
     
       
         
               
               
               
             
           
               
                   
               
               
                 Time (min) 
                 % A 
                 % B 
               
               
                   
               
             
             
               
                 0.0-8.5 
                 75 
                 25 
               
               
                 10.0 
                 71 
                 29 
               
               
                 16.5 
                 70 
                 30 
               
               
                 18.5-24.5 
                 66 
                 34 
               
               
                 26.5-29.0 
                 48 
                 52 
               
               
                 31-37 
                 30 
                 70 
               
               
                 38   
                 75 
                 25 
               
               
                   
               
             
          
         
       
     
     Analyses of semi-preparative purification fractions were performed with the following method: Waters Atlantis dC18, 4.6×100 mm, 5 μm (p/n 186001340); Mobile Phase A: 25% MeCN in water; Mobile Phase B: 30% MeCN in water; Flow Rate: 1.0 mL/min; Injection volume: 10 μL. Detection was by CAD. 
     Gradient: 
                                                   Time (min)   % A   % B                                0.0-5.0   100   0       20   20   80       25   20   80       30   100   0                    
LC-MS.
 
     Preliminary analysis of the semi-synthetic steviol glycoside mixture was carried out on a Waters AutoPurification HPLC/MS System with a Waters 3100 Mass Detector operating in negative ion mode. Analysis of the sample was performed using the following method: Phenomenex Synergi Hydro-RP, 4.6×250 mm, 4 μm (p/n 00G-4375-E0); Column Temp: 55° C.; Mobile Phase A: 0.0284% NH 4 OAc and 0.0116% HOAc in water; Mobile Phase B: Acetonitrile; Flow Rate: 1.0 mL/min; Injection volume: 10 μL. Detection was by UV (210 nm), and MSD (−ESI m/z 500-2000). Gradient conditions were as listed above. 
     Isolation by HPLC. 
     The purification was performed in two steps. The first method used for the semi-preparative purification is summarized below. Column: Waters Atlantis dC18, 30×100 mm, 5 (p/n 186001375); Mobile Phase A: 25% MeCN in water; Mobile Phase B: 30% MeCN in water; Flow Rate: 45 mL/min; Injection load: 160 mg dissolved in 20 mL of water. Detection was by UV (205 nm). 
     Gradient: 
     
       
         
               
               
               
             
               
               
               
             
           
               
                   
               
               
                 Time (min) 
                 % A 
                 % B 
               
               
                   
               
             
             
               
                   
               
             
          
           
               
                 0.0-5.0 
                 100 
                 0 
               
               
                 20 
                 20 
                 80 
               
               
                 25 
                 20 
                 80 
               
               
                 30 
                 100 
                 0 
               
               
                   
               
             
          
         
       
     
     The secondary purification used the same column and conditions, but isocratic mobile phase: 20% MeCN in water. 
     Purification from Natural Extracts. 
     The purification was performed in three steps. The first method used for the preparative purification is summarized below. Primary Process: Waters Symmetry C18, 50×250 mm, 7 μm (p/n WAT248000); Isocratic mobile phase: 50% methanol (MeOH) in water with 0.05% HOAc; Flow Rate: 85 mL/min; Injection load: 6 g crude extract dissolved in 50 mL of mobile phase. Detection was by UV (210 nm). Following the elution of target analytes, the column was flushed with 85% MeOH in water. 
     Secondary Process: Waters Symmetry Shield RP18, 50×250 mm, 7 μm (p/n WAT248000); Isocratic mobile phase: 20% MeCN in water; Flow Rate: 100 mL/min; Injection load: 0.5 g primary fraction dissolved in 30 mL of water. Detection was by UV (210 nm). 
     Tertiary Process: Waters Symmetry Shield RP18, 50×250 mm, 7 μm (p/n WAT248000); Isocratic mobile phase: 20% MeCN in water; Flow Rate: 100 mL/min; Injection load: 0.5 g secondary fraction dissolved in 30 mL of water. Detection was by UV (210 nm). 
     MS and MS/MS. 
     MS and MS/MS data were generated with a Waters QT of Premier mass spectrometer equipped with an electrospray ionization source. Samples were analyzed by negative ESI. Samples were diluted with H 2 O:acetonitrile (1:1) by 50 fold and introduced via infusion using the onboard syringe pump. The samples were diluted to yield good s/n which occurred at an approximate concentration of 0.01 mg/mL. 
     NMR. 
     The sample was prepared by dissolving 1-2 mg in 150 μL of pyridine-d 5  and NMR data were acquired on a Bruker Avance 500 MHz instrument with a 2.5 mm inverse detection probe. The NMR spectrum was referenced to the residual solvent signal (δ H  8.74 and δ C  150.35 for pyridine-d 5 ). 
     Results and Discussion 
     Isolation and Purification. 
     Isolation was performed on steviol glycoside mixture, Lot number CB-2977-106, prepared according to Example 22 with UGTSL (GI #460409128) The material was analyzed by LC-MS using the method described above and results are provided in  FIG. 11 . The targeted peak of interest was that at 7.7 min in the TIC chromatogram. The mass spectrum of this peak provided a [M-H] −  ion at m/z 1127.6. The provided sample was preliminarily processed in a single injection (160 mg) using the first method condition provided above. This method fractionated the material into ‘polar’ and ‘non-polar’ mixtures of glycosides. The ‘polar’ mixture was then reprocessed using the second-step conditions above. The semi-preparative HPLC trace is provided in  FIG. 12 . From this semi-preparative collection, the compound was isolated with a purity&gt;99% (CAD, AUC). The fraction analysis is provided in  FIG. 13 . Following the purification, the combined fractions were concentrated by rotary evaporation at 35° C. and lyophilized. Approximately 1-2 mg was obtained for characterization. 
     Mass Spectrometry. 
     The ESI-TOF mass spectrum acquired by infusing a sample showed a [M-H] −  ion at m/z 1127.4709. The mass of the [M-H] −  ion was in good agreement with the molecular formula C 50 H 80 O 28  (calcd for C 50 H 79 O 28 : 1127.4758, error: −4.3 ppm). The MS data confirmed a nominal mass of 1128 Daltons with the molecular formula, C 50 H 80 O 28 . 
     The MS/MS spectrum (selecting the [M-H] −  ion at m/z 1127.5 for fragmentation) indicated the loss of two glucose units and sequential loss of three glucose moieties at m/z 641.3187, 479.2655 and 317.2065. 
     NMR Spectroscopy. 
     A series of NMR experiments including  1 H NMR ( FIG. 14 ),  13 C NMR ( FIGS. 15 and 16 ),  1 H- 1 H COSY ( FIG. 17 ), HSQC-DEPT ( FIG. 18 ), HMBC ( FIGS. 19 and 20 ), NOESY ( FIG. 21 ) and 1D-TOCSY ( FIG. 22-26 ) were performed to allow assignment of the compound. In the  1 H NMR acquired after ˜46 hrs of sample preparation ( FIGS. 27-28 ), the anomeric resonance at δ H  5.04 is resolved which was obscured by the solvent (HOD) in the original spectrum ( FIG. 14 ) 
     The  1 H,  1 H- 1 H COSY,  1 H- 13 C HSQC-DEPT and  1 H- 13 C HMBC NMR data indicated that the central core of the glycoside is a diterpene. The presence of five anomeric protons observed in the  1 H and  1 H- 13 C HSQC-DEPT spectra confirm five sugar units in the structure. The methylene  13 C resonance at δ C  69.9 in the  1 H- 13 C HSQC-DEPT spectrum indicated the presence of a sugar linkage in the structure. The linkages of sugar units were assigned using  1 H- 13 C HMBC and 1D-TOCSY correlations. 
     A HMBC correlation from the methyl protons at δ H  1.29 to the carbonyl at δ C  177.7 allowed assignment of one of the tertiary methyl groups (C-18) as well as C-19 and provided a starting point for the assignment of the rest of the aglycone. Additional HMBC correlations from the methyl protons (H-18) to carbons at δ C  38.9, 45.0, and 57.8 allowed assignment of C-3, C-4, and C-5. Analysis of the  1 H- 13 C HSQC-DEPT data indicated that the carbon at δ C  38.9 was a methylene group and the carbon at δ C  57.8 was a methine which were assigned as C-3 and C-5, respectively. This left the carbon at δ C  45.0, which did not show a correlation in the HSQC-DEPT spectrum, to be assigned as the quaternary carbon, C-4. The  1 H chemical shifts for C-3 (δ H  0.98 and 2j.36) and C-5 (δ H  1.04) were assigned using the HSQC-DEPT data. A COSY correlation between one of the H-3 protons (δ H  0.98) and a proton at δ H  1.43 allowed assignment of one of the H-2 protons which in turn showed a correlation with a proton at δ H  0.75 which was assigned to C-1. The remaining  1 H and  13 C chemical shifts for C-1 and C-2 were then assigned on the basis of additional COSY and HSQC-DEPT correlations and are summarized in the table below. 
     
       
         
               
             
               
               
               
             
               
               
               
               
             
               
               
               
               
             
           
               
                   
               
               
                   1 H and  13 C NMR (500 and 125 MHz, pyridine-d 5 ), Assignments of Reb D2. 
               
             
          
           
               
                   
                   
                 Reb D2 
               
             
          
           
               
                   
                 Position 
                   13 C 
                   1 H 
               
               
                   
                   
               
             
          
           
               
                   
                 1 
                 41.3 
                 0.75 t (11.0) 
               
               
                   
                   
                   
                 1.76 m 
               
               
                   
                 2 
                 19.9 
                 1.43 m 
               
               
                   
                   
                   
                 2.20 m 
               
               
                   
                 3 
                 38.9 
                 0.98 m 
               
               
                   
                   
                   
                 2.36 d (12.1) 
               
               
                   
                 4 
                 45.0 
                 — 
               
               
                   
                 5 
                 57.8 
                 1.04 d (12.5) 
               
               
                   
                 6 
                 22.7 
                 1.92 m 
               
               
                   
                   
                   
                 2.43 m 
               
               
                   
                 7 
                 42.2 
                 1.22 m 
               
               
                   
                   
                   
                 1.30 m 
               
               
                   
                 8 
                 43.1 
                 — 
               
               
                   
                 9 
                 54.5 
                 0.88 brs 
               
               
                   
                 10 
                 40.3 
                 — 
               
               
                   
                 11 
                 21.1 
                 1.65 m 
               
               
                   
                   
                   
                 1.69 m 
               
               
                   
                 12 
                 37.5 
                 1.99 m 
               
               
                   
                   
                   
                 2.25 m 
               
               
                   
                 13 
                 87.1 
                 — 
               
               
                   
                 14 
                 44.5 
                 1.80 d (11.7) 
               
               
                   
                   
                   
                 2.65 d (11.7) 
               
               
                   
                 15 
                 48.3 
                 1.31 m 
               
               
                   
                   
                   
                 2.04 brs 
               
               
                   
                 16 
                 154.7 
                 — 
               
               
                   
                 17 
                 105.2 
                 5.01 s 
               
               
                   
                   
                   
                 5.64 s 
               
               
                   
                 18 
                 28.8 
                 1.29 s 
               
               
                   
                 19 
                 177.7 
                 — 
               
               
                   
                 20 
                 16.0 
                 1.30 s 
               
               
                   
                   
               
             
          
         
       
     
     The other tertiary methyl singlet, observed at δ H  1.30 showed HMBC correlations to C-1 and C-5 and was assigned as C-20. The methyl protons showed additional HMBC correlations to a quaternary carbon (δ C  40.3) and a methine carbon (δ C  54.5) which were assigned as C-10 and C-9, respectively. COSY correlations between H-5 (δ H  1.04) and protons at δ H  1.92 and 2.43 then allowed assignment of the H-6 protons which in turn showed correlations to protons at δ H  1.22 and 1.30 which were assigned to C-7. The  13 C chemical shifts for C-6 (δ C  22.7) and C-7 (δ C  42.2) were then determined from the HSQC-DEPT data. COSY correlations between H-9 (δ H  0.88) and protons at δ H  1.65 and 1.69 allowed assignment of the H-11 protons which in turn showed COSY correlations to protons at δ H  1.99 and 2.25 which were assigned as the H-12 protons. The HSQC-DEPT data was then used to assign C-11 (δ C  21.1) and C-12 (δ C  37.5). HMBC correlations from the H-12 proton (δ H  2.25) to carbons at δ C  87.1 and 154.7 allowed assignment of C-13 and C-16, respectively. The olefinic protons observed at δ H  5.01 and 5.64 showed HMBC correlations to C-13 and were assigned to C-17 (δ C  105.2 via HSQC-DEPT). The olefinic protons H-17 and the methine proton H-9 showed HMBC correlations to a carbon at δ C  48.3 which was assigned as C-15. An additional HMBC correlation from H-9 to a methylene carbon at δ C  44.5 then allowed assignment of C-14. The  1 H chemical shifts at C-14 (δ H  1.80 and 2.65) and C-15 δ H  1.31 and 2.04) were assigned using the HSQC-DEPT data. 
     Correlations observed in the NOESY spectrum were used to assign the relative stereochemistry of the central diterpene core. In the NOESY spectrum, NOE correlations were observed between H-14 and H-20 indicating that H-14 and H-20 are on the same face of the rings. Similarly, NOE correlations were observed between H-9 and H-5; H-9 and H-18 as well as H-5 and H-18 but NOE correlations were not observed between H-9 and H-14 indicating that H-5, H-9 and H-18 were on the opposite face of the rings compared to H-14 and H-20 as presented in  FIG. 21 . These data thus indicated that the relative stereochemistry in the central core was retained during the glycosylation step. 
     The key HMBC and COSY correlations used to assign the aglycone region are provided below: 
     
       
                 
         
             
             
         
      
     
     Analysis of the  1 H- 13 C HSQC-DEPT data confirmed the presence of five anomeric protons. Three of the anomeric protons were well resolved at δ H  6.02 (δ C  96.1), 5.57 (δ C  105.3), and 5.34 (δ C  105.3) in the  1 H NMR spectrum. The remaining two anomeric protons observed at δ H  5.04 (δ C  105.6) and 5.07 (δ C  98.7) which were obscured by solvent (HOD) resonance in the  1 H spectrum were identified by  1 H- 13 C HSQC-DEPT data. The anomeric proton observed at δ H  6.02 showed HMBC correlation to C-19 which indicated that it corresponds to the anomeric proton of Glc I . Similarly, the anomeric proton observed at δ H  5.07 showed an HMBC correlation to C-13 allowing it to be assigned as the anomeric proton of Glc II . 
     The Glc I  anomeric proton (δ H  6.02) showed a COSY correlation to a proton at δ H  4.07 was assigned as Glc I  H-2 which in turn showed a COSY correlation to a proton at δ H  4.22 (Glc I  H-3) which showed a COSY correlation with a proton at δ H  4.12 (Glc I  H-4). Due to data overlap, the COSY spectrum did not allow assignment of H-5 or the H-6 protons. Therefore, a series of 1D-TOCSY experiments were performed using selective irradiation of the Glc I  anomeric proton with several different mixing times. In addition to confirming the assignments for Glc I  H-2 through H-4, the 1D-TOCSY data showed a proton at δ H  4.04 assigned as Glc I  H-5 and a proton at δ H  4.68 assigned as one of the Glc I  H-6 protons. The latter proton was also used for 1D-TOCSY experiments. The selective irradiation of H-6 with several different mixing times also confirmed the assignment of Glc I  H-1 to H-5 as well as the remaining methylene proton of H-6 (δ H  4.30). Assignment of the  13 C chemical shifts for Glc I  C-2 (δ C  74.2), C-3 (δ C  79.1), C-4 (δ C  72.1), C-5 (δ C  78.5), and C-6 (δ C  69.9) was determined using the  1 H- 13 C HSQC-DEPT data to complete the assignment of Glc I . Furthermore, the presence of a methylene  13 C resonance at δ C  69.9 in the  1 H- 13 C HSQC-DEPT spectrum indicated a 1→6 sugar linkage of Glc I  in the structure. 
     Out of four remaining unassigned glucose moieties, one was assigned as a substituent at C-6 of Glc I  on the basis of  1 H- 13 C HSQC-DEPT, HMBC, and 1D-TOCSY correlations. The relatively downfield shift of a methylene  13 C resonance of Glc I  at δ C  69.9 in the HSQC-DEPT spectrum indicated a 1→6 sugar linkage of Glc I . The anomeric proton observed at δ H  5.04 showed HMBC correlation to Glc I  C-6 and was assigned as the anomeric proton of Glc V . Similarly, methylene protons of Glc I  showed HMBC correlations to anomeric carbon of Glc V  confirming the presence of a 1→6 sugar linkage between Glc I  and Glc V . The Glc V  anomeric proton showed a COSY correlation to a proton at δ H  4.00 which was assigned as Glc V  H-2 which in turn showed a COSY correlation to a proton at δ H  4.22 (Glc V  H-3). Due to data overlap, the COSY spectrum did not allow assignment of Glc V  H-4 based on the COSY correlation of Glc V  H-3. However, in the HMBC spectrum, Glc V  H-3 showed a correlation to Glc V  C-5 (δ C  78.9). In HSQC-DEPT spectrum, Glc V  C-5 showed a correlation to δ H  3.89 (Glc V  H-5). The Glc V  H-5 showed COSY correlations to δ H  4.21, 4.37, and 4.48. In the HSQC-DEPT spectrum, δ H  4.21 showed a correlation to δ C  71.4 (Glc V  H-4), while δ H  4.37 and 4.48 showed a correlation to δ C  63.1 and were assigned to Glc V  H-6a and H-6b, respectively. Assignment of the  13 C chemical shifts for Glc V  C-2 (δ C  75.7) and C-3 (δ C  79.1) was determined using the  1 H- 13 C HSQC-DEPT data to complete the assignment of Glc V . 
     A summary of the  1 H and  13 C chemical shifts for the glycoside at C-19 are shown in the following table: 
     
       
         
               
             
               
               
             
               
               
               
               
             
               
               
               
               
             
           
               
                   
               
               
                   1 H and  13 C NMR (500 and 125 MHz, 
               
               
                 pyridine-d 5 ), Assignments of the reb D2 C-19 glycoside. 
               
             
          
           
               
                   
                 Reb D2 
               
             
          
           
               
                   
                 Position 
                   13 C 
                   1 H 
               
               
                   
               
             
          
           
               
                   
                 Glc I -1 
                 96.1 
                 6.02 d (8.1) 
               
               
                   
                 Glc I -2 
                 74.2 
                 4.07 m 
               
               
                   
                 Glc I -3 
                 79.1 #   
                 4.22 m #   
               
               
                   
                 Glc I -4 
                 72.1 
                 4.12 m 
               
               
                   
                 Glc I -5 
                 78.5 
                 4.04 m 
               
               
                   
                 Glc I -6 
                 69.9 
                 4.30 m 
               
               
                   
                   
                   
                 4.68 d (10.7) 
               
               
                   
                 Glc V -1 
                 105.6 
                 5.04 (8.1) 
               
               
                   
                 Glc V -2 
                 75.7 
                 4.00 m 
               
               
                   
                 Glc V -3 
                 79.1 #   
                 4.22 m #   
               
               
                   
                 Glc V -4 
                 71.4 
                 4.21 m 
               
               
                   
                 Glc V -5 
                 78.9 
                 3.89 m 
               
               
                   
                 Glc V -6 
                 63.1 
                 4.37 m 
               
               
                   
                   
                   
                 4.48 m 
               
               
                   
               
               
                   #1 H and  13 C values can be exchangeable between positions Glc 1 -3, Glc V -3 and Glc IV -3. 
               
             
          
         
       
     
     A summary of the key HMBC, COSY, and 1D-TOCSY correlations used to assign the C-19 glycoside region are provided below. 
     
       
                 
         
             
             
         
      
     
     Assignment of Glc II  was carried out in a similar manner. The Glc II  anomeric proton (δ H  5.07) showed a COSY correlation to a proton at δ H  4.37, assigned as Glc II  H-2, which in turn showed a COSY correlation to a proton at δ H  4.18 (Glc II  H-3). This latter proton showed an additional correlation with a proton at δ H  3.88 (Glc II  H-4) which also showed a COSY correlation to a proton at δ H  3.79 (Glc II  H-5). Glc II  H-5 also showed a COSY correlation to Glc II  H-6 protons (δ H  4.08 and 4.46). Assignment of the  13 C chemical shifts for Glc II  C-2 (δ C  81.3), C-3 (δ C  88.4), C-4 (δ C  71.1), C-5 (δ C  77.9), and C-6 (δ C  63.2) was determined using the HSQC-DEPT data. HMBC correlations from Glc II  H-3 to C-2 and C-4 and also from Glc II  H-4 to C-2 and C-5 confirmed the assignments made above. Additional HMBC correlations of Glc II  H-4 to Glc II  C-6 further support to complete the assignment of Glc II . 
     Two of the remaining unassigned glucose moieties were assigned as substituents at C-2 and C-3 of Glc II  on the basis of HMBC correlations. The anomeric proton observed at δ H  5.57 showed a HMBC correlation to Glc II  C-2 and was assigned as the anomeric proton of Glc III . The anomeric proton observed at δ H  5.34 showed a HMBC correlation to Glc II  C-3 and was assigned as the anomeric proton of Glc IV . The reciprocal HMBC correlations from Glc II  H-2 to the anomeric carbon of Glc III  and from Glc II  H-3 to the anomeric carbon of Glc IV  were also observed. 
     The anomeric proton of Glc III  (δ H  5.57) showed a COSY correlation with a proton at δ H  4.19 which was assigned as Glc III  H-2. Due to data overlap, the COSY spectrum did not allow assignment of H-3 to H-6 protons. Therefore, a series of 1D-TOCSY experiments were performed using selective irradiation of the Glc III  anomeric proton with several different mixing times. In addition to confirming the assignments for Glc III  H-2, the 1D-TOCSY data showed protons at δ H  4.24 (Glc III  H-3), δ H  4.27 (Glc III  H-4), and δ H  3.94 (Glc III  H-5). Once H-4 was assigned using 1D-TOCSY data, COSY correlations from H-4 to H-5 and in turn to H-6 were used to assign H-6. In the COSY spectrum, Glc III  H-4 showed a correlation to Glc III  H-5, which in turn showed COSY correlations to δ H  4.41 and 4.50 of Glc III  H-6a and H-6b, respectively. The  13 C chemical shifts for Glc III  C-2 (δ C  76.8), C-3 (δ C  78.9), C-4 (δ C  72.4), C-5 (δ C  78.8), and C-6 (δ C  63.5) were then determined using the  1 H- 13 C HSQC-DEPT correlations to complete the assignment of Glc III . 
     The anomeric proton of Glc IV  (δ H  5.34) showed a COSY correlation with a proton at δ H  4.06 which was assigned as Glc IV  H-2. Due to data overlap, the COSY spectrum did not allow assignment of H-3 to H-6 protons. Therefore, a series of 1D-TOCSY experiments were performed using selective irradiation of the Glc IV  anomeric proton with several different mixing times. In addition to confirming the assignments for Glc IV  H-2, the 1D-TOCSY data showed protons at δ H  4.22 (Glc IV  H-3), δ H  4.18 (Glc IV  H-4), and δ H  4.10 (Glc IV  H-5). Once H-4 was assigned using 1D-TOCSY data, COSY correlations from H-4 to H-5 and in turn to H-6 were used to assign H-6. In the COSY spectrum, Glc IV  H-4 showed a correlation to Glc IV  H-5, which in turn showed COSY correlations to δ H  4.32 and 4.58, Glc IV  H-6a and H-6b, respectively. The  13 C chemical shifts for Glc IV  C-2 (δ C  75.8), C-3 (δ C  78.9), C-4 (δ C  72.0), C-5 (δ C  79.3), and C-6 (δ C  62.9) were then determined using the  1 H- 13 C HSQC-DEPT correlations to complete the assignment of Glc IV . 
     The large coupling constants observed for the anomeric protons of the glucose moieties at δ H  6.02 (d, J=8.1 Hz), 5.57 (d, J=7.6 Hz), 5.34 (d, J=7.9 Hz) and δ H  5.04 (d, J=8.1 Hz), suggested their β-orientation ( FIGS. 14, 27, and 28 ). While the remaining anomeric proton at δ H  5.07 was obscured by the solvent resonance (HDO) it&#39;s coupling constant (J=˜8 Hz) evident from 1D TOCSY data ( FIG. 24 ) also indicated β-orientation. 
     A summary of the and  13 C chemical shifts for the glycoside at C-13 are shown in the table below: 
     
       
         
               
             
               
               
             
               
               
               
               
             
               
               
               
               
             
           
               
                   
               
               
                   1 H and  13 C NMR (500 and 125 MHz, 
               
               
                 pyridine-d 5 ), Assignments of the Reb D2 C-13 glycoside. 
               
             
          
           
               
                   
                 Reb D2 
               
             
          
           
               
                   
                 Position 
                   13 C 
                   1 H 
               
               
                   
               
             
          
           
               
                   
                 Glc II -1 
                 98.7 
                 5.07 (~8)* 
               
               
                   
                 Glc II -2 
                 81.3 
                 4.37 m 
               
               
                   
                 Glc II -3 
                 88.4 
                 4.18 m 
               
               
                   
                 Glc II -4 
                 71.1 
                 3.88 m 
               
               
                   
                 Glc II -5 
                 77.9 
                 3.79 m 
               
               
                   
                 Glc II -6 
                 63.2 
                 4.08 m 
               
               
                   
                   
                   
                 4.47 m 
               
               
                   
                 Glc III -1 
                 105.3 
                 5.57 d (7.6) 
               
               
                   
                 Glc III -2 
                 76.8 
                 4.19 m 
               
               
                   
                 Glc III -3 
                 78.9 
                 4.24 m 
               
               
                   
                 Glc III -4 
                 72.4 
                 4.27 m 
               
               
                   
                 Glc III -5 
                 78.8 
                 3.94 m 
               
               
                   
                 Glc III -6 
                 63.5 
                 4.41 m 
               
               
                   
                   
                   
                 4.50 m 
               
               
                   
                 Glc IV -1 
                 105.3 
                 5.34 d (7.9) 
               
               
                   
                 Glc IV -2 
                 75.8 
                 4.06 m 
               
               
                   
                 Glc IV -3 
                 78.9 #   
                 4.22 m #   
               
               
                   
                 Glc IV -4 
                 72.0 
                 4.18 m 
               
               
                   
                 Glc IV -5 
                 79.3 
                 4.10 m 
               
               
                   
                 Glc IV -6 
                 62.9 
                 4.32 m 
               
               
                   
                   
                   
                 4.58 m 
               
               
                   
               
               
                 *Anomeric proton was obscured by solvent (HDO) resonance, coupling constant value obtained from 1D-TOCSY data. 
               
               
                   #1 H and  13 C values can be exchangeable between Glc I -3, Glc V -3 and Glc IV -3. 
               
             
          
         
       
     
     A summary of the key HMBC, COSY, and 1D-TOCSY correlations used to assign the C-13 glycoside region are provided below: 
     
       
                 
         
             
             
         
      
     
     NMR and MS analyses allowed a full assignment of structure, shown below. The chemical name of the compound is 13-[(2-O-β-D-glucopyranosyl-3-O-β-D-glucopyranosyl-β-D-glucopyranosyl)oxy] ent-kaur-16-en-19-oic acid-[(6-O-β-D-glucopyranosyl-β-D-glucopyranosyl) ester] (rebaudioside D2 or reb D2). The compound is an isomer of rebaudioside D. 
     
       
                 
         
             
             
         
      
     
     Example 40 
     Isolation and Characterization of Reb M2 
     Crude Reaction Sample. 
     The sample, Lot CB-2977-106, used for isolation was prepared according to Example 22 with UGTSL (GI #460409128). 
     HPLC Analysis. 
     Preliminary HPLC analyses was performed using a Waters 2695 Alliance System with the following method: Phenomenex Synergi Hydro-RP, 4.6×250 mm, 4 μm (p/n 00G-4375-E0); Column Temp: 55° C.; Mobile Phase A: 0.0284% NH 4 OAc and 0.0116% HOAc in water; Mobile Phase B: Acetonitrile (MeCN); Flow Rate: 1.0 mL/min; Injection volume: 10 μL. Detection was by UV (210 nm) and CAD. 
     Gradient: 
     
       
         
               
               
               
             
               
               
               
             
           
               
                   
               
               
                 Time (min) 
                 % A 
                 % B 
               
               
                   
               
             
             
               
                   
               
             
          
           
               
                 0.0-5.0 
                 100 
                 0 
               
               
                 20 
                 20 
                 80 
               
               
                 25 
                 20 
                 80 
               
               
                 30 
                 100 
                 0 
               
               
                   
               
             
          
         
       
     
     Analyses of semi-preparative purification fractions were performed with the following method: Waters Atlantis dC18, 4.6×100 mm, 5 μm (p/n 186001340); Mobile Phase A: 25% MeCN in water; Mobile Phase B: 30% MeCN in water; Flow Rate: 1.0 mL/min; Injection volume: 10 Detection was by CAD. 
     Gradient: 
                                     Time (min)   % A   % B                   0.0-8.5   75   25       10.0   71   29       16.5   70   30       18.5-24.5   66   34       26.5-29.0   48   52       31-37   30   70       38     75   25                    
LC-MS.
 
     Preliminary analysis of the semi-synthetic steviol glycoside mixture was carried out on a Waters AutoPurification HPLC/MS System with a Waters 3100 Mass Detector operating in negative ion mode. Analysis of the sample was performed using the following method: Phenomenex Synergi Hydro-RP, 4.6×250 mm, 4 μm (p/n 00G-4375-E0); Column Temp: 55° C.; Mobile Phase A: 0.0284% NH 4 OAc and 0.0116% HOAc in water; Mobile Phase B: MeCN; Flow Rate: 1.0 mL/min; Injection volume: 10 μL. Detection was by UV (210 nm), and MSD (−ESI m/z 500-2000). Gradient conditions were as listed above. 
     Isolation by HPLC. 
     The purification was performed in two steps. The first method used for the semi-preparative purification is summarized below. Column: Waters Atlantis dC18, 30×100 mm, 5 μm (p/n 186001375); Mobile Phase A: 25% MeCN in water; Mobile Phase B: 30% MeCN in water; Flow Rate: 45 mL/min; Injection load: 160 mg dissolved in 20 mL of water. Detection was by UV (205 nm). 
     Gradient: 
     
       
         
               
               
               
             
               
               
               
             
           
               
                   
               
               
                 Time (min) 
                 % A 
                 % B 
               
               
                   
               
             
             
               
                   
               
             
          
           
               
                 0.0-5.0 
                 100 
                 0 
               
               
                 20 
                 20 
                 80 
               
               
                 25 
                 20 
                 80 
               
               
                 30 
                 100 
                 0 
               
               
                   
               
             
          
         
       
     
     The secondary purification used the same column and conditions, but isocratic mobile phase: 20% MeCN in water. 
     MS and MS/MS. 
     MS and MS/MS data were generated with a Waters QTof Premier mass spectrometer equipped with an electrospray ionization source. Samples were analyzed by negative ESI. Samples were diluted with H 2 O:MeCN (1:1) by 50 fold and introduced via infusion using the onboard syringe pump. The samples were diluted to yield good s/n which occurred at an approximate concentration of 0.01 mg/mL. 
     NMR. 
     The sample was prepared by dissolving ˜1.0 mg in 150 μL of D 2 O and NMR data were acquired on a Bruker Avance 500 MHz instrument with a 2.5 mm inverse detection probe. The  1 H NMR and  13 C NMR spectra were referenced to the residual solvent signal HDO (δ H  4.79 ppm) and TSP (δ C  0.00 ppm), respectively. 
     Results and Discussion 
     Isolation and Purification. 
     Isolation was performed using on a steviol glycoside mixture, Lot number CB-2977-106, prepared according to Example 22 with UGTSL (GI #460409128). The material was analyzed by LC-MS using the method described above ( FIG. 11 ). The targeted peak of interest was that at 4.1 min in the TIC chromatogram. The mass spectrum of this peak provided a [M-H] −  ion at m/z 1289.7. The provided sample was preliminarily processed in a single injection (160 mg) using the first method condition provided above. This method fractionated the material into ‘polar’ and ‘non-polar’ mixtures of glycosides. The ‘polar’ mixture was then reprocessed using the second-step conditions provided above. The semi-preparative HPLC trace is shown in  FIG. 12 . From this semi-preparative collection, the peak was isolated with a purity&gt;99% (CAD, AUC). The fraction analysis is provided in  FIG. 13 . Following the purification, the fractions were concentrated by rotary evaporation at 35° C. and lyophilized. Approximately 1 mg was obtained. 
     Mass Spectrometry. 
     The ESI-TOF mass spectrum acquired by infusing a sample of CC-00300 showed a [M-H] −  ion at m/z 1289.5266. The mass of the [M-H] −  ion was in good agreement with the molecular formula C 56 H 90 O 33  (calcd for C 56 H 89 O 33 : 1289.5286, error: −1.6 ppm) expected for reb M2. The MS data confirmed that CC-00300 has a nominal mass of 1290 Daltons with the molecular formula, C 56 H 90 O 33 . 
     The MS/MS spectrum (selecting the [M-H] −  ion at m/z 1289.5 for fragmentation) indicated the loss of three glucose units at m/z 803.3688 and sequential loss of three glucose moieties at m/z 641.3165, 479.2633 and 317.2082. 
     NMR Spectroscopy. 
     A series of NMR experiments including  1 H NMR ( FIG. 29 ),  13 C NMR ( FIGS. 30 and 31 ),  1 H- 1 H COSY ( FIG. 32 ), HSQC-DEPT ( FIG. 33 ), HMBC ( FIGS. 34 and 35 ), and 1D-TOCSY ( FIG. 36-39 ) were performed to allow assignment of reb M2. 
     The  1 H,  1 H- 1 H COSY,  1 H- 13 C HSQC-DEPT and  1 H- 13 C HMBC NMR data indicated that the central core of the glycoside is a diterpene. The presence of six anomeric protons observed in the  1 H and  1 H- 13 C HSQC-DEPT spectra confirm six sugar units in the structure. The methylene  13 C resonance at δ C  70.9 in the  1 H- 13 C HSQC-DEPT spectrum indicated the presence of a 1→6 sugar linkage in the structure. The linkages of sugar units were assigned using  1 H- 13 C HMBC and 1D-TOCSY correlations. 
     A HMBC correlation from the methyl protons at δ H  1.29 to the carbonyl at δ C  181.5 allowed assignment of one of the tertiary methyl groups (C-18) as well as C-19 and provided a starting point for the assignment of the rest of the aglycone. Additional HMBC correlations from the methyl protons (H-18) to carbons at δ C  39.8, 43.7, and 59.2 allowed assignment of C3, C4, and C5. Analysis of the  1 H- 13 C HSQC-DEPT data indicated that the carbon at δ C  39.8 was a methylene group and the carbon at δ C  59.2 was a methine which were assigned as C-3 and C-5, respectively. This left the carbon at δ C  43.7, which did not show a correlation in the HSQC-DEPT spectrum, to be assigned as the quaternary carbon, C-4. The  1 H chemical shifts for C-3 (δ H  1.16 and 2.28) and C-5 (δ H  1.24) were assigned using the HSQC-DEPT data. A COSY correlation between one of the H-3 protons (δ H  1.16) and a proton at δ H  1.49 allowed assignment of one of the H-2 protons which in turn showed a correlation with a proton at δ H  0.92 which was assigned to C-1. The remaining  1 H and  13 C chemical shifts for C-1 and C-2 were then assigned on the basis of additional COSY and HSQC-DEPT correlations and are summarized in the table below. 
     
       
         
               
             
               
               
               
               
             
               
               
               
               
             
           
               
                   
               
               
                   1 H NMR (500 MHz, D 2 O) and  13 C NMR (125 MHz, 
               
               
                 D 2 O/TSP) Assignments of the Reb M2 aglycone. 
               
             
          
           
               
                   
                 Position 
                   13 C 
                   1 H 
               
               
                   
                   
               
             
          
           
               
                   
                 1 
                 41.9 
                 0.92 m 
               
               
                   
                   
                   
                 1.93 m 
               
               
                   
                 2 
                 21.8 
                 1.49 m 
               
               
                   
                   
                   
                 1.86 m 
               
               
                   
                 3 
                 39.8 
                 1.16 m 
               
               
                   
                   
                   
                 2.28 d (13.4) 
               
               
                   
                 4 
                 43.7 
                 — 
               
               
                   
                 5 
                 59.2 
                 1.24 d (12.1) 
               
               
                   
                 6 
                 24.4 
                 1.73 m 
               
               
                   
                   
                   
                 1.94 m 
               
               
                   
                 7 
                 44.2 
                 1.49 m 
               
               
                   
                   
                   
                 1.56 m 
               
               
                   
                 8 
                 46.9 
                 — 
               
               
                   
                 9 
                 55.5 
                 1.09 d (7.7) 
               
               
                   
                 10 
                 42.4 
                 — 
               
               
                   
                 11 
                 22.6 
                 1.66 m 
               
               
                   
                   
                   
                 1.70 m 
               
               
                   
                 12 
                 39.9 
                 1.60 m 
               
               
                   
                   
                   
                 2.00 m 
               
               
                   
                 13 
                 90.9 
                 — 
               
               
                   
                 14 
                 46.9 
                 1.53 d (12.6) 
               
               
                   
                   
                   
                 2.21 d (13.6) 
               
               
                   
                 15 
                 49.4 
                 2.15 d (17.2) 
               
               
                   
                   
                   
                 2.18 d (18.1) 
               
               
                   
                 16 
                 164.0 
                 — 
               
               
                   
                 17 
                 107.0 
                 4.98 s 
               
               
                   
                   
                   
                 5.16 s 
               
               
                   
                 18 
                 31.0 
                 1.29 s 
               
               
                   
                 19 
                 181.5 
                 — 
               
               
                   
                 20 
                 19.1 
                 0.92 s 
               
               
                   
                   
               
             
          
         
       
     
     The other tertiary methyl singlet, observed at δ H  0.92 showed HMBC correlations to C-1 and C-5 and was assigned as C-20. The methyl protons showed additional HMBC correlations to a quaternary carbon (δ C  42.4) and a methine (δ C  55.5) which were assigned as C-10 and C-9, respectively. COSY correlations between H-5 (δ H  1.24) and protons at δ H  1.73 and 1.94 then allowed assignment of the H-6 protons which in turn showed correlations to protons at δ H  1.49 and 1.56 which were assigned to C-7. The  13 C chemical shifts for C-6 (δ C  24.4) and C-7 (δ C  44.2) were then determined from the HSQC-DEPT data. COSY correlations between H-9 (δ H  1.09) and protons at δ H  1.66 and 1.70 allowed assignment of the H-11 protons which in turn showed COSY correlations to protons at δ H  1.60 and 2.00 which were assigned as the H-12 protons. The HSQC-DEPT data was then used to assign C-11 (δ C  22.6) and C-12 (δ C  39.9). The olefinic protons observed at δ H  4.98 and 5.16 showed HMBC correlations to C-13 (δ C  90.9) and were assigned to C-17 (δ C  107.0 via HSQC-DEPT). The olefinic protons H-17 showed HMBC correlations to a carbon at δ C  49.4 which was assigned as C-15. An additional HMBC correlation from H-9 to a methylene carbon at δ C  46.9 then allowed assignment of C-14. The  1 H chemical shifts at C-14 (δ H  1.53 and 2.21) and C-15 (δ H  2.15 and 2.18) were assigned using the HSQC-DEPT data. 
     A summary of the key HMBC and COSY correlations used to assign the aglycone region are provided below: 
     
       
                 
         
             
             
         
      
     
     Analysis of the  1 H- 13 C HSQC-DEPT data confirmed the presence of six anomeric protons. Three of the anomeric protons were well resolved at δ H  5.65 (δ C  95.5), 4.92 (δ C  104.9), and 4.50 (δ C  105.7) in the  1 H NMR spectrum. The remaining three anomeric protons observed at δ H  4.85 (δ C  98.4), 4.84 (δ C  105.0), and 4.83 (δ C  105.3) were overlapped by the residual solvent resonance in the  1 H spectrum. The anomeric proton observed at δ H  5.65 showed a HMBC correlation to C-19 which indicated that it corresponds to the anomeric proton of Glc I . Similarly, the anomeric proton observed at δ H  4.85 showed a HMBC correlation to C-13 allowing it to be assigned as the anomeric proton of Glc II . 
     The Glc I  anomeric proton (δ H  5.65) showed a COSY correlation to a proton at δ H  3.96 which was assigned as Glc I  H-2 which in turn showed a COSY correlation to a proton at δ H  3.89 (Glc I  H-3) which showed a COSY correlation with a proton at δ H  3.71 (Glc I  H-4). Due to data overlap, the COSY spectrum did not allow assignment of the H-5 or H-6 protons. Therefore, a series of 1D-TOCSY experiments were performed using selective irradiation of the Glc I  anomeric proton with several different mixing times. In addition to confirming the assignments for Glc I  H-2 through H-4, the 1D-TOCSY data showed a proton at δ H  3.73 assigned as Glc I  H-5 and a proton at δ H  4.15 assigned as one of the Glc I  H-6 protons. The latter proton was also used for 1D-TOCSY experiments. The selective irradiation of H-6 with several different mixing times also confirmed the assignment of Glc I  H-1 to H-5 as well as the remaining methylene proton of H-6 (δ H  4.00). Assignment of the  13 C chemical shifts for Glc I  C-2 (δ C  80.5), C-3 (δ C  79.0), C-4 (δ C  71.5), C-5 (δ C  79.0), and C-6 (δ C  70.9) was determined using the  1 H- 13 C HSQC-DEPT data to complete the assignment of Glc I . Furthermore, the presence of a methylene  13 C resonance at δ C  70.9 in the  1 H- 13 C HSQC-DEPT spectrum indicated a 1→6 sugar linkage of Glc I  in the structure. 
     Two of the unassigned glucose moieties were assigned as substituents at C-2 and C-6 of Glc I  on the basis of HMBC correlations. The anomeric proton observed at δ H  4.83 showed an HMBC correlation to Glc I  C-2 and was assigned as the anomeric proton of Glc V . The anomeric proton observed at δ H  4.50 showed a HMBC correlation to Glc I  C-6 and was assigned as the anomeric proton of Glc VI . The reciprocal HMBC correlations from Glc I  H-2 to the anomeric carbon of Glc V  and from Glc I  H-6 to the anomeric carbon of Glc VI  were also observed. 
     The anomeric proton of Glc V  (δ H  4.83) showed a COSY correlation with a proton at δ H  3.32 which was assigned as Glc V  H-2. The Glc V  H-2 in turn showed a COSY correlation to a proton at δ H  3.51 (Glc V  H-3). This latter proton showed an additional correlation with a proton at δ H  3.38 (Glc V  H-4). H-4 also showed a COSY correlation to a proton at δ H  3.55 (Glc V  H-5) and Glc V  H-5 in turn showed a COSY correlation to Glc V  H-6 protons (δ H  3.76 and 3.97). Assignment of the  13 C chemical shifts for Glc V  C-2 (δ C  78.5), C-3 (δ C  78.7), C-4 (δ C  72.9), C-5 (δ C  78.8), and C-6 (δ C  63.6) was determined using the HSQC-DEPT data. HMBC correlations from Glc V  H-3 to C-2 and C-4 and also from Glc V  H-4 to C-3 and C-6 confirmed the assignments made above to complete the assignment of Glc V . 
     Another glucose moiety was assigned as a substituent at C-6 of Glc I  on the basis of  1 H- 13 C HSQC-DEPT and HMBC correlations. The relatively downfield shift of a methylene  13 C resonance of Glc I  at δ C  70.9 in the HSQC-DEPT spectrum indicated a 1-46 sugar linkage of Glc I . The anomeric proton observed at δ H  4.50 showed a HMBC correlation to Glc I  C-6 and was assigned as the anomeric proton of Glc VI . Similarly, methylene protons of Glc I  showed HMBC correlations to the anomeric carbon of Glc VI  and this confirmed the presence of a 1→6 sugar linkage between Glc I  and Glc VI . The Glc VI  anomeric proton showed a COSY correlation to a proton at δ H  3.33 which was assigned as Glc VI  H-2 which in turn showed a COSY correlation to a proton at δ H  3.49 (Glc VI  H-3). Due to data overlap, the COSY spectrum did not allow assignment of Glc V  H-4 to H-6 based on the COSY correlations. Therefore, a series of 1D-TOCSY experiments were performed using selective irradiation of the Glc VI  anomeric proton with different mixing times. In addition to confirming the assignments for Glc VI  H-2 through H-3, the 1D-TOCSY data showed protons at δ H  3.45 (Glc VI  H-4) and δ H  3.48 (Glc VI  H-5) and protons at δ H  3.92 and 3.94 assigned for Glc VI  H-6 protons. Assignment of the  13 C chemical shifts for Glc VI  C-2 (δ C  78.1), C-3 (δ C  78.6), C-4 (δ C  72.3), C-5 (δ C  78.8), and C-6 (δ C  64.1) was determined using the  1 H- 13 C HSQC-DEPT data to complete the assignment of Glc VI . 
     A summary of the  1 H and  13 C chemical shifts for the glycoside at C-19 are found in the table below: 
     
       
         
               
             
               
               
               
               
             
               
               
               
               
             
           
               
                   
               
               
                 H NMR (500 MHz, D 2 O) and  13 C NMR (125 MHz, 
               
               
                 D 2 O/TSP) Assignments of the Reb M2 glycoside. 
               
             
          
           
               
                   
                 Position 
                   13 C 
                   1 H 
               
               
                   
               
             
          
           
               
                   
                 Glc I -1 
                 95.5 
                 5.65 d (7.6) 
               
               
                   
                 Glc I -2 
                 80.5 
                 3.96 m 
               
               
                   
                 Glc I -3 
                 79.0 
                 3.89 m 
               
               
                   
                 Glc I -4 
                 71.5 
                 3.71 m 
               
               
                   
                 Glc I -5 
                 79.0 
                 3.73 m 
               
               
                   
                 Glc I -6 
                 70.9 
                 4.00 m 
               
               
                   
                   
                   
                 4.15 d (11.7) 
               
               
                   
                 Glc V -1 
                 105.3* 
                 4.83* d (8.0) 
               
               
                   
                 Glc V -2 
                 78.5 
                 3.32 m 
               
               
                   
                 Glc V -3 
                 78.7 
                 3.51 m 
               
               
                   
                 Glc V -4 
                 72.9 
                 3.38 m 
               
               
                   
                 Glc V -5 
                 78.8 
                 3.55 m 
               
               
                   
                 Glc V -6 
                 63.6 
                 3.76 m 
               
               
                   
                   
                   
                 3.97 m 
               
               
                   
                 Glc VI -1 
                 105.7 
                 4.50 d (7.9) 
               
               
                   
                 Glc VI -2 
                 78.1 
                 3.33 m 
               
               
                   
                 Glc VI -3 
                 78.6 
                 3.49 m 
               
               
                   
                 Glc VI -4 
                 72.3 
                 3.45 m 
               
               
                   
                 Glc VI -5 
                 78.8 
                 3.48 m 
               
               
                   
                 Glc VI -6 
                 64.1 
                 3.92 m 
               
               
                   
                   
                   
                 3.94 m 
               
               
                   
               
               
                 * 1 H and  13 C values can be exchangeable with Glc IV -1 of the following table. 
               
             
          
         
       
     
     A summary of the key HMBC, COSY, and 1D-TOCSY correlations used to assign the C-19 glycoside region are provided below: 
     
       
         
               
             
               
               
               
               
             
               
               
               
               
             
           
               
                   
               
               
                   1 H NMR (500 MHz, D 2 O) and  13 C NMR (125 MHz, 
               
               
                 D 2 O/TSP) Assignments of the Reb M2 glycoside. 
               
             
          
           
               
                   
                 Position 
                   13 C #   
                   1 H 
               
               
                   
               
             
          
           
               
                   
                 Glc II -1 
                 98.4 
                 4.85 d (7.8) 
               
               
                   
                 Glc II -2 
                 81.7 
                 3.75 m 
               
               
                   
                 Glc II -3 
                 88.0 
                 3.98 m 
               
               
                   
                 Glc II -4 
                 71.3 
                 3.54 m 
               
               
                   
                 Glc II -5 
                 80.5 
                 3.96 m 
               
               
                   
                 Glc II -6 
                 63.6 
                 3.45 m 
               
               
                   
                   
                   
                 3.77 m 
               
               
                   
                 Glc III -1 
                 104.9 
                 4.92 d (7.9) 
               
               
                   
                 Glc III -2 
                 76.3 
                 3.32 m 
               
               
                   
                 Glc III -3 
                 78.8 
                 3.51 m 
               
               
                   
                 Glc III -4 
                 73.3 
                 3.26 t (9.5) 
               
               
                   
                 Glc III -5 
                 78.8 
                 3.44 m 
               
               
                   
                 Glc III -6 
                 64.4 
                 3.75 m 
               
               
                   
                   
                   
                 3.94 m 
               
               
                   
                 Glc IV -1 
                 105.0 
                 4.84 d (7.8) 
               
               
                   
                 Glc IV -2 
                 76.1 
                 3.41 m 
               
               
                   
                 Glc IV -3 
                 78.8 
                 3.46 m 
               
               
                   
                 Glc IV -4 
                 72.5 
                 3.45 m 
               
               
                   
                 Glc IV -5 
                 81.7 
                 3.75 m 
               
               
                   
                 Glc IV -6 
                 65.8 
                 3.55 m 
               
               
                   
                   
                   
                 3.78 m 
               
               
                   
               
             
          
         
       
     
     Assignment of Glc II  was carried out in a similar manner. The Glc II  anomeric proton (δ H  4.85) showed a COSY correlation to a proton at δ H  3.75 which was assigned as Glc II  H-2 which in turn showed a COSY correlation to a proton at δ H  3.98 (Glc II  H-3). This latter proton showed an additional correlation with a proton at δ H  3.54 (Glc II  H-4). H-4 also showed a COSY correlation to a proton at δ H  3.96 (Glc II  H-5). Glc II  H-5 also showed a COSY correlation to Glc II  H-6 protons (δ H  3.77 and 3.45). Assignment of the  13 C chemical shifts for Glc II  C-2 (δ C  81.7), C-3 (δ C  88.0), C-4 (δ C  71.3), C-5 (δ C  80.5), and C-6 (δ C  63.6) was determined using the HSQC-DEPT data. HMBC correlations from Glc II  H-3 to C-2 and C-4 and also from Glc II  H-4 to C-3 and C-6 confirmed the assignments made above to complete the assignment of Glc II . 
     Two of the remaining unassigned glucose moieties were assigned as substituents at C-2 and C-3 of Glc II  on the basis of HMBC correlations. The anomeric proton observed at δ H  4.92 showed a HMBC correlation to Glc II  C-2 and was assigned as the anomeric proton of Glc III . The anomeric proton observed at δ H  4.84 showed a HMBC correlation to Glc II  C-3 and was assigned as the anomeric proton of Glc IV . The reciprocal HMBC correlations between Glc II  H-2 and the anomeric carbon of Glc III  and between Glen H-3 and the anomeric carbon of Glc IV  were also observed. 
     The anomeric proton of Glc iii  (δ H  4.92) showed a COSY correlation with a proton at δ H  3.32 which was assigned as Glc III  H-2. Due to data overlap, the COSY spectrum did not allow assignment of H-3 to H-6 protons. Therefore, a series of 1D-TOCSY experiments were performed using selective irradiation of the Glc III  anomeric proton with different mixing times. In addition to confirming the assignments for Glc III  H-2, the 1D-TOCSY data showed protons at δ H  3.51 (Glc III  H-3), δ H  3.26 (Glc iii  H-4), and δ H  3.44 (Glc iii  H-5). Once H-4 was assigned using 1D-TOCSY data, COSY correlations from H-4 to H-5 and in turn to H-6 were used to assign H-6. In the COSY spectrum, Glc iii  H-4 showed a correlation to Glc III  H-5, which in turn showed COSY correlations to δ H  3.94 and 3.75 of Glc iii  H-6a and H-6b, respectively. The  13 C chemical shifts for Glc III  C-2 (δ C  76.3), C-3 (δ C  78.8), C-4 (δ C  73.3), C-5 (δ C  78.8), and C-6 (δ C  64.4) were then determined using the  1 H- 13 C HSQC-DEPT correlations to complete the assignment of Glc III . 
     The anomeric proton of Glc IV  (δ H  4.84) which showed a COSY correlation to a proton at δ H  3.41 was assigned as Glc IV  H-2 which in turn showed a COSY correlation to a proton at δ H  3.46 (Glc IV  H-3). This latter proton showed an additional correlation with a proton at δ H  3.45 (Glc IV  H-4) which also showed a COSY correlation to a proton at δ H  3.75 (Glc IV  H-5). Glc IV  H-5 also showed a COSY correlation to Glc IV  H-6 protons OH 3.55 and 3.78). Assignment of the  13 C chemical shifts for Glc IV  C-2 (δ C  76.1), C-3 (δ C  78.8), C-4 (δ C  72.5), C-5 (δ C  81.7), and C-6 (δ C  65.8) was determined using the HSQC-DEPT data. HMBC correlations from Glc IV  H-3 to C-4 and C-5 and also from Glc IV  H-4 to C-3 and C-6 confirmed the assignments made above to complete the assignment of Glc IV . 
     A summary of the  1 H and  13 C chemical shifts for the glycoside at C-13 are found in the following table: 
     
       
         
               
             
               
               
               
               
             
               
               
               
               
             
           
               
                   
               
               
                   1 H NMR (500 MHz, D 2 O) and  13 C NMR (125 MHz, 
               
               
                 D 2 O/TSP) Assignments of the Reb M2 glycoside. 
               
             
          
           
               
                   
                 Position 
                   13 C #   
                   1 H 
               
               
                   
               
             
          
           
               
                   
                 Glc II -1 
                 98.4 
                 4.85 d (7.8) 
               
               
                   
                 Glc II -2 
                 81.7 
                 3.75 m 
               
               
                   
                 Glc II -3 
                 88.0 
                 3.98 m 
               
               
                   
                 Glc II -4 
                 71.3 
                 3.54 m 
               
               
                   
                 Glc II -5 
                 80.5 
                 3.96 m 
               
               
                   
                 Glc II -6 
                 63.6 
                 3.45 m 
               
               
                   
                   
                   
                 3.77 m 
               
               
                   
                 Glc III -1 
                 104.9 
                 4.92 d (7.9) 
               
               
                   
                 Glc III -2 
                 76.3 
                 3.32 m 
               
               
                   
                 Glc III -3 
                 78.8 
                 3.51 m 
               
               
                   
                 Glc III -4 
                 73.3 
                 3.26 t (9.5) 
               
               
                   
                 Glc III -5 
                 78.8 
                 3.44 m 
               
               
                   
                 Glc III -6 
                 64.4 
                 3.75 m 
               
               
                   
                   
                   
                 3.94 m 
               
               
                   
                 Glc IV -1 
                 105.0 
                 4.84 d (7.8) 
               
               
                   
                 Glc IV -2 
                 76.1 
                 3.41 m 
               
               
                   
                 Glc IV -3 
                 78.8 
                 3.46 m 
               
               
                   
                 Glc IV -4 
                 72.5 
                 3.45 m 
               
               
                   
                 Glc IV -5 
                 81.7 
                 3.75 m 
               
               
                   
                 Glc IV -6 
                 65.8 
                 3.55 m 
               
               
                   
                   
                   
                 3.78 m 
               
               
                   
               
             
          
         
       
     
     A summary of the key HMBC, COSY, and 1D-TOCSY correlations used to assign the C-13 glycoside region are provided below: 
     
       
                 
         
             
             
         
      
     
     NMR and MS analyses allowed a full assignment of its structure, shown below. The chemical name of the compound is 13-[(2-O-β-D-glucopyranosyl-3-O-β-D-glucopyranosyl-β-D-glucopyranosyl)oxy] ent-kaur-16-en-19-oic acid-[(2-O-β-D-glucopyranosyl-6-O-β-D-glucopyranosyl-β-D-glucopyranosyl) ester] (rebaudioside M2 or reb M2). The compound is an isomer of rebaudioside M. 
     
       
                 
         
             
             
         
      
     
     Example 41 
     Directed Evolution of UGT76G1 for the Conversion of Rebaudioside D to Rebaudioside M (Round 2) 
     The most active clone from the first round of directed evolution of UGT76G1 (see EXAMPLE 26 UGT76G1var94 containing mutations: Q266E_P272A_R334K_G348P_L379G) was chosen as baseline clone for round 2. A list of 53 mutations was established containing different identified positive mutations from the first round and new mutations obtained by DNA2.0 ProteinGPS™ strategy. This list of mutations was subsequently used to design 92 variant genes that contained each 3 different mutations. After codon-optimized for expression in  E. coli  the genes were synthesized, subcloned in the pET30a+ plasmid and used for transformation of  E. coli  BL21 (DE3) chemically competent cells. The obtained cells were grown in Petri-dishes on solid LB medium in the presence of Kanamycin. Suitable colonies were selected and allowed to grow in liquid LB medium in tubes. Glycerol was added to the suspension as cryoprotectant and 400 μL aliquots were stored at −20° C. and at −80° C. 
     These storage aliquots of  E. coli  BL21(DE3) containing the pET30a+_UGT76G1var plasmids were thawed and added to LBGKP medium (20 g/L Luria Broth Lennox; 50 mM PIPES buffer pH 7.00; 50 mM Phosphate buffer pH 7.00; 2.5 g/L glucose and 50 mg/L of Kanamycine). This culture was allowed to shake in a 96 microtiter plate at 30° C. for 8 h. 
     3.95 mL of production medium containing 60 g/L of Overnight Express™ Instant TB medium (Novagen®), 10 g/L of glycerol and 50 mg/L of Kanamycin was inoculated with 50 μL of above described culture. In a 48 deepwell plate the resulting culture was allowed to stir at 20° C. The cultures gave significant growth and a good OD (600 nm) was obtained. After 44 h, the cells were harvested by centrifugation and frozen. 
     Lysis was performed by addition of Bugbuster® Master mix (Novagen®) to the thawed cells and the lysate was recovered by centrifugation. Activity tests were performed with 100 μL of fresh lysate that was added to a solution of Rebaudioside D (final concentration 0.5 mM), MgCl 2  (final concentration 3 mM) and UDP-Glucose (final concentration 2.5 mM) in 50 mM phosphate buffer pH 7.2. 
     The reaction was allowed to run at 30° C. and samples were taken after 2, 4, 7 and 24 h. to determine conversion and initial rate by HPLC (CAD detection) using the analytical method that was described above for the transformation of Rebaudioside D to Rebaudioside M. In parallel the experiments were performed with baseline clone, Round1-Var94. The conversion after 22 h. and initial rate for this baseline clone was defined as 100% and the normalized conversions and initial rates for the round 2 clones are depicted in the following table: 
     
       
         
               
               
               
               
             
           
               
                   
               
               
                   
                   
                 Normalized 
                   
               
               
                   
                   
                 conversion 
                 Normalized 
               
               
                   
                   
                 Reb D to Reb 
                 initial 
               
               
                 Clone 
                 Mutations* 
                 Mafter 22 h. 
                 rate (0-4 h) 
               
               
                   
               
             
             
               
                 Round1-Var94 
                 UGT76G1 
                 100%  
                 100%  
               
               
                   
                 (Q266E_P272A_R334K_G348P_L379G) 
                   
                   
               
               
                   
                 baseline clone 
                   
                   
               
               
                 Round2-Var1 
                 Round1-Var94 (A213N_P348G_I411V) 
                 70% 
                 86% 
               
               
                 Round2-Var2 
                 Round1-Var94 (K303G_I423M_Q425E) 
                 120%  
                 134%  
               
               
                 Round2-Var3 
                 Round1-Var94 (V20L_N138K_S147G) 
                 14% 
                 15% 
               
               
                 Round2-Var4 
                 Round1-Var94 (I16V_V133A_L299I) 
                 37% 
                 43% 
               
               
                 Round2-Var5 
                 Round1-Var94 (S241V_S274G_Q432E) 
                 75% 
                 72% 
               
               
                 Round2-Var6 
                 Round1-Var94 (I16V_L139V_I218V) 
                 62% 
                 68% 
               
               
                 Round2-Var7 
                 Round1-Var94 (K334R_N409K_Q432E) 
                 104%  
                 92% 
               
               
                 Round2-Var8 
                 Round1-Var94 (I15L_R141T_I407V) 
                 17% 
                 26% 
               
               
                 Round2-Var9 
                 Round1-Var94 (R141T_K303G_G379L) 
                 31% 
                 42% 
               
               
                 Round2-Var10 
                 Round1-Var94 (I190L_K303G_P348G) 
                 131%  
                 149%  
               
               
                 Round2-Var11 
                 Round1-Var94 (E266Q_F314S_N409R) 
                 106%  
                 132%  
               
               
                 Round2-Var12 
                 Round1-Var94 (V133A_I295V_K303G) 
                 43% 
                 49% 
               
               
                 Round2-Var13 
                 Round1-Var94 (I16V_S241V_N409R) 
                 80% 
                 79% 
               
               
                 Round2-Var14 
                 Round1-Var94 (A239V_K334R_G379L) 
                 58% 
                 55% 
               
               
                 Round2-Var15 
                 Round1-Var94 (I190L_K393R_V396L) 
                 118%  
                 126%  
               
               
                 Round2-Var16 
                 Round1-Var94 (L101F_I295M_K393R) 
                 84% 
                 89% 
               
               
                 Round2-Var17 
                 Round1-Var94 (A239V_E266Q_Q425E) 
                 96% 
                 101%  
               
               
                 Round2-Var18 
                 Round1-Var94 (V20L_I190L_I423M) 
                 98% 
                 98% 
               
               
                 Round2-Var19 
                 Round1-Var94 (V20L_G379L_S456L) 
                 84% 
                 81% 
               
               
                 Round2-Var20 
                 Round1-Var94 (K334R_P348G_N409R) 
                 73% 
                 73% 
               
               
                 Round2-Var21 
                 Round1-Var94 (E231A_S241V_E449D) 
                 53% 
                 50% 
               
               
                 Round2-Var22 
                 Round1-Var94 (K188R_L299I_V394I) 
                 56% 
                 59% 
               
               
                 Round2-Var23 
                 Round1-Var94 (E231A_S274G_V394I) 
                 110%  
                 124%  
               
               
                 Round2-Var24 
                 Round1-Var94 (S42A_I295V_Q432E) 
                 71% 
                 78% 
               
               
                 Round2-Var25 
                 Round1-Var94 (A213N_A272P_K334R) 
                 95% 
                 80% 
               
               
                 Round2-Var26 
                 Round1-Var94 (L158Y_S274K_N409K) 
                 80% 
                 50% 
               
               
                 Round2-Var27 
                 Round1-Var94 (K188R_I295M_Q425E) 
                 132%  
                 116%  
               
               
                 Round2-Var28 
                 Round1-Var94 (I15L_I295M_V394I) 
                 53% 
                 36% 
               
               
                 Round2-Var29 
                 Round1-Var94 (V133A_A239V_V394I) 
                 47% 
                 30% 
               
               
                 Round2-Var30 
                 Round1-Var94 (L158Y_F314S_K316R) 
                 107%  
                 72% 
               
               
                 Round2-Var31 
                 Round1-Var94 (L158Y_A239V_A272P) 
                 54% 
                 30% 
               
               
                 Round2-Var32 
                 Round1-Var94 (F46I_D301N_V396L) 
                 109%  
                 101%  
               
               
                 Round2-Var33 
                 Round1-Var94 (L101F_I218V_Q432E) 
                 78% 
                 54% 
               
               
                 Round2-Var34 
                 Round1-Var94 (I16V_F46I_I295M) 
                 110%  
                 95% 
               
               
                 Round2-Var35 
                 Round1-Var94 (A213N_E266S_I407V) 
                 98% 
                 79% 
               
               
                 Round2-Var36 
                 Round1-Var94 (A239V_S274K_I295M) 
                 102%  
                 89% 
               
               
                 Round2-Var37 
                 Round1-Var94 (A239V_F314S_S450K) 
                 105%  
                 99% 
               
               
                 Round2-Var38 
                 Round1-Var94 (L139V_K188R_D301N) 
                 66% 
                 51% 
               
               
                 Round2-Var39 
                 Round1-Var94 (I45V_I218V_S274K) 
                 87% 
                 58% 
               
               
                 Round2-Var40 
                 Round1-Var94 (S241V_K303G_V394I) 
                 78% 
                 57% 
               
               
                 Round2-Var41 
                 Round1-Var94 (R141T_S274G_K334R) 
                 41% 
                 28% 
               
               
                 Round2-Var42 
                 Round1-Var94 (V217L_S274G_L299I) 
                 47% 
                 34% 
               
               
                 Round2-Var43 
                 Round1-Var94 (S274G_D301N_P348G) 
                 98% 
                 91% 
               
               
                 Round2-Var44 
                 Round1-Var94 (E231A_N409R_S450K) 
                 87% 
                 65% 
               
               
                 Round2-Var45 
                 Round1-Var94 (R64H_E231A_K316R) 
                 88% 
                 64% 
               
               
                 Round2-Var46 
                 Round1-Var94 (V394I_N409K_I411V) 
                 110%  
                 100%  
               
               
                 Round2-Var47 
                 Round1-Var94 (I45V_I295M_K303G) 
                 113%  
                 88% 
               
               
                 Round2-Var48 
                 Round1-Var94 (L101F_V396L_L398V) 
                 46% 
                 43% 
               
               
                 Round2-Var49 
                 Round1-Var94 (N27S_L101F_S447A) 
                 54% 
                 37% 
               
               
                 Round2-Var50 
                 Round1-Var94 (S274G_F314S_L398V) 
                 129%  
                 156%  
               
               
                 Round2-Var51 
                 Round1-Var94 (E266Q_L299I_K393R) 
                 70% 
                 51% 
               
               
                 Round2-Var52 
                 Round1-Var94 (V217L_E266S_V394I) 
                 62% 
                 48% 
               
               
                 Round2-Var53 
                 Round1-Var94 (N138K_A272P_N409R) 
                 118%  
                 102%  
               
               
                 Round2-Var54 
                 Round1-Var94 (E266S_F314S_Q432E) 
                 124%  
                 146%  
               
               
                 Round2-Var55 
                 Round1-Var94 (D301N_G379L_L398V) 
                 56% 
                 45% 
               
               
                 Round2-Var56 
                 Round1-Var94 (F46I_E266S_K334R) 
                 123%  
                 142%  
               
               
                 Round2-Var57 
                 Round1-Var94 (A272P_V394I_Q432E) 
                 133%  
                 142%  
               
               
                 Round2-Var58 
                 Round1-Var94 (V394I_I407V_S456L) 
                 118%  
                 114%  
               
               
                 Round2-Var59 
                 Round1-Var94 (I218V_E266Q_I423M) 
                 106%  
                 98% 
               
               
                 Round2-Var60 
                 Round1-Var94 (A272P_G379L_I407V) 
                 80% 
                 63% 
               
               
                 Round2-Var61 
                 Round1-Var94 (E231A_K303G_S456L) 
                 113%  
                 110%  
               
               
                 Round2-Var62 
                 Round1-Var94 (I190L_E266Q_I407V) 
                 150%  
                 167%  
               
               
                 Round2-Var63 
                 Round1-Var94 (N27S_L139V_I295V) 
                 43% 
                 25% 
               
               
                 Round2-Var64 
                 Round1-Var94 (V217L_I423M_S447A) 
                 67% 
                 51% 
               
               
                 Round2-Var65 
                 Round1-Var94 (L158Y_E266S_E449D) 
                 68% 
                 43% 
               
               
                 Round2-Var66 
                 Round1-Var94 (S42A_F46I_I407V) 
                 160%  
                 203%  
               
               
                 Round2-Var67 
                 Round1-Var94 (N138K_E231A_D301N) 
                 118%  
                 93% 
               
               
                 Round2-Var68 
                 Round1-Var94 (K188R_G379L_N409R) 
                 52% 
                 35% 
               
               
                 Round2-Var69 
                 Round1-Var94 (I15L_E231A_V396L) 
                 38% 
                 22% 
               
               
                 Round2-Var70 
                 Round1-Var94 (E231A_Q425E_Q432E) 
                 115%  
                 119%  
               
               
                 Round2-Var71 
                 Round1-Var94 (D301N_K316R_Q425E) 
                 126%  
                 121%  
               
               
                 Round2-Var72 
                 Round1-Var94 (L139V_I295M_F314S) 
                 76% 
                 91% 
               
               
                 Round2-Var73 
                 Round1-Var94 (S147G_E266S_D301N) 
                 30% 
                 18% 
               
               
                 Round2-Var74 
                 Round1-Var94 (R64H_S147G_S447A) 
                 23% 
                 12% 
               
               
                 Round2-Var75 
                 Round1-Var94 (S42A_K303G_L398V) 
                 95% 
                 110%  
               
               
                 Round2-Var76 
                 Round1-Var94 (I45V_D301N_E449D) 
                 62% 
                 60% 
               
               
                 Round2-Var77 
                 Round1-Var94 (V133A_E266S_I411V) 
                 37% 
                 28% 
               
               
                 Round2-Var78 
                 Round1-Var94 (I45V_N409R_Q425E) 
                 63% 
                 59% 
               
               
                 Round2-Var79 
                 Round1-Var94 (R141T_A272P_F314S) 
                 23% 
                 10% 
               
               
                 Round2-Var80 
                 Round1-Var94 (E266S_S274G_N409R) 
                 81% 
                 91% 
               
               
                 Round2-Var81 
                 Round1-Var94 (N409K_Q425E_S450K) 
                 81% 
                 84% 
               
               
                 Round2-Var82 
                 Round1-Var94 (N27S_R64H_K393R) 
                 47% 
                 37% 
               
               
                 Round2-Var83 
                 Round1-Var94 (S42A_A213N_V217L) 
                 62% 
                 46% 
               
               
                 Round2-Var84 
                 Round1-Var94 (N27S_S274K_I407V) 
                 49% 
                 44% 
               
               
                 Round2-Var85 
                 Round1-Var94 (I411V_Q425E_S456L) 
                 75% 
                 81% 
               
               
                 Round2-Var86 
                 Round1-Var94 (A239V_K316R_E449D) 
                 83% 
                 72% 
               
               
                 Round2-Var87 
                 Round1-Var94 (S147G_A239V_P348G) 
                 18% 
                  7% 
               
               
                 Round2-Var88 
                 Round1-Var94 (V20L_S274G_S450K) 
                 71% 
                 68% 
               
               
                 Round2-Var89 
                 Round1-Var94 (F314S_V394I_S447A) 
                 88% 
                 123%  
               
               
                 Round2-Var90 
                 Round1-Var94 (R64H_E266Q_I295M) 
                 45% 
                 47% 
               
               
                 Round2-Var91 
                 Round1-Var94 (N138K_I295V_I407V) 
                 50% 
                 51% 
               
               
                 Round2-Var92 
                 Round1-Var94 (I15L_P348G_Q432E) 
                 18% 
                 13% 
               
               
                   
               
               
                 *Mutations are noted as follows: reference gene-original amino acid-position-new amino acid: For example the mutation of an alanine at position 33 to a glycine for variant 94 from the first round of directed evolution of UGT76G1 is noted as Round1-Var94 (A33G) 
               
             
          
         
       
     
     Modeling of these results allowed to obtain a ranking of the effect of each mutation. The following mutations were determined as being beneficial for activity: S42A, F46I, I190L, S274G, I295M, K303G, F314S, K316R, K393R, V394I, I407V, N409K, N409R, Q425E, Q432E, S447A, S456L. 
     Example 42 
     In Vivo Production of AtSUS 
     
       
         
               
             
           
               
                 SEQ ID 13 
               
               
                 AtSUS 
               
               
                 &gt;gi|79328294|ref|NP_001031915.1| sucrose synthase 
               
               
                 1 [ Arabidopsis thaliana ] 
               
               
                 MANAERMITRVHSQRERLNETLVSERNEVLALLSRVEAKGKGILQQNQII 
               
               
                   
               
               
                 AEFEALPEQTRKKLEGGPFFDLLKSTQEAIVLPPWVALAVRPRPGVWEYL 
               
               
                   
               
               
                 RVNLHALVVEELQPAEFLHFKEELVDGVKNGNFTLELDFEPFNASIPRPT 
               
               
                   
               
               
                 LHKYIGNGVDFLNRHLSAKLFHDKESLLPLLKFLRLHSHQGKNLMLSEKI 
               
               
                   
               
               
                 QNLNTLQHTLRKAEEYLAELKSETLYEEFEAKFEEIGLERGWGDNAERVL 
               
               
                   
               
               
                 DMIRLLLDLLEAPDPCTLETFLGRVPMVFNVVILSPHGYFAQDNVLGYPD 
               
               
                   
               
               
                 TGGQVVYILDQVRALEIEMLQRIKQQGLNIKPRILILTRLLPDAVGTTCG 
               
               
                   
               
               
                 ERLERVYDSEYCDILRVPFRTEKGIVRKWISRFEVWPYLETYTEDAAVEL 
               
               
                   
               
               
                 SKELNGKPDLIIGNYSDGNLVASLLAHKLGVTQCTIAHALEKTKYPDSDI 
               
               
                   
               
               
                 YWKKLDDKYHFSCQFTADIFAMNHTDFIITSTFQEIAGSKETVGQYESHT 
               
               
                   
               
               
                 AFTLPGLYRVVHGIDVFDPKFNIVSPGADMSIYFPYTEEKRRLTKFHSEI 
               
               
                   
               
               
                 EELLYSDVENKEHLCVLKDKKKPILFTMARLDRVKNLSGLVEWYGKNTRL 
               
               
                   
               
               
                 RELANLVVVGGDRRKESKDNEEKAEMKKMYDLIEEYKLNGQFRWISSQMD 
               
               
                   
               
               
                 RVRNGELYRYICDTKGAFVQPALYEAFGLTVVEAMTCGLPTFATCKGGPA 
               
               
                   
               
               
                 EIIVHGKSGFHIDPYHGDQAADTLADFFTKCKEDPSHWDEISKGGLQRIE 
               
               
                   
               
               
                 EKYTWQIYSQRLLTLTGVYGFWKHVSNLDRLEARRYLEMFYALKYRPLAQ 
               
               
                   
               
               
                 AVPLAQDD 
               
             
          
         
       
     
     The synthetic gene of AtSuS that was codon optimized for expression in  E. coli  and subcloned in the pET30a+ plasmid using the NdeI and XhoI restriction sites. The pET30A+ vector containing the AtSUS gene was used to transform electrocompetent  E. coli  B121(DE3) cells. The obtained cells were grown in petri-dishes in the presence of Kanamycin and suitable colonies were selected and allowed to grow in liquid LB medium (erlenmeyer flasks). Glycerol was added to the suspension as cryoprotectant and 400 μL aliquots were stored at −20° C. and at −80° C. 
     The storage aliquots of  E. coli  BL21(DE3) containing the pET30A+_AtSUS plasmids were thawed and added to 30 mL of LBGKP medium (20 g/L Luria Broth Lennox; 50 mM PIPES buffer pH 7.00; 50 mM Phosphate buffer pH 7.00; 2.5 g/L glucose and 50 mg/L of Kanamycine). This culture was allowed to shake at 135 rpm at 30° C. for 8 h. 
     The production medium contained 60 g/L of overnight express instant TB medium (Novagen), 10 g/L of glycerol and 50 mg/L of Kanamycine. The preculture was added to 800 mL of this medium and the solution was allowed to stir at 20° C. while taking samples to measure the OD and pH. The culture gave significant growth and a good OD was obtained. After 40 h, the cells were harvested by centrifugation and frozen to obtain 30.1 g of cell wet weight. 
     Lysis was performed by Fastprep (MP Biomedicals, Lysing matrix B, speed 6.0, 3×40 sec) with a cell suspension of 200 mg of cells in 1.0 mL of 50 mM Tris buffer pH 7.5. The lysate was recovered by centrifugation and used fresh. 
     Example 43 
     Conversion of Rebaudioside A to Rebaudioside M with In Situ Prepared UDP-Glucose Using UGTSL2, UGT76G1-R1-F12 and AtSUS 
     The reaction was performed at 1 mL scale using 100 mM of sucrose, 3 mM of MgCl 2 , 0.25 mM of UDP and 0.5 mM of Rebaudioside A in potassium phosphate buffer (50 mM final concentration, pH 7.5). The reaction was started by adding 15 μL of UGTSL2 (see EXAMPLE 27) lysate (2 U/mL), 150 μL of UGT76G1var94 (see EXAMPLE 26) (2.5 U/mL) and 15 μL of AtSUS (see EXAMPLE 42) (400 U/mL). The reaction was followed by HPLC after quenching 125 μL samples with 10 μL of 2 N H 2 SO 4  and 115 μL of 60% methanol. 68% of Rebaudioside M and 26% of Rebaudioside M2 was obtained after 21 h of reaction time. The results are presented in  FIG. 69 . 
     Although various embodiments of the present invention have been disclosed in the foregoing description for purposes of illustration, it should be understood that a variety of changes, modifications and substitutions may be incorporated without departing from either the spirit of scope of the present invention.